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Abstract 
The peptidoglycan (PG) layer is responsible for maintaining cell shape and permitting cell 
division in almost all bacteria. Made of glycan chains connected by short peptides, PG forms a 
net-like structure surrounding the cytoplasmic membrane. Membrane-anchored PG synthases, 
called penicillin-binding proteins (PBPs), synthesize PG during cell growth and division by 
utilising the precursor lipid II but the molecular mechanism of these processes in Bacillus 
subtilis are largely unknown. The genetic and phenotypic analysis of B. subtilis has shown that 
PG synthesis and cell division are modulated by components of the central carbon metabolism 
(Weart et al., 2007). In particular, UgtP, which synthesises the glucolipid precursor for the 
lipoteichoic acid, has been suggested to function as a metabolic sensor governing cell size. 
However, the mechanism by which UgtP impacts cell wall synthesis remained unknown. 
Here we have constructed different B. subtilis strains with deletions in cell wall synthesis and/or 
carbon metabolism genes. Cells lacking the LTA precursor glucolipid grew with similar rate as 
wild type cells but were shorter and wider. The overexpression of ugtP caused filamentation, 
supporting the hypothesis that UgtP inhibits FtsZ polymerization (Weart et al., 2007). The ugtP 
mutant had increased level of several PG precursors and mild alterations in PG composition 
suggesting an increased DL-endopeptidase activity. Combining ugtP deletion/depletion with 
deletions with several cell wall genes resulted in morphological effects. The deletion of the 
PBP1 gene and simultaneous depletion of ugtP resulted in thin and bent cells. The double 
deletion of ugtP and lytE, a hydrolase important for cell elongation, produced shorter bent cells 
with severe shape defects. These results suggest that the function of UgtP contributes to 
balanced cell wall synthesis and hydrolysis.  
We also characterised several crucial cell wall enzymes. The depletion of the essential PBP2B 
caused cell division defects followed by lysis. Interestingly, cells expressing a catalytically 
inactive PBP2B were viable, but they required functional PBP3, a homologue of PBP2B that is 
dispensable in wild-type cells. PBP3 showed enhanced septal localisation in a strain with 
inactive PBP2B, but this strain produced aberrant septa. Biochemical assays were used to 
characterize for the first time the activities and interactions of PBP1, PBP2B, and PBP3. Novel 
interactions between these PBPs and with the lytic transglycosylase homologue YrrL were 
detected.  
In summary, this work contributes to our understanding of the PG synthesis during cell division.  
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2 
1.1 Bacillus subtilis growth and morphology 
Hans Christian Gram differentiated bacteria into Gram-positive and Gram-negative species 
using the Gram stain (Gram, 1884). In Gram-negative species, like proteobacteria, the 
cytoplasmic membrane is surrounded by a thin peptidoglycan (PG) of 3 – 6 nm thickness and 
an outer membrane. In Gram-positive species, such as firmicutes, the cell wall consists of a 
thick 10 – 60 nm PG with anionic polymers such as wall teichoic acid (WTA) and lipoteichoic 
acid (LTA) (Section 1.4). During the cell cycle, rod-shaped cells grow and elongate until they 
double in length and then divide forming two identical daughter cells. In parallel, the genomic 
DNA is duplicated and the sister chromosomes are segregated before the cell division 
machinery starts assembling.  
Bacillus subtilis is a rod-shaped Gram-positive bacterium with the ability to form endospores 
allowing the microorganism to tolerate extreme environmental conditions (Errington, 2003).  It 
is a non-pathogenic organism and is widely used as a model to study the growth and 
morphology of Gram-positive bacteria. B. subtilis cells sporulate by dividing asymmetrically, 
near one pole, resulting in a smaller cell called the forespore and a larger mother cell (Higgins 
and Dworkin, 2012). The cell shape of the bacterium is maintained by the cell wall surrounding 
the cytoplasmic membrane and is composed of major and minor components. The major 
components are the PG, the WTA and the LTA. The PG is essential to protect the cell from 
bursting due to the turgor while all three polymers are crucial for cell shape. The minor 
component is the minor teichoic acid and the absence of the latter has no effect on cell 
morphology or growth under laboratory conditions (Estrela et al.,1991). Maintaining structural 
integrity of the PG is crucial for cell survival during growth, thus understanding the process of 
PG synthesis during cell elongation and division is a fundamental but largely unanswered 
question in microbiology. 
The PG in B. subtilis is a three dimensional mesh-like molecule referred to as the sacculus that 
is continuously synthesised, modified and hydrolysed to maintain the integrity of the cell and 
allow growth (Hayhurst et al., 2008). The importance of the PG is exemplified by the variety 
of antibiotics, such as β-lactams and glycopeptides, which target its synthesis to kill the cell. In 
γ-proteobacteria, the PG is mostly single layered hence the tight coordination between the 
synthesis and hydrolysis of the PG. In Gram-positive bacteria the PG is multilayered, the 
mechanisms of PG synthesis is mostly unknown with limited information about the structure 
of the PG or the protein complexes involved in it synthesis.  
3 
On a different note, recent work in Petra Levin’s lab showed that the size of the cell is 
coordinated by the presence of nutrients in the cytoplasm (Weart et al., 2007). The UDP-
glucose diacylglycerol glucosyltransferase, UgtP, was suggested to be a metabolic sensor that 
controls the timing of cell division by inhibiting Z-ring formation. However, the absence of 
UgtP causes wider cells providing questions whether UgtP has a more direct effect on cell wall 
synthesis.  
 
1.2 Peptidoglycan synthesis 
1.2.1 lipid II synthesis 
PG precursor synthesis starts in the cytoplasm with the synthesis of the nucleotide precursors 
UDP-N-acetylglucosamine (GlcNAc) and UDP-N-acetylmuramic acid (MurNAc) (Figure 1.1). 
Successive addition of L-Ala, D-Glu, diaminopimelic acid (DAP) and the dipeptide D-Ala-D-
Ala to UDP-MurNAc is catalysed by four ligases MurC, MurD MurE and MurF, respectively 
(Barreteau et al., 2008). Afterwards, the MurNAc-pentapeptide is transferred onto the 
membrane bound undecaprenyl phosphate molecule by MraY to form lipid I (Bouhss et al., 
2008).  GlcNAc is added to lipid I by MurG forming lipid II, which is mostly amidated on the 
ɛ-carboxyl group of meso-A2pm, followed by flipping across the cytoplasmic membrane by 
three transmembrane proteins RodA, FtsW and SpoVE (Miyao et al., 1992). RodA is required 
for rod-shape during elongation by transporting cell wall precursors at the side wall, while FtsW 
presumably mediates lipid II flipping at the divisome (Henriques et al.,1998; Mohammadi et 
al., 2011). RodA has been described recently to have a GTase activity (See section 1.3.4) 
(Meeske et al.,2016). SpoVE is 39.8% similar to FtsW, localises at the membrane surface of 
the emerging spore and is required for the synthesis of the spore PG (Ikeda et al., 1989). It was 
recently published that the lipid II flippase in E. coli is MurJ (Ruiz, 2008; Sham et al., 2014). 
A BLASTp-based analysis identified four MurJ homologs in B. subtilis called YtgP, SpoVB, 
YkvU and YabM (Fay and Dworkin, 2009). While MurJ was found to be essential for E. coli 
growth, the absence of the four homologs simultaneously in B. subtilis did not affect either the 
growth or the morphology of cells (Fay and Dworkin, 2009).  
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1.2.2 Growth of the sacculus  
The synthesis of peptidoglycan occurs extracellularly, by polymerizing the flipped lipid II into 
nascent glycan chains by a glycosyltransferase (GTase) reaction performed by monofunctional 
or bifunctional PG synthases (See section 1.3.1) (Barrett et al.,2007; Lovering et al.,2012). 
Recently, Meeske et al., (2016) suggested that RodA from Bacillus subtilis is a PG polymerase 
(Section 1.3.4). The GTase reaction involves the formation of a β-1,4-glycosidic bond resulting 
in the release of the undecaprenyl pyrophosphate moiety (Van Heijenoort, 2001). In B. subtilis, 
as in Gram-negative bacteria, the glycan polymer terminates with a 1,6-anhydroMurNAc 
residue formed by an intramolecular ring from C1 to C6 (Burmant and Park, 1983; Vollmer et 
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Figure 1.1 Peptidoglycan biosynthesis and components of the cell wall 
Products of the mur operon, MraY and MurG catalyse the synthesis of the PG precursor lipid II from 
sugar nucleotide UDP-GlcNAc in the cytoplasm. Lipid II is then flipped across the membrane and 
delivered to penicillin-binding proteins (PBPs). Lipid II is polymerised into glycan chains by GTase 
reaction and peptides are crosslinked by TPase reaction. Hydrolases modify the PG by cleaving various 
types of bonds. WTA is covalently bound to the MurNAc sugar. LTA is bound to the cell membrane via 
a diacylglycerol anchor. Both the WTA and LTA have the same glycerol-phosphate repeating unit. 
CPase, carboxypeptidase; Endo-LT, endo-lytic transglycosylase; EPase, endopeptidase; TPase, 
transpeptidase; GTase, glycosyltransferase.  
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al., 2008). The peptide crosslink is achieved by the formation of an isopeptide bond between 
the fourth amino acid (D-Ala) of one stem with the third (meso-A2pm-NH2) of the other via a 
transpeptidase (TPase) reaction (Popham and Young, 2003). The TPase reaction is carried out 
by bi-functional (class A PBPs) or mono-functional penicillin-binding proteins (class B PBPs) 
to produce the net-like PG structure.  
 
1.2.3 Structure of the sacculus  
Understanding the architecture of the peptidoglycan is important to determine the mechanisms 
underlying sacculus growth during elongation and division. A few proposed models describe 
the possible structure for B. subtilis PG. First, the “scaffold” model in which the glycan strands 
run perpendicularly to the cytoplasmic membrane and the peptide in crosslinks run parallel to 
the cell long axis (Dmitriev et al., 1999, 2005). Second, the “layered” topology where the glycan 
strands and the peptide crosslinks run horizontal to the membrane (Vollmer and Seligman, 
2010). The development of the microscopic techniques in the last decade allowed a better 
visualization of the cell wall which helped in further characterising the architecture of the PG. 
The use of the cryo-transmission electron microscopy showed that the B. subtilis cell wall is 45 
to 55 nm thick with two regions with distinct densities (Matias and Beveridge, 2005). The inner-
wall zone (IWZ) was compared to the periplasmic space in Gram-negative bacteria and 
consisted of a low density zone with 22 nm thickness surrounding the plasma membrane. The 
outer-wall zone (OWZ) was suggested to contain the actual cell wall and had a thickness of up 
to 33 nm. The use of atomic force microscopy (AFM) supported a helical structure model where 
a number of glycan chains are polymerized and cross-linked to form a peptidoglycan “rope” 
(Hayhurst et al., 2008). Subsequently, this rope acquires a helical structure with a 50 nm width, 
which is then crosslinked with two existing ropes and all are roughly oriented perpendicularly 
to the long axis of the cell. However, work done in Jensen’s lab using electron cryotomography 
contradicted the helical model and proposed a uniformly dense cell wall model with a 
circumferentially oriented glycan strands (Beeby et al., 2013). The IWZ observed previously 
was also contradicted by Beeby et al. and was suggested to be an artefact caused by the use of 
cryoprotectants. Beeby and colleagues also showed that the denaturation of PG using urea 
altered the secondary structure of linking peptides resulting in an increase in the length, but not 
the width, of the sacculus. This result is consistent with a circumferential model where the 
glycan strands are oriented perpendicularly to the long axis of the cell (Beeby et al., 2013). 
Thus, despite significant progress made recently with the characterization of PG structure, many 
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components of the cell wall, such as the teichoic acids, haven’t been considered or described in 
these models. 
 
1.2.4 Role of the bacterial cytoskeleton  
B. subtilis has three actin homologues, MreB, Mbl and MreBH, controlling its rod-shape 
(Section 1.3.4) (Jones et al., 2001). The three homologues colocalised in a helical structure 
below the cytoplasmic membrane and along the cell length. MreB had a dynamic structure and 
formed small filamentous patches with a circumferential motion (Dominguez-Escobar et al., 
2011; Garner et al., 2011). The growth and hydrolysis of the PG during cell elongation occurred 
in a helical-like configuration along the actin-like filaments, hence the hypothesis of 
interdependency between peptidoglycan synthesis and the actin homologues´ dynamic motion 
(Carballido-Lopez et al., 2006; Daniel and Errington, 2003). These actin isoforms are engaged 
in different roles in B. subtilis and their absence leads to cell shape defects. Mbl is thought to 
direct the insertion of new PG material at the lateral cell wall (Daniel and Errington, 2003). 
MreBH is thought to control the autolytic activity at the lateral wall as it directed the localisation 
of the cell wall hydrolase LytE (Carballido-Lopez et al., 2006). MreB maintains cell width and 
was also proposed to direct the assembly of the cell wall components (Kawai et al., 2009). 
Recently, Kawai et al., suggested that MreB coordinates not only PG insertion into the cell wall 
by controlling the localisation of PBP1 but also the binding of anionic polymer WTA to PG via 
TagTUV (Daniel and Errington, 2003; Kawai et al., 2009, 2011).  
FtsZ is another cytoskeletal element, required for cell division. It is a tubulin-like protein that 
polymerizes at midcell forming a dynamic ring called the Z ring (Bi and Lutkenhaus, 1991). 
During cell division the Z ring, which is used as a scaffold to recruit essential cell division 
proteins, is stabilized and tethered in the cytoplasmic membrane by EzrA, FtsA and SepF 
(Errington et al.,2003). In liposomes, FtsZ proteins polymerized causing membrane bending 
followed by constricted protrusions, indicating that FtsZ could probably generate force during 
cell division to separate daughter cells (Osawa and Erickson, 2013). Following Z-ring 
formation, PBP2B is the first protein to be recruited to midcell followed by PG synthases and 
hydrolases (Errington et al., 2003; Scheffers et al., 2004; Smith et al., 1996; Daniel et al., 2000). 
This divisome complex enables peptidoglycan synthesis, septum formation and cell separation 
for a complete cell division. Recently, a glucosyltransferase UgtP protein, involved in LTA 
synthesis, was shown to localise at midcell in nutrient-rich medium and to inhibit FtsZ 
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polymerization (Section 1.3.4). This metabolic sensor is suggested to coordinate growth rate 
with cell size (Weart et al., 2007). 
 
1.3 Peptidoglycan synthesis machinery  
1.3.1 Class A and B penicillin-binding protein 
PG is synthesised by high molecular weight (HMW) proteins called PBPs. All PBPs have a 
cytoplasmic region near their N-terminus, a short transmembrane region, and an 
extracytoplasmic part. PBPs are supposed to be involved in cell elongation and/or division due 
to their localisation and enzymatic activities and can be divided into 2 classes, class A bi-
functional proteins and class B mono-functional PBPs (Table 1.1) (Bhavsar and Brown, 2006). 
B. subtilis Class A PBPs include PBP1, PBP2C, PBP4 and PBP2D and are capable of 
performing both GTase and TPase reactions. The absence of PBP2C, PBP4, or PBP2D had no 
effect on growth or cell morphology, whereas cells lacking PBP1 grew slower than wild type 
and they were thinner, bent and chaining (Murray et al., 1998a). PBP1, PBP2C, PBP4 and 
PBP2D are thought to be involved in cell division due to their midcell localisation (Scheffers 
et al., 2004). PBP2C and PBP4 have a role in the spore PG synthesis (Driks and Popham, 2001). 
PBP1 was suggested to have an additional role in cell elongation due to its additional 
localisation at the cell periphery (Pedersen et al., 1999; Scheffers et al., 2004). In vitro, PBP1 
polymerized the cell wall precursor lipid II into glycan chains and crosslinked amidated or non 
amidated peptides (Lebar et al., 2014). Moreover, PBP1 exhibited a carboxypeptidase activity 
by removing the terminal D-Ala residue of the pentapeptide chain (Lebar et al., 2014).  PBP1 
was recruited to the MreB helix at the lateral cell wall but thought to localise at the septum 
during the late stages of cell division (Claessen et al., 2008; Kawai et al., 2009). In addition, 
PBP1 was partially targeted to the division site and this localisation pattern was affected by 
several proteins such as GpsB, DivIB, DivIC and YvcK (Claessen et al., 2008; Foulquier et al., 
2011; Pedersen et al., 1999; Scheffers and Errington, 2004). The shuttling in PBP1 localisation 
between midcell and lateral wall is thought to be controlled by EzrA and GpsB via a direct 
interaction with the cytosolic N-terminus of PBP1 (Claessen et al., 2008; Cleverley et al., 
2016). However, this interaction had no effect on the GTase or TPase activity of PBP1 in vitro 
(Cleverley et al., 2016). McPherson and Popham were able to create a strain with deletions of 
the four Class A HMW PBP genes simultaneously (McPherson and Popham, 2003). 
Theoretically, this strain cannot polymerize new glycan strands due to the lack of GTase 
activity, however, they detected an unknown GTase activity in this quadruple mutant explaining 
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cell survival and growth (McPherson and Popham, 2003). Recently, Meeske et al,. suggested 
that RodA is not a lipid II flippase but has GTase activity and is responsible for PG synthesis 
in the quadruple mutant (Meeske et al., 2016).   
Class B PBPs includes PBP2A, PBP2B, PBP3, PBPH and YrrR, which have a non-catalytic 
domain and a transpeptidase domain (Table 1.1) (Bhavsar and Brown, 2006). The two mono-
functional TPases, PBP2A and PBPH, are essentially redundant for lateral cell wall synthesis 
during cell elongation (Dominguez-Escobar et al., 2011; Murray et al., 1998b; Wei et al., 2003). 
PBP2B is the only essential PBP in B. subtilis and it localised at midcell during exponential 
growth (Daniel et al., 1996; Scheffers et al., 2004). Midcell localisation of PBP2B is dependent 
on FtsZ, DivIB, DivIC and FtsL and it was suggested that PBP2B is required for initiation of 
septal PG synthesis and continued septal ingrowth (Daniel et al., 2000). Little is known about 
the function of PBP3. The deletion of pbpC (PBP3 gene) had no effect on the growth rate, cell 
morphology or sporulation compared to wild type (Murray et al., 1996). In addition, the absence 
of PBP3 in the ponA, pbpD or pbpF single mutants had no additional effect on cell morphology, 
growth or sporulation efficiency (Murray et al., 1996). PBP3 has an enriched localisation at the 
septum but foci distributed along the cell periphery were also identified in vegetative cells 
(Scheffers et al., 2004).  
 
Table 1.1 List of B. subtilis high molecular weight PBPs  
Gene Protein Role / Remarks  
Class A PBPs (Bifunctional GTase/TPase) 
ponA PBP1 Cell division, elongation and sporulation 
pbpF  PBP2C Cell division and later stages of sporulation 
pbpD PBP4 Cell division, elongation and sporulation 
pbpG PBP2D Sporulation 
Class B PBPs (Monofunctional TPase) 
pbpA PBP2A Cell elongation 
pbpB† PBP2B Cell division and sporulation 
pbpC PBP3 Cell division 
spoVD SpoVD Sporulation  
phpH PBPH Cell elongation 
yrrR YrrR Not known 
†, gene essential for cell division 
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1.3.2 Peptidoglycan hydrolases  
Hydrolases are essential for the insertion of new PG material into the sacculus without 
thickening the cell wall. They contribute to PG growth, cell division, and septum cleavage 
allowing the formation of two daughter cells (Blackman et al., 1998). B. subtilis has as many 
as 35 PG hydrolases with redundant functions, which makes it difficult to understand the 
physiological role of each enzyme (Smith et al., 1996, 2000; Vollmer, 2012).  
Amidases hydrolyse the amide bond between the N-acetylmuramoyl residue and the L-Ala 
residue of PG (Hill, 1984). Several amidases such as LytC, CwlC, and CwlD cleave the septum 
during cell division allowing the separation of daughter cells (Blackman et al.,1998; Smith and 
Foster, 1995). LytA, lytB and lytC are all encoded in the same operon and LytA or LytB were 
suggested to be chaperons for LytC but their functions are still unclear (Lazarevic et al., 1992). 
LytC localises at midcell as well as the cell periphery and in its absence a chaining cell 
morphology is exhibited (Margot and Karamata, 1992).   
Endopeptidases cleave within peptides and are divided into 3 types, DD-peptidases, LD-
peptidases and DL-peptidases (Smith et al., 2000). LytF, a DL-endopeptidase, hydrolyses the 
linkage between the D-γ-Glu residue and the meso-diaminopimelic acid (Ohnishi et al., 1999). 
Based on the sequence analysis of the lytF gene, the protein was suggested to have 5 LysM 
domains that are involved in PG binding (Yamamoto et al., 2003). The absence of LytF caused 
cell chaining and localisation studies suggested that LytF has a role in cell separation due to its 
septal localisation (Ohnishi et al., 1999; Yamamoto et al., 2003).  The localisation pattern and 
the expression of LytF was altered in cells lacking the LTA synthase LtaS (Kiriyama et al., 
2014). In the ΔugtP mutant, the expression and the localisation of LytF was similar to wild 
type. However, in cells lacking the enzymes involved in the glucolipid synthesis pathway PgcA 
or GtaB, the expression level of LytF was lower compared to wild type cells for unknown 
reasons (Kiriyama et al., 2014). 
Another DL-endopeptidase, CwlO, localises at the cell periphery and is suggested to have a 
role in cell elongation (Yamamoto et al., 2003). The absence of CwlO caused shorter and wider 
cells than wild type when grown in LB medium (Dominguez-Cuevas et al., 2013). The ATP-
binding cassette (ABC) transporter-like complex, FtsEX, regulates the activity of CwlO in the 
cell. CwlO interacts with FtsX in vivo and the absence of FtsX resulted in the release of CwlO 
in the culture supernatant (Figure 1.2) (Dominguez-Cuevas et al., 2013). However, no 
interaction between the two proteins was detected in vitro (Meisner et al., 2013). 
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Interestingly, the double deletion of two DL-endopeptidases, CwlO and LytE, is lethal in B. 
subtilis (Bisicchia et al., 2007). LytE, like CwlO and LytF, has a DL-endopeptidase activity 
(Yamamoto et al., 2003). LytE localised at midcell and in foci at the cell periphery during 
vegetative growth (Carballido-Lopez et al., 2006; Yamamoto et al., 2003). The absence of LytE 
caused bent cells and mild chaining suggesting a role in both cell division and elongation 
(Ohnishi et al., 1999). In the mreBH-null mutant, the localisation of LytE at the cell periphery 
was diminished (Carballido-Lopez et al., 2006). Additionally, a genomic screen for MreBH 
interaction partners identified LytE, hence the hypothesis of a transient interaction between the 
two proteins that positions LytE at the cell periphery prior to transport to the cell wall 
(Carballido-Lopez et al., 2006).  
The lethality of the lytE cwlO double deletion is caused by the lack of DL-endopeptidase 
activity at the cell periphery (Bisicchia et al., 2007; Hashimoto et al., 2012). This redundant 
essentiality of LytE and CwlO was used to identify regulators for both proteins. The lethality 
of  the mbl lytE double mutant suggested a role for Mbl in controlling the function of CwlO via 
the FtsEX complex (Dominguez-Cuevas et al., 2013). A similar lethality was observed for the 
cwlO mreBH or ftsEX mreBH double mutants hence the potential role of MreBH in the LytE 
system (Figure 1.2) (Dominguez-Cuevas et al., 2013).  
A σI –dependent increase in lytE expression was identified in the ltaS and ugtP mutants 
(Kasahara et al., 2016). Likewise, the σI –dependent transcription of mreBH increased in the 
ltaS mutant cells (Matsuoka et al., 2011a). Interestingly, LytE exhibited a midcell and lateral 
wall localisation in the ltaS mreBH mutant suggesting that the localisation of LytE in the ltaS 
mutant is independent of MreBH. Moreover, a cwlO ltaS mreBH triple mutant is viable and had 
a similar growth to the cwlO ltaS mutant suggesting that LytE is functional for lateral PG 
hydrolysis in the ltaS mutants and dispensable of MreBH (Kasahara et al., 2016).  
Endopeptidases and carboxypeptidases hydrolyse different amide bonds in the PG. 
Carboxypeptidases such as PBP5 and PBP4a remove the terminal D-Ala residue of the 
pentapeptide chain (Buchanan and Ling, 1992; Pedersen et al.,1998). Several hydrolases 
involved in different roles in bacteria like endospore formation and protein secretion were not 
mentioned above due to their irrelevance to this work at the moment (Lee and Huang, 2013).  
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1.3.3 Lytic transglycosylase 
Other hydrolases, such as CwlJ and SleB, are lytic transglycosylases (LT). These enzymes 
cleave the β1,4-glycosidic bond between GlcNAc and MurNAc and catalyse the formation of 
the 1,6-anhydro bond between C1 and C6 of N-acetylmuramic acid (Höltje et al., 1975). Pulse-
chase studies indicated that the formation of the anhydroMurNAc sugar occurs shortly after 
lipid II polymerization (Burman and Park, 1983; Glauner and Höltje, 1990). Recently, a 
synthetic lethal screen in E. coli cells lacking the PG synthase PBP1B identified the LT MltG 
(Yunck et al., 2016). The overexpression of MtlG in the ΔponB mutant lacking PBP1B resulted 
in spherical cells followed by lysis. MltG had sequence similarities in the catalytic cleft with 
SleB, an LT in B. subtilis. MltG exhibited activity against PG causing the release of sugar 
polymers capped by anhydroMurNAc ends. MltG has a single α-helix that spans the cell 
membrane. The ΔmltG mutant had longer glycan strands and a 1.8 fold increase in the relative 
percentage of pentapeptides compared to wild type. Bacterial two-hybrid experiments indicated 
that MltG interacts with PBP1B but not PBP1A. Taken together, these results suggest that MltG 
has a weak endo-LT activity and presumably plays a role as a terminase during PG synthesis 
(Yunck et al., 2016). A homologue for MltG was identified in Streptococcus pneumoniae 
(SpMltG) (47% sequence similarity) (Tsui et al., 2016). The absence of SpMltG caused growth 
MblMreBMreBH
FtsX
FtsE
CwlO
LytEPG
MreB MreBH
LytE
Mbl
FtsEX
CwlO
CwlO
system
LytE
system
Figure 1.2 The control of hydrolases during cell elongation 
(A) The actin cytoskeleton isoforms regulate the PG hydrolases CwlO and LytE required for cell 
elongation. MreBH ensures the localisation of LytE to the lateral wall via a transient interaction before 
LytE gets secreted into the extracellular domain. Mbl regulates the activity of CwlO via FtsEX by 
controlling the localisation of these proteins.   
(B) The two proposed distinct pathways for the lateral PG hydrolysis during cell elongation 
(Dominguez-Cuevas et al., 2013).     
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defect and a spherical cell shape, suggesting a defect in peripheral PG synthesis. The growth of 
the mltG mutant was dependent on the increase in the WalRK regulon expression of PG 
hydrolases. Interestingly, the deletion of mltG rescued the lethality caused by the absence of 
essential proteins such as PBP2b, MreCD, RodZ or RodA. Moreover, the localisation pattern 
of SpMltG relative to FtsZ was similar to that of PBP1a, PBP2b and MreC suggesting a role in 
cell elongation (Tsui et al., 2016). B. subtilis has an MltG homologue called YrrL with an 
YceG-like superfamily domain. YrrL shows 32% amino acid sequence identity and 50% 
similarity with E. coli MltG extending over 356 amino acid residues. There is no information 
about the function or activity of YrrL in the published literature. 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.4 Elongasome 
The actin-like MreB, Mbl or MreBH are required for lateral cell wall synthesis during cell 
growth. The synthesis and hydrolysis of the cell wall are presumably controlled by the MreB 
homologues through various protein-protein interactions which form the elongasome. MreB, 
Mbl, MreBH, MreC, MreD, RodZ, RodA, PBP2A, PBPH, PBP1, FtsEX, CwlO, LytE and 
TagGHO are all suggested to have roles in cell elongation (Figure 1.4) (Carballido-López and 
Formstone, 2007). The MreB isoforms, MreB, Mbl and MreBH, are soluble cytoplasmic 
A B
Variable Conserved
Lytic 
transglycosylase
Figure 1.3 Lytic Transglycosylase 
(A) The scheme adapted from Höltje et al. 1975 shows the conversion of the muramic acid moiety upon 
transglycosylase action. 
(B) A space-filling model of the E. coli MltG structure with a highlight of the amino acid conservation. 
The ribbon diagram represents the structural alignment of the catalytic domain of the lytic 
transglycosylase SleB with the proposed catalytic region of MltG. The catalytic glutamate is shown in 
stick form and highlighted with an asterisk (Yunck et al., 2016). 
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proteins required for cells to maintain their rod shape (Jones et al., 2001; Varley and Stewart, 
1992). MreB and mbl are essential for cell viability in the absence of magnesium ion 
supplements unlike mreBH which could be deleted resulting in helical shaped cells 
(Abhayawardhane and Stewart, 1995; Formstone and Errington, 2005; Jones et al., 2001; 
Varley and Stewart, 1992). The depletion of MreB caused wider, rod-shaped cells while the 
depletion of Mbl caused the formation of small, bloated cells (Abhayawardhane and Stewart, 
1995; Jones et al., 2001). The differences in cell shape of the mutants suggest different functions 
for the MreB isoforms in the cell. The localisation of MreB, Mlb and MreBH showed extensive 
overlap between the three proteins that moved at similar speed and angle along the cell 
periphery, hence the suggestion that the MreB isoforms coexist in motile patches (Dominguez-
Escobar et al., 2011). A mutation in the MreB ATP binding site resulted in perturbed cell 
morphology but had no effect on the MreB motion, suggesting that the hydrolysis of ATP by 
MreB is essential for cell elongation (Garner et al., 2011).  
MreC and MreD are essential membrane bound proteins that play a role in cell elongation. The 
loss of MreC or MreD resulted in a round cell morphology (Defeu Soufo and Graumann, 2005). 
Fluorescence microscopy with high precision particle tracking showed colocalisation of MreC 
and MreD with the MreB homologues in the cell (Garner et al., 2011). The localisation of MreC 
or MreD depended on the localisation of MreB and Mbl along the lateral wall and vice versa 
(Defeu Soufo and Graumann, 2005; Leaver and Errington, 2005). Thus, this interdependency 
between the MreB homologues, MreC and MreD suggests that these proteins coexist in the 
elongasome complex. Bacterial two-hybrid assays showed interaction between MreC and class 
A or B PBP2A, PBPH and PBP1 that are potentially playing a role in the PG synthesis at the 
lateral cell wall (Ent et al., 2006). Consequently, MreC and MreD seem to link the scaffold 
proteins, the MreB homologues, to cell wall synthesis by interacting with and regulating both 
components during cell elongation.   
RodZ is an essential membrane bound protein localising along the cell periphery in a spiral 
pattern similar to that of MreB (Garner et al., 2011). The depletion of RodZ resulted in shorter 
and rounder cells and mislocalisation of FtsZ resulting in the formation of mini cells (Muchová 
et al., 2013). The stability and localisation of RodZ are dependent on MreB and not Mbl or 
MreBH. RodZ interacted with MreD in bacterial two-hybrid assay and interacted with MreB, 
Mbl and MreBH in pull-down experiments (Muchová et al., 2013). These results suggest that 
RodZ is a key player in PG synthesis during cell elongation, however, the role of RodZ in the 
cell remains unclear.  
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RodA, a member of the SEDS family (shape, elongation, division, spore), is an integral 
membrane protein required for cell elongation in B. subtilis (Henriques et al., 1998). The 
depletion of RodA resulted in the loss of the side wall PG synthesis. Moreover, TEM imaging 
for cells lacking RodA showed a spherical morphology with no or impaired septation 
suggesting a role for RodA in cell division and cell elongation (Henriques et al., 1998). RodA 
is presumably the lipid II flippase of the elongasome, responsible for the delivery of PG 
precursors to the synthases. Recently, RodA was suggested to be the missing 
glycosyltransferase in B. subtilis (Meeske et al., 2016). The morphology and growth of cells 
lacking all class A PBPs (Δ4) were rescued by overexpressing RodA. The overexpression of 
RodA variants W105A or D280A did not rescue the Δ4 strain suggesting either of these amino 
acids to be the GTase active site. Partially purified RodA showed poor PG polymerization 
activity unlike RodA W105A or D280A that showed none. However, the purity of RodA 
purification was low which makes it unclear whether the detected activity is from RodA or a 
contaminant (Meeske et al., 2016).   
The synthesis of PG is performed by class A and B PBPs. PBP2A and PBPH are redundantly 
essential PBPs with TPase activities. The absence of both proteins caused round cell 
morphology (Wei et al., 2003). PBP2A and PBPH colocalise with the elongation machinery 
(MreB, Mbl, MreBH, RodA, MreC and MreD) and their localisation pattern is dependent on 
the availability of the lipid II substrate (Dominguez-Escobar et al., 2011; Garner et al., 2011). 
The recruitment of the class A PBP1 to the elongasome is enabled by the cytosolic protein 
GpsB, which interacts with both PBP1 and MreC (Claessen et al., 2008). Moreover, MreB 
interacts directly or in a complex with several PG synthases including PBP1, PBP2A and PBPH, 
and the bulging in the ΔmreB mutant was associated with the abnormal localisation of PBP1 
(Kawai et al., 2009). These results support the model in which the MreB homologues coordinate 
lateral cell wall synthesis during cell elongation. 
PG hydrolysis is also controlled by cytoskeletal proteins, however there is no proof yet whether 
synthases and hydrolases in B. subtilis coexist in the same elongasome complex. The PG 
hydrolase LytE interacts with MreBH to ensure proper localisation at the lateral cell wall 
(Carballido-Lopez et al., 2006), whereas the localisation and activity of CwlO are regulated by 
Mbl via the ABC-transporter like complex FtsEX (Section 1.3.2) (Dominguez-Cuevas et al., 
2013).  
Interestingly, proteins involved in the WTA synthesis machinery such as TagGHO localised in 
a helical pattern at the lateral cell wall, and interacted with other elongasome proteins, MreC 
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and MreD (Formstone et al., 2008). All these data support the model of a multiprotein complex 
controlling the synthesis of the PG and potentially WTA during cell elongation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.5 The initiation of divisome formation  
Cell division is a dynamic process where several proteins assemble at midcell to synthesise and 
cleave the septal cell wall to produce the new poles of daughter cells. This process requires at 
least 12 proteins whose activities are tightly controlled (Errington et al., 2003). The loss of any 
essential cell division protein causes the absence of septal formation resulting in filamentous 
cells and eventually lysis. The polymerization of a tubulin-like protein FtsZ into the Z-ring 
marks the initiation of cell division (Erickson et al., 1996; Löwe and Amos, 1999; Mukherjee 
and Lutkenhaus, 1994). FtsZ polymerizes into filaments in a head to tail association dependent 
on GTP (Mukherjee and Lutkenhaus, 1998; Oliva et al., 2004). FtsZ is a self-activating GTPase, 
and this activity depends on FtsZ polymerization (de Boer et al., 1992; Mukherjee et al., 1993; 
Figure 1.4 The elongasome 
Schematic representation of proteins involved in PG synthesis, growth or maintenance during cell 
elongation. Proteins are represented with their structural features. The three actin homologues are 
proposed to be the scaffold for the PG synthesis machinery. RodA is presumably the lipid II flippase 
that delivers the PG substrate to the synthases. MreC and MreD are important in coordinating the 
intracellular and extracellular elongation machinery. PBP2A, PBPH and PBP1 represent the synthases 
involved in the PG synthesis during cell elongation. There is no proof for the coexistence of the 
hydrolases LytE and CwlO in the same complex as the PG synthesis machinery, however, at least one 
of these two hydrolases is essential for cell elongation and survival. 
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RayChaudhuri and Park, 1992; Scheffers et al., 2002). The polymerization of FtsZ is highly 
dynamic and takes 8-9 seconds to exchange FtsZ subunits (Stricker et al., 2002). CryoEM 
tomography of C. crescentus FtsZ showed that the Z-ring is arranged in protofilaments rather 
than a continuous ring (Li et al., 2007). The polymerization of FtsZ in liposomes caused convex 
bulging, which is presumably caused by the constrictive force generated by protofilaments (Li 
et al., 2007; Osawa et al., 2013).  
To ensure midcell localisation of the Z-ring, the polymerization of FtsZ is positively and 
negatively regulated by several mechanisms which will be discussed below. The min system, 
which includes MinCDJ and DivIVA, prevents FtsZ assembly near the poles (Figure 1.5) 
(Bramkamp and Van Baarle, 2009). The absence of any component of the min system causes 
misplacement of the division site resulting in anucleated cells called mini cells (Adler et al., 
1967; Bramkamp et al., 2008; Edwards and Errington, 1997; Reeve et al., 1973). MinD is a 
membrane bound ATPase that belongs to the ParA/MinD family of proteins (Cordell and Löwe, 
2001; Szeto et al., 2003).  MinD recruits MinC to the membrane, and the membrane association 
of the MinCD complex is essential for the inhibition of FtsZ polymerization (Gregory et al., 
2008). MinC also antagonizes the scaffolding of FtsZ by inhibiting its lateral interactions 
(Dajkovic et al., 2008; Scheffers, 2008). MinC moves along the cell membrane and is presumed 
to rotate around the division site and accumulate at the cell poles, suggesting that MinCD acts 
at the new cell poles to prevent FtsZ re-polymering into the Z-ring (Gregory et al., 2008). 
DivIVA localises at the assembling divisome and the cell poles, and  is the topological 
determinant of MinCD (Edwards and Errington, 1997; Gamba et al., 2009). DivIVA 
accumulates at negatively curved membranes without being able to impose curvature (Lenarcic 
et al., 2009). MinJ has a transmembrane segment and interacts with MinD and DivIVA 
(Bramkamp et al., 2008). MinJ is suggested to have an adaptor role linking the topology factor 
DivIVA to the inhibitory complex MinCD. MinJ also interacts with FtsL and the PG synthase 
PBP2B and facilitates the localisation of both proteins to midcell. This suggests another role 
for the min system in the regulation of membrane bound divisome components (Bramkamp et 
al., 2008).  
The second regulatory system for FtsZ polymerization is nucleoid occlusion (Figure 1.5). Noc 
prevents the polymerization if FtsZ into protofilaments over the nucleoid (Wu and Errington, 
2004). Noc is a DNA dependent membrane binding protein. It has a highly conserved N-
terminal domain responsible for Noc association to the cell membrane. The simultaneous 
binding of Noc to the DNA and the membrane is essential for nucleoid occlusion. This suggests 
that the mechanism by which Noc acts requires recruitment of DNA to the cell membrane 
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(Adams and Errington, 2009; Wu et al., 2009). The overexpression of Noc blocked cell division 
in wild type cells but not in the minCD mutant (Wu and Errington, 2004). In cells lacking both 
the min and the nucleoid occlusion systems, FtsZ still preferentially polymerized at midcell 
between the nucleoids suggesting the presence of another regulatory factor (Rodrigues and 
Harry, 2012; Wu and Errington, 2004). It was also proposed that the role of both systems is to 
ensure efficient utilization of the division site by positioning the Z-ring at midcell. Such a 
hypothesis suggests the presence of an as yet unknown mechanism by which FtsZ identifies the 
division site (Rodrigues and Harry, 2012).  
A third element that influences FtsZ polymerization at midcell is the glucolipid transferase UgtP 
(Weart et al., 2007). UgtP was described as a metabolic sensor that coordinates cell size with 
cell division. The role of UgtP and the mechanism of such regulation are discussed in section 
1.5.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MinCDJ
DivIVA
Noc
FtsZ
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DNA
Figure 1.5 The selection of the division site 
The polymerization of FtsZ at midcell is regulated by the Min system and the nucleoid occlusion 
system. The Min system including MinCDJ and DivIVA, prevents the polymerization of FtsZ at the 
cell poles. MinC inhibits FtsZ polymerization while MinDJ and DivIVA control the activity and the 
localisation of MinC. The nucleoid system, Noc, prevents Z-ring formation over the nucleoid. The 
binding of Noc to the DNA and to the membrane simultaneously is essential for nucleoid occlusion.  
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1.3.6 The assembly of the divisome  
In E. coli, the divisome assembles in a sequential manner by the hierarchical recruitment of cell 
division proteins to midcell (Goehring et al., 2006). Conversely, B. subtilis appears to have a 
two-step assembly dynamics of the divisome where division proteins are recruited in a 
cooperative rather than a sequential manner (Gamba et al., 2009). In this system, FtsZ, FtsA, 
EzrA and ZapA are recruited to the assembling divisome in the first 25% of the cell cycle 
followed by the recruitment of PBP2B, FtsL, DivIB, DivIVA and FtsW with a delay of at least 
20% of the cell cycle (Figure 1.6) (Gamba et al., 2009). The Z-ring is stabilized at midcell by 
its positive regulators including FtsA, ZapA and SepF. FtsA has an actin-like structure and an 
ATP-binding site, however, the oligomerization of FtsA is ATP independent (van den Ent and 
Löwe, 2000; Feucht et al., 2001; Shiomi and Margolin, 2007; Singh et al., 2013; Yim et al., 
2000). E. coli FtsA interacts with the cell membrane via an amphipathic helix. Also, FtsA 
interacts with FtsZ and enables its anchoring to the cytoplasmic membrane (Wang et al., 1997). 
The ratio of FtsZ to FtsA in the cell is 5 to 1 and as such the balance between the two proteins 
must be maintained for correct cell division (Feucht et al., 2001).  
SepF, like FtsA, interacts directly with FtsZ and promotes Z-ring formation and bundling 
(Duman et al., 2013; Singh et al., 2008). SepF binds to lipid membranes and is proposed to 
function as a cell membrane anchor for the Z-ring (Duman et al., 2013). SepF-null cells, like 
ftsA-null cells, are elongated and have distorted and abnormally thick septa, hence the potential 
role of SepF in modulating septal PG synthesis or constriction (Hamoen et al., 2006). The 
overexpression of SepF complements the ftsA-null phenotype suggesting partial redundancy 
between the two proteins (Ishikawa et al., 2006). 
ZapA, which is recruited at the early stages of cell division, interacts with FtsZ and promotes 
FtsZ polymerization into protofilaments (Gueiros-Filho and Losick, 2002). In addition, ZapA 
inhibits the GTPase activity of FtsZ resulting in increased stability and rigidity of FtsZ 
protofilaments (Gueiros-Filho and Losick, 2002; Low et al., 2004; Small et al., 2007).  
EzrA, a membrane bound protein, negatively regulates Z-ring formation by inhibiting FtsZ 
polymerization (Chung et al., 2007; Cleverley et al., 2014; Haeusser et al., 2004; Land et al., 
2014; Levin et al., 1999; Singh et al., 2007). EzrA localises at midcell and the cell periphery, 
and the ezrA mutant has polar Z-rings in addition to thin cell morphology (Levin et al., 1999). 
These results suggest a role for EzrA not only in cell division but also in cell elongation. 
However, it is still unclear why a negative regulator of FtsZ assembly is recruited at the early 
stages of the cell division. Moreover, EzrA interacts directly with GpsB and coordinates the 
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recruitment of PBP1 to the division site (Claessen et al., 2008; Tavares et al., 2008). The 
absence of both EzrA and GpsB resulted in the delocalisation of the cell wall synthesis 
machinery and impaired septal PG synthesis (Claessen et al., 2008). In addition, cells lacking 
both SepF and EzrA do not recruit the essential PG synthase PBP2B to the divisome leading to 
cell death (Hamoen et al., 2006). These results provide evidence for the importance of these 
proteins not only in regulating FtsZ polymerization but also in recruiting PG synthases during 
cell division.   
The second step in divisome assembly involves the recruitment of several proteins such as FtsL, 
DivIB, DivIC, FtsW, PBP2B, GpsB and PBP1 to midcell (Figure 1.6) (Gamba et al., 2009). 
Each of these proteins has a unique role during cell division that will be discussed below. FtsL 
is essential for cell viability and has a N-terminal cytoplasmic domain, a transmembrane 
segment and a C-terminal extracellular domain (Bramkamp et al., 2006; Daniel et al., 1996, 
1998). The cytosolic region of FtsL is important for the  stability of the protein but is 
dispensable for division (Bramkamp et al., 2006). FtsL formed a trimeric complex with cell 
division proteins DivIB and DivIC in yeast three-hybrid assays (Daniel et al., 2006; Robichon 
et al., 2008). Furthermore, the marked instability of FtsL in the absence of the essential cell 
division proteins DivIB, DivIC and PBP2B presumably made it a key control point in cell 
division (Daniel et al., 2006; Wadenpohl and Bramkamp, 2010).  
DivIC is an essential cell division protein with a similar topology to FtsL (Katis et al., 1997). 
DivIC has dispensable cytoplasmic and transmembrane regions and an essential extracellular 
domain for function and midcell localisation (Katis et al., 1997). The stability and turnover of 
DivIC depends on DivIB in wild-type cells or the ΔftsL mutant (Daniel et al., 1998, 2006). 
DivIB is a membrane bound cell division protein not essential for viability at 30˚C (Beall and 
Lutkenhaus, 1989, 1992; Harry and Wake, 1989). The overexpression of FtsL supresses the 
divIB-null lethality at high temperature suggesting either an overlap in divIB and FtsL functions 
or the division defect in divIB-null resulted from FtsL degradation (Daniel and Errington, 2000). 
Moreover, DivIB is important for the synthesis of the polar septum during sporulation 
suggesting an additional sporulation-specific role (Rowland et al., 1997; Thompson et al., 
2006).  
FtsW is an essential protein that belongs to the SEDS family of proteins (Boyle et al., 1997; 
Ikeda et al., 1989). The deletion of ftsW resulted in long filamentous cells and PBP2B 
mislocalisation suggesting a block in cell division (Boyle et al., 1997; Gamba et al., 2016). The 
FtsW homologue from E. coli has ten transmembrane segments and functions as a lipid II 
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flippase that transfers lipid II from the cytoplasm to the extracellular region where it is delivered 
to PBPs (Höltje, 1998; Mohammadi et al., 2011, 2014).  
PBP2B is the first PBP to be recruited to the assembling divisome and is crucial for septal PG 
synthesis (Daniel et al., 1996). The depletion of FtsL, DivIB, DivIC or FtsW causes 
mislocalisation of PBP2B from midcell, which results in a block in cell division (Daniel et al., 
2000; Gamba et al., 2016). More information about PBP2B can be found in section 1.3.1.  
The localisation of the synthase PBP1 to the lateral cell wall during cell elongation is controlled 
by GpsB (Section 1.3.4). However, PBP1 is also involved in septal PG synthesis and the 
recruitment of the synthase to midcell is coordinated by EzrA (Claessen et al., 2008). Thus, the 
shuttling of PBP1 between midcell and the cell periphery is presumably controlling the cell 
elongation-division cycle. Moreover, GpsB is essential in absence of EzrA suggesting a partial 
redundancy in the control of PBP1 localisation (Tavares et al., 2008).  
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Figure 1.6 The assembly of the divisome  
(A) Schematic representation of proteins involved in cell division (Adams and Errington, 2009). 
Proteins are represented with their structural features. The tubulin-like protein FtsZ works as scaffold 
for the PG synthesis machinery. ZapA and Ezra are positive and negative regulators for FtsZ 
polymerization, respectively. FtsA and SepF stabilize the Z-ring and tether it to the membrane. FtsW is 
presumably the lipid II flippase that delivers the PG substrate to the synthases. DivIB, DivIC and FtsL 
are essential for cell division but their roles are unclear. PBP2B is the first PG synthase recruited to the 
assembling divisome. PBP1 is involved in PG synthesis during cell division and its localisation to the 
septum is regulated by GpsB and EzrA.  
(B) The scheme represents the two-step assembly process of the divisome. During the early step, FtsZ 
polymerize into a ring at midcell. This polymerization is regulated by ZapA, SepF, FtsA and EzrA. The 
late step of the divisome assembly is the step during which DivIB, DivIC, FtsL and FtsW are co-
recruited to the assembling divisome. The absence of any of the later proteins causes a destabilization 
of the divisome. PBP2B is the first synthase recruited to the divisome for septal PG synthesis followed 
by PBP1 and the rest of the unmentioned cell division machinery.  
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1.4 Anionic cell wall polymers  
1.4.1 Wall teichoic acid WTA 
WTA accounts for up to 60% of the mass of the cell wall (Ellwood, 1970). It is an anionic 
polymer composed of a disaccharide linkage unit and a chain of glycerol-phosphate residues 
(Figure 1.7). WTA is covalently linked to PG by a phosphodiester bond to the C6 hydroxyl 
group of the N-acetyl muramic acid sugars (Araki and Ito, 1989; Yokoyama et al.,1986). In B. 
subtilis, WTA is synthesised by tag (teichoic acid glycerol) gene products. The synthesis starts 
at the cytoplasmic face of the cellular membrane on an undecaprenyl-phosphate lipid anchor. 
TagO catalyses the transfer of GlcNAc-1-P from UDP-GlcNAc to undecaprenyl phosphate 
(Soldo et al., 2002), followed by the addition of N-acetylmannosamine (ManNAc) catalysed by 
TagA (Ginsberg et al., 2006). The glycerolphosphotransferase TagB catalyses the addition of 
sn-glycerol-3-phosphate unit to ManNAc (Bhavsar et al., 2005; Ginsberg et al., 2006). These 
three steps are required for the synthesis of the disaccharide linkage unit and they are highly 
conserved among all B. subtilis strains characterized so far. Once the synthesis of the linkage 
unit is complete, TagF catalyses the addition of up to 60 glycerol phosphate Gro-P units to sn-
glycerol-3-phosphate to assemble the polymer (Schertzer and Brown, 2003). The transfer of the 
polymer across the membrane is performed by an ABC-transport system, TagGH (Lazarevic 
and Karamata, 1995). Once at the outer leaflet, the polymer is D-alanylated by the products of 
the dltABCD operon then transferred to the PG where it covalently binds MurNAc (Araki and 
Ito, 1989; Coley et al., 1978; Perego et al., 1995). This transfer from the undecaprenylphosphate 
to the PG is done by 3 redundant enzymes TagT, TagU and TagV (Kawai et al.,2011). 
WTA polymers have numerous roles in cell morphology and growth but the molecular details 
of their function are still not well understood. B. subtilis cells lacking WTA grew slower than 
wild type cells and they had cell wall abnormalities, thick PG layer with an increase in cell size 
and aberrant cell division (Cole et al., 1970; D'Elia et al., 2006). WTA also has a role in 
regulating the activities of autolytic enzymes in the cell wall in addition to an increase in 
antibiotic resistance (Brown et al., 2013). 
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1.4.2 Lipoteichoic acid LTA 
A second anionic polymer in B. subtilis is lipoteichoic acid (LTA). It is composed of a 
membrane anchored glycolipid and glycerol-phosphate repeats (Figure 1.8). The synthesis of 
LTA starts at the cytoplasmic side of the cell membrane where cytidine diphosphate 
diacylglycerol (CDP-DG) is first synthesised from phosphatidic acid PA by a phosphatidate 
cytidylyltransferase CdsA (Figure 1.9) (Gaillard et al., 1983). The 
phosphatidylglycerophosphate synthase PgsA catalyses the synthesis of phosphatidylglycerol 
phosphate (PGP) from CDP-DG (Miyazaki et al., 1985). PGP is then dephosphorylated 
producing phosphatidylglycerol. UDP-glucose diacylglycerol glucosyltransferase UgtP 
transfers two glucose molecules from UDP-glucose to the phosphatidylglycerol anchor which 
is then transported across the membrane by a transmembrane protein LtaA (Grundling and 
Schneewind, 2007). At the extra-cellular membrane the lipoteichoic acid synthases polymerise 
the addition of Gro-P repeats to the glycolipid molecule. B. subtilis has four synthase isoforms 
encoded by ltaS, yfnI, yqgS and yvgJ (Schirner et al., 2009). The LTA is D-alanylated at the 
outer leaflet in the same way as the WTA by the products of the dltABCD operon. The lack of 
the D-alanyl-ester in LTA and WTA has no effect on the cell shape. However, an increase in 
autolysis activity and an increase in susceptibility to antimicrobial peptides has been detected 
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Figure 1.7 Wall teichoic acid biosynthesis 
Products of the tag operon catalyses the synthesis of the WTA from the sugar nucleotide UDP-GlcNAc. 
The lipid anchor undecaprenyl-pyrophosphate is used as a carrier molecule. TagGH are suggested to 
catalyse the transfer of the precursor from the cytoplasm to the extracellular domain. TagTUV suggested 
to be involved in the transfer of the WTA from the undecaprenyl-pyrophosphate to the PG.  
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in such cells (Perego et al., 1995; Wecke et al., 1997; Wecke et al., 1996). CryoEM studies 
indicated a continuous layer of LTA along the membrane (Matias and Beveridge, 2008). Such 
a distribution of LTA suggests a role for this polymer in the overall structural organisation of 
the cell envelope (Matias and Beveridge, 2008). LtaS and its homologue YqgS both localised 
predominantly at midcell in vegetative cells (Schirner et al., 2009). The ΔltaS mutant exhibited 
a reduction in cell diameter, cell bending in addition to cell division defects described by the 
presence of long aseptate regions and aberrant septa (Schirner et al., 2009). The absence of the 
LTA synthase LtaS suppressed the magnesium dependency of the Δmbl and ΔmreB mutants 
(Schirner et al., 2009). The ΔltaS mutant exhibited bigger LTA size suggesting an alteration of 
the LTA structure. Interestingly, the synthase quadruple mutant was viable, but cells grew 
slower than wild-type and with cell division defects (Schirner et al., 2009). No LTA was found 
in this quadruple mutant, meaning the lipoteichoic acid synthases were required for LTA 
synthesis, along with CdsA and PgsA (Wormann et al., 2011). The ΔltaS mutant exhibited an 
increase in total phosphatidic acid and CDP-DG levels in the cell. Cells lacking LtaS also had 
an 8-fold decrease in the diglucosyldiacylglycerol (DGDG) level, which is synthesised by UgtP 
(Section 1.4.3) (Hashimoto et al., 2013). The transcription of sigM increased up to 8-fold in the 
ΔltaS and the ΔugtP mutant, suggesting that the SigM upregulation response in the ΔltaS or the 
ΔugtP mutants could be caused by the low levels or absence of the diacylglucose moiety, 
respectively (Hashimoto et al., 2013; Seki et al., 2015). In Bacillus anthracis, the absence of 
the LTA synthases LtaS1 and LtsS2 exhibited rough cell surfaces compared to wild type cells 
suggesting increased PG hydrolase activity (Garufi et al., 2012).  
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Figure 1.8 LTA biosynthesis  
Schematic representation of LTA synthesis in B. subtilis adopted and modified from (Schneewind and 
Missiakas, 2014). PgcA and GtaB synthesise glucose-1-P and UDP-glucose, respectively. Two glucose 
residues are transferred successively from UDP-glucose to diacylglycerol by UgtP to synthesise 
Glc2DAG. This latter is flipped across the cytoplasmic membrane by LtaA. Subsequently, LtaS 
catalyses the addition of the Gro-P repeats to Glc2DAG to synthesise LTA.   
Figure 1.9 Phospholipids, glycolipids and LTA biosynthesis pathways in B. subtilis 
Thick arrows on the left side of the figure represent the diacylglycerol cycle for lipoteichoic acid 
synthesis (Jerga et al., 2007). The right side of the diagram represents the pathway for glucolipid 
biosynthesis (Yasbin et al., 1976).  
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1.4.3 Glucolipid biosynthesis 
Glucolipids constitute one of the components used for LTA synthesis. Their production start by 
transforming glucose-6 phosphate to α-glucose-1 phosphate by the α-phosphoglucomutase 
PgcA, followed by the synthesis of UDP-glucose by α-glucose-1-phosphate uridylyltransferase 
GtaB (Figure 1.8 and 1.9) (Yasbin et al.,1976). UDP-glucose is used as a precursor for the 
synthesis of three teichoic acids: the minor teichoic acid (GlcGalNAc1-P)n-ManNAc-GlcNAc-
P by two sugar transferases GgaA and GgaB (Freymond et al., 2006), the major teichoic acid 
(Glc-Gro-P)n-ManNAc-GlcNAc-P by the glucosyltransferase TagE (Mauel et al.,1991) and the 
LTA (Figure 1.9). The diacylglycerol glucosyltransferase UgtP catalyses three consecutive 
transfers of glucose residues to a membrane anchored diacylglycerol (Jorasch et al.,1998). B. 
subtilis has monoglucosyldiacylglycerol (MGDG), diglucosyldiacylglycerol (DGDG) and 
triglucosyldiacylglycerol (TGDG), forming 1.2%, 9.8% and 0.3% of the total membrane lipids, 
respectively (Kawai et al.,2006). In S. aureus, MGDG is flipped across the membrane by multi-
transmembrane spanning protein LtaA to be used for LTA synthesis (Grundling and 
Schneewind, 2007). 
 
1.5 UgtP, a metabolic sensor for cell size homeostasis 
1.5.1 Cell growth coordinates cell division  
Bacteria are significantly larger in nutrient rich media than in nutrient poor medium. Therefore, 
the coordination between cell size and growth rate is important for cells to be at the appropriate 
size to face a given environment. It was suggested that the glycolipid pathway functions as a 
metabolic sensor to control cell size in B. subtilis in addition to its role in teichoic acid synthesis 
(Weart et al.,2007). Transposon-based screen searching for FtsZ assembly inhibitors identified 
the α-phosphoglucomutase PgcA (Weart et al., 2007). PgcA, gtaB and ugtP mutants exhibited 
short cell morphologies and were able to suppress the cell division block associated with 
MinCD overexpression. The expression level of FtsZ in the pgcA mutant was similar to wild 
type suggesting that PgcA modulates the assembly dynamics and not the expression level of 
FtsZ (Weart et al.,2007). The absence of PgcA or GtaB did not affect the expression level of 
UgtP in the cell but it interfered with the midcell localisation of UgtP in vegetative cells in 
nutrient rich medium (Nishibori et al., 2005; Weart et al., 2007). For cells grown in minimal 
sorbitol medium, UgtP was randomly distributed in foci and the level of UgtP expression 
decreased 6-fold compared to wild type. These results suggested that PgcA and GtaB modulated 
FtsZ assembly by controlling UDP-glucose availability in nutrient rich conditions. The 
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overexpression of UgtP caused 22% increase in cell length (Weart et al., 2007). In vitro, UgtP 
inhibited FtsZ assembly in a concentration dependent manner and destabilized the lateral 
interactions between FtsZ protofilaments (Chien et al.,2012). In the presence of UDP-glucose, 
UgtP had a higher affinity for FtsZ than for itself (Chien et al., 2012). Thus a shift from the 
UgtP-UgtP complex to the UgtP-FtsZ complex is presumably dependent on the increased levels 
of UDP-glucose, hence the stimulation of the UgtP-mediated inhibition of FtsZ assembly. 
Taken together these results suggests that nutrient availability altered both the expression and 
localisation of UgtP, thus ensuring that the inhibition of Z-ring formation is coupled to growth 
rate (Chien et al., 2012; Weart et al., 2007). 
 
1.5.2 The effect of glycolipids on bacterial actin homologues 
Matsuoka el at., (2011) studied the effect of UgtP on the actin polymers. They tested the actin-
homologs´ expression levels by lacZ transcriptional fusion in B. subtilis ugtP mutant cells. The 
mreB operon has 2 promoters, a Pupstream mreB and a PmreB (Tseng and Shaw, 2008). In ugtP 
mutants, mreB (Pupstream mreB) and mreBH transcription levels were 4.3 and 2.3 times higher than 
wild type, respectively (Matsuoka et al.,2011). However, mbl expression was not affected. 
Strains lacking both MreB and UgtP were viable and cells had an oval shape (Matsuoka et 
al.,2011). The absence of UgtP altered MreB localisation during exponential growth but not 
during stationary phase. The levels of MreB decreased significantly during exponential phase 
in the absence of UgtP, however, the addition of 10 mM MgSO4 supressed the abnormal 
localisation and level of MreB in the ugtP mutant. No interaction has been identified between 
MreB and UgtP by bacterial two-hybrid experiments, suggesting that glycolipids stabilise MreB 
polymerization or protect it from proteolysis (Matsuoka et al., 2011).  
 
1.5.3 The effect of glycolipids on the cell wall  
UgtP catalyses the transfer of glucose residues to a membrane anchored diacylglycerol during 
LTA synthesis. The absence of UgtP caused a significant decrease in the levels of glucolipids 
in the cell membrane (Salzberg and Helmann, 2008). In B. subtilis, ΔugtP, ΔpgcA and ΔgtaB 
mutants had similar LTA content to wild type cells (Matsuoka et al., 2011b). However, in S. 
aureus the ypfP-null (UgtP homologue) and the ltaS-null both exhibited a bigger LTA size 
compared to wild type suggesting an alteration in the LTA structure (Reichmann et al., 2014). 
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In addition, YpfP interacted directly or indirectly with the LTA synthesis machinery LtaA and 
LtaS by bacterial two-hybrid assays (Reichmann et al., 2014).  
Extracytoplasmic function sigma factors were another element studied in the ugtP mutant to 
understand the changes in cell morphology. In the ΔugtP mutant, the promoter activity of σM, 
σV and σX increased 6.9, 3.4, and 1.5 folds, respectively (Hashimoto et al., 2013; Seki et al., 
2015). σM is involved in cell wall synthesis and cell shape maintenance by its regulation of 
several genes such as murBF, ponA and rodA (Cao et al., 2002; Jervis et al., 2007). In the 168 
Marburg strain, cells lacking SigM had wild type shape while cells lacking UgtP were thick, 
filamentous and bent during exponential phase. However, cells lacking both SigM and UgtP 
had an oval shape and lysed (Matsuoka et al., 2011a). In addition, a microarray analysis for the 
PY79ΔugtP mutant showed up to 30% of the genes in the SigM, SigK and SigG regulons had 
increased transcription levels compared to wild type (Salzberg and Helmann, 2008). 
Furthermore, the absence of GtaB or PgcA but not UgtP diminished biofilm formation, 
however, the ΔugtP mutant showed flatter and matte biofilm compared to wild-type cells 
(Lazarevic et al., 2005; Salzberg and Helmann, 2008).  
The effect of UgtP on PG synthesis is still poorly characterized. The treatment of the ΔugtP 
mutant with fluorescently-labelled vancomycin showed a similar staining pattern to wild type 
cells suggesting that PG synthesis and lipid II incorporation were mostly unimpaired (Salzberg 
and Helmann, 2008). Moreover, the S. aureus YpfP interacted directly or indirectly with the 
divisome members DivIB, DivIC, FtsL, FtsW and PBP1 by bacterial two-hybrid experiments 
(Reichmann et al., 2014). These results suggest that UgtP might have an effect not only on FtsZ 
polymerization but also on other cell division proteins. The expression of LytE increased up to 
two fold in cells lacking LtaS, UgtP, PgcA or GtaB compared to wild type, however, the 
localisation of LytE in the latter mutants was unaffected (Kasahara et al., 2016). The reasons 
behind this increase in LytE expression in cells with defective LTA synthesis is not clear.  
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1.6 Aims of the project  
Changes in the concentrations of glucose or magnesium ions in culture media helped several 
mutants to recover from defective aspects of the cell wall (Murray et al., 1998; Formstone and 
Errington, 2005). However, the mechanisms behind such recovery and how the metabolism of 
the cell impacts PG synthesis is unclear. Moreover, the mechanism of peptidoglycan synthesis 
in B. subtilis is mostly uncharacterized. Therefore, the following questions were investigated in 
this work: 
1. How does the absence of glucolipids in the cell impact the cell wall synthesis? 
2. How does PBP3 complement the lack of the TPase activity of PBP2B? What are the 
roles of PBP1, PBP2B and PBP3 in the synthesis of PG during cell division?  
3. What is the role of YrrL, a lytic transglycosylase homologue, in B. subtilis?  
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2 Methods 
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2.1 Strains and plasmids 
 
Table 2.1 List of B. subtilis strains used in this study 
Strain Genotype Reference/Source 
168CA trpC2 Laboratory collection 
2083 trpC2 ponA::(Pxyl gfp-ponA cat) (Claessen et al., 2008) 
3105 trpC2 pbpC::pSG5045 (cat Pxyl gfp-pbpC) Laboratory collection 
4001 trpC2 pbpB(S309A) Laboratory collection 
4015 trpC2 pbpC::cat Laboratory collection 
BGSC1 yrrL::erm BGSC 
BGSC2 yocA::erm BGSC 
BGSC3 sigM::erm BGSC 
KS53 trpC2 amyE::(spc Pspac pbpC
(S410A)) Laboratory collection 
PG237 trpC2 ugtP::neo Laboratory collection 
PDC463 trpC2 cwlO::spc (Dominguez-Cuevas et 
al., 2013) 
PDC464 trpC2 lytE::cat (Dominguez-Cuevas et 
al., 2013) 
PS2062 trpC2 ponA::spc (Popham and Setlow, 
1995) 
SSB122 trpC2 pgcA::tet (Weart et al., 2007) 
JS07 trpC2 gtaB::erm This work 
JS45 trpC2 yrrL::erm 168CA transformed with 
BGSC1 DNA 
JS46 trpC2 yocA::erm 168CA transformed with 
BGSC2 DNA 
JS48 trpC2 sigM::erm 168CA transformed with 
BGSC3 DNA 
JS55 trpC2 ugtP::neo ponA::cat PG237 transformed with 
JS06 DNA 
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JS60 trpC2 ΔyrrL This work 
JS62 trpC2 ΔyrrL yocA::erm JS60 transformed with 
JS46 DNA 
KS10 lytABC::neo Kenneth Seistrup, 
unpublished 
KS07 lytF::spc Kenneth Seistrup, 
unpublished 
BSB1 Autotroph Nicolas et al., 2012 
JS03 BSB1 ugtP::neo BSB1 transformed with 
PG237 DNA 
JS04 BSB1 pgcA::tet BSB1 transformed with 
SSB122 DNA 
JS05 BSB1 ugtP::neo amyE::(spc Pspank ugtP) JS03 transformed with 
pJS01 
JS06 BSB1 ponA::cat This work 
JS07 BSB1 pgcA::tet aprE::(spc Pspac pgcA) JS04 transformed with 
pJS02 
JS09 BSB1 gtaB::erm This work 
JS12 BSB1 gtaB::erm aprE::(spc Pspac gtaB) JS09 transformed with 
pJS03 
JS13 BSB1 ugtP::neo cwlo::spc JS03 transformed with 
PDC463 DNA 
JS14 BSB1 ugtP::neo lytE::cat amyE::(Pspank ugtP 
spc) 
JS05 transformed with 
PDC464 DNA 
JS15 BSB1 ugtP::neo ponA::cat amyE::(spc Pspank 
ugtP) 
JS05 transformed with 
JS06 DNA 
JS17 BSB1 gtaB::erm lytABC::neo JS09 transformed with 
KS10 DNA 
JS19 BSB1 pgcA::tet lytF::spc JS04 transformed with 
KS07 DNA 
JS20 BSB1 lytABC::neo BSB1 transformed with 
KS10 DNA 
JS21 BSB1 lytF::spc BSB1 transformed with 
KS07 DNA 
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JS23 BSB1 lytF::spc ugtP::neo JS03 transformed with 
KS07 DNA 
JS32 BSB1 S827::erm This work 
JS36 BSB1 gtaB::erm ponA::cat aprE::(spc Pspac gtaB) JS12 transformed with 
JS06 DNA 
JS38 BSB1 pgcA::tet ponA::(Pxyl gfp-ponA cat) JS04 transformed with 
2083 DNA 
JS39 BSB1 ugtP::neo ponA::(Pxyl gfp-ponA cat) JS03 transformed with 
2083 DNA 
JS40 BSB1  ponA::(Pxyl gfp-ponA cat) BSB1 transformed with 
2083 DNA 
JS41 BSB1 ugtP::neo amyE::(spc Pspank ugtP-S827) JS03 transformed with 
pJS04  
JS42 BSB1 cwlO::spc BSB1 transformed with 
PDC463 DNA 
JS43 BSB1 lytE::cat BSB1 transformed with 
PDC464 DNA 
JS44 BSB1 ugtP::neo lytE::cat JS03 transformed with 
PDC464 DNA 
JS49 BSB1 ugtP::neo lytE::cat sigM::erm JS44 transformed with 
BGSC3 DNA 
JS52 BSB1 ugtP::neo lytE::cat ponA::spc JS44 transformed with 
JS06 DNA 
JS54 BSB1 lytE::cat ugtP::neo amyE::(spc Pspank 
ugtP) 
JS05 transformed with 
JS43 DNA 
JS56 BSB1 ugtP::neo ponA::Cm amyE::(spc Pspank 
ugtP-S827) 
JS41 transformed with 
JS06 DNA 
DH5α E. coli F– φ80lacZΔM15, Δ(lacZYArgF)U196, 
recA1, endA1, hsdR17, (rk- , mk+), phoA, supE44, 
λ-, thi-1, gyrA96, relA1 
Invitrogen  
BL21(DE3) E. coli B F– ompT gal dcm lon hsdSB(rB
–mB
–) 
λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5]) 
[malB+]K-12(λS) 
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Table 2.2 List of plasmids used in this study 
Plasmid Characteristics Reference/Source 
pAPNC213 bla aprE’ spc lacI  Pspac’ aprE Morimoto et al., 2002 
pDR111 bla amyE’ spc lacI  Pspank’ amyE David Rudner, Harvard 
University 
PcotC-GFP bla cat PcotC cotC-gfp Veening et al., 2006 
pET-28a(+) kan PT7 lacI This work 
pET28-
28a(+)::ponA 
kan PT7 ponA lacI Cleverley et al., 2016; 
Rismondo et al., 2016 
pMUTIN erm Pspac lacZ lacI Vagner et al., 1998 
pJS01 bla amyE’ spc lacI  Pspank  ugtP’ amyE This work 
pJS02 bla aprE’ spc lacI  Pspac pgcA’ aprE This work 
pJS03 bla aprE’ spc lacI  Pspac gtaB’ aprE This work 
pJS04 bla amyE’ spc lacI  Pspank  ugtP-S827’ amyE This work 
pJS05 kan PT7 pbpC lacI This work 
pJS06 kan PT7 pbpC
(17-668) lacI This work 
pJS07 kan PT7 pbpB lacI This work 
pJS08 kan PT7 pbpB
(24-716) lacI This work 
pJS09 kan PT7 pbpB
(S309A)lacI This work 
pJS10 kan PT7 pbpC
(S410A) lacI This work 
pJS11 kan PT7 yrrL lacI This work 
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2.2 Growth and Media 
2.2.1 Media supplements and antibiotics  
Table 2.3 List of media supplements 
 Supplements  
Final 
concentration 
Chloramphenicol (dissolved in 100% ethanol) 5 µg/ml 
Erythromycin (dissolved in 50% ethanol) 1 µg/ml 
Ampicillin  5 µg/ml 
Kanamycin for B. subtilis 2-5 µg/ml 
Kanamycin for E. coli 25 µg/ml 
Tetracycline 10 µg/ml 
Xylose 0.5% 
IPTG 0.1-1 mM 
MgCl2 20 mM 
 
 
2.2.3 Bacterial growth and storage 
B. subtilis or E. coli cells were cultivated in Luria Britani (LB), Difco antibiotic medium no. 3 
(PAB), competence medium or M9 medium (Kleijn et al., 2010) depending on the experiments’ 
requirements. Fresh cultures were inoculated with overnight culture and grown at 30 or 37˚C 
with continuous shaking. For growth curves the OD600 was recorded every 15 min when cells 
were grown in nutrient rich medium and every 30 min when grown in minimal medium. For 
solid media, 1% agar (Bacteriological agar no. 1, Oxoid) was added in addition to the 
appropriate amount of supplements (Table 2.3). For short term growth and selection, nutrient 
agar (Oxoid) plates were used. For long term storage, liquid cultures (in LB) were grown to OD 
0.4 to 0.6 and mixed with sterile glycerol to a final concentration of 20% glycerol, frozen in 
liquid nitrogen and stored at -80˚C.   
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2.3 DNA methods 
2.3.1 Polymerase chain reaction (PCR)  
Q5 High-Fidelity DNA Polymerase (NEB, UK) was used for gene amplification during cloning 
and a Gotaq Flexi DNA Polymerase (Promega, USA) was used for confirming DNA 
modifications and/or gene deletions. Reactions (20 to 100 µl) were prepared as per the 
manufacturer’s instruction including 0.3 µM forward and reverse primers, 0.2 mM dNTPs, 
reaction buffer, DNA template and polymerase. The PCR amplification steps consisted of an 
initial denaturation (98°C, 2 min), 30 amplification cycles and a final oligonucleotides 
extension step (72°C for 4 min). Each amplification cycle consisted of denaturation (98°C, 10 
s), annealing (2°C lower than the oligonucleotides melting temperatures, 30 s) and 
oligonucleotide extension (72°C, 30 s/kb). 
 
2.3.2 Isolation of plasmid DNA 
E. coli DH5α cells carrying the plasmid were grown overnight in 5 ml LB with appropriate 
antibiotics at 37°C. Cells were pelleted by centrifugation (3893 g/ 5 min) and plasmids were 
purified by using a QIAprep Spin Miniprep Kit (Qiagen) as per the manufacturer’s instructions. 
 
2.3.3 Purification of DNA products 
PCR amplified DNA or plasmid DNA digested with restriction endonucleases were purified 
using QIAquick PCR Purification Kit (Qiagen, Germany) as per the manufacturer’s 
instructions.  
 
2.3.4 Agarose gel electrophoresis of DNA fragments 
DNA loading dye (phenol red) was mixed with DNA fragments at a 1:3 ratio and loaded to a 
1% agarose gel made with TAE buffer (2 M Tris/HCl pH 8.3, 5.7% acetate, 50 mM sodium 
acetate). A constant voltage (100 V) was applied for 1 h followed by the immersion of the gel 
in a TAE buffer with 0.75 µg/ml ethidium bromide for 15 min. Bands were visualised with a 
UV transilluminator and pictures were taken using a lumenera USB 2.0 camera. 
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2.3.5 Restriction endonuclease (RE) digestion 
Restriction enzymes were obtained from Roche, New England, Biolabs or Promega and they 
were used as per the manufacturer’s instructions. Samples contained DNA, the manufacturer’s 
recommended buffer and enzymes and were incubated for 3 h at 37˚C. Enzymes were 
deactivated by incubation at 65˚C or 80˚C for 20 min. alternatively, with heat stable enzymes, 
a PCR cleanup kit was used to stop the reaction.  
 
2.3.6 DNA dephosphorylation reaction  
Restriction digested plasmids were dephosphorylated using shrimp alkaline phosphatase (SAP, 
Usb). The reaction was performed directly in the restriction endonuclease buffer with the 
addition of phosphatase (1 µl) and incubating at 37˚C for 1h.  
    
2.3.7 Ligation of DNA 
DNA fragments with compatible ends were ligated using a T4 DNA ligase (Roche, Switzerland) 
as per the manufacturer’s instructions. The reaction consisted of DNA fragments, a provided 
ligation buffer and 1 unit of T4 ligase. Samples were incubated overnight at 4˚C then heated at 
80˚C for 15 min followed by a transformation into E. coli or B. subtilis cells. 
 
2.4 Bacillus subtilis methods  
2.4.1 Bacillus subtilis transformation 
The method was performed as published (Anagnostopoulos and Spizizen, 1961) with 
modifications (Hamoen et al.,2002). Competence medium (5 ml) (Table 2.5) was inoculated 
with B. subtilis strains and incubated overnight at 30°C with agitation. Fresh competence 
medium (5 ml) was inoculated with 500 µl of the overnight culture and incubated for 3 h at 
37°C with shaking. Pre-warmed starvation medium (5 ml) (Table 2.6) was added to the previous 
culture and cells were incubated at 37°C for another 2 h with shacking (cells are competent). 
DNA (1-3 ng/ml) was added to competent cells (900 µl) and incubated at 37°C for 1 h. Cells 
were plated on nutrient agar plates with appropriate antibiotics and incubated overnight at 37°C.  
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Table 2.4 SMM medium composition 
SMM medium concentration 
Ammonium sulphate 0.2% 
Dipotassium phosphate 1.4% 
Potassium dihydrogen phosphate 0.6% 
Sodium citrate dihydrate 0.1% 
Magnesium sulphate 0.02% 
The pH was adjusted to 7.5 
  
 
Table 2.5 Competence medium composition 
 
 
 
 
 
 
Table 2.6 Starvation medium composition 
 
 
 
 
 
 
 
 
 
Competence medium Volume 
SMM medium 10 ml 
Glucose (40%) 125 µl 
Tryptophan solution 2 mg/ml 100  µl 
1 M MgSO4 60 µl 
Casamino acid (20%) 10 µl 
Fe-NH4-citrate (0.22%) 5 µl 
Starvation medium Volume 
SMM medium 10 ml 
Glucose (40%) 125 µl 
1 M MgSO4 60 µl 
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2.4.2 Purification of chromosomal DNA  
Luria Broth (LB) medium (5 ml) was inoculated with cells from an overnight culture and 
incubated for 5 h at 37˚C. Cells were pelleted (3893 g/ 5 min) and resuspended with 100 µl 
EDTA (50 mM). Lysozyme [3 µl of a 10 mg/ml stock prepared in TES buffer (0.2 M Tris/HCl, 
5 mM EDTA, 100 mM NaCl, pH 7.5)] and RNase (3 µl of a 10 mg/ml stock in TES buffer) 
were added to the suspension and samples were incubated for 1 h at 37˚C. Nuclei lysis solution 
(Promega) (500 µl) was added and cells were incubated for 5 min at 80°C then cooled down to 
room temperature (25°C). Protein precipitation solution (200 µl) was added and the mixture 
and vortexed for 20 s at high speed. Cells were incubated afterwards on ice for 10 min then 
centrifuged for 10 min at 13000 g. The supernatant was transferred to a clean microfuge tube 
containing 600 µl of isopropanol (Sigma, Germany), mixed gently then centrifuged (13000 g/10 
min/ 4°C). The supernatant was discarded and 600 µl of 70% ethanol was added to the pellet. 
Samples were centrifuged as before, the supernatant was discarded carefully and the tubes were 
left to dry. DNA was resuspended in distilled water (100 µl) and incubated at 65°C for 15 min.  
 
2.5 Escherichia coli methods  
2.5.1 Generation of competent cells  
DH5α or BL21(DE3) cells were grown in 10 ml LB for overnight at 37˚C. LB medium (50 ml) 
was inoculated with 500 µl of the overnight culture and cells were grown at 37°C to OD600 0.5. 
Cells were pelleted by centrifugation (3893 g/ 10 min/ 4˚C) and resuspended in cold TFB1 
solution (100 mM RbCl, 50 mM MnCl2, 30 mM potassium acetate, 10 mM CaCl2, 15% 
glycerol, pH 5.8). The suspension was incubated on ice for 90 min then pelleted again as before 
in 2 ml cold TFB2 solution (10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 15% glycerol, pH 
6.8). Aliquots of 100 µl of the previous suspension were transferred into sterile tubes then stored 
immediately at -80°C.  
 
2.5.2 Transformation of competent cells 
 Cells were thawed on ice for 10 min and the DNA (600 ng/ml) was added and incubated on 
ice for 15 min. Cells were heat-shocked for 60 s at 42°C in a water bath, then transferred back 
on ice for 5 min. Cells were plated on nutrient agar plates with appropriate antibiotics and 
incubated overnight at 37°C.  
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2.6 Cloning  
2.6.1 Ligase free cloning  
This experiment was adopted from (Richardson et al., 2016) and requires two sets of primers, 
the first and second sets were used to amplify the plasmid and the insert, respectively (Figure 
2.1). The 5’ end of the insert primers should include one homologue and one complementary 
sequence to the plasmid primers. The plasmid and the insert were amplified using standard 
conditions (Section 2.3.1). PCR products were analysed using agarose gels. Products were then 
mixed at a 1:1 ratio (30 µl total volume) and heated to 98°C for 2 minutes in a heat block.  The 
mixed products were then incubated at RT for 2 minutes. This heating/cooling step was repeated 
twice. On the last cooling step the mixture was left in the heat block to cool down slowly to a 
temperature of 45°C. Restriction enzyme buffer was added to the mix in addition to the 
restriction endonuclease DpnI (1 µl) and incubated for 3 h at 37˚C, followed by transformation 
into E. coli DH5α (Section 2.5.2) 
 
2.6.2 Construction of plasmids   
Two methods were used for the insertion of DNA fragments into plasmids. All constructed 
plasmids were transformed into E. coli DH5α cells.  
The first was the ligase free method which required 4 sets of primers and 2 DNA templates, 
plasmid DNA and genomic DNA (section 2.6.1). pET-28a(+) plasmid was amplified using 
JS98-JS99 primers, and pbpC*, pbpB*, and yrrL were amplified using the oligonucleotides 
JS130-JS131, JS132-JS133 and JS134-JS135, respectively (Table S1).  
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Figure 2.1 Ligase free cloning diagram  
Diagram showing the steps of the ligase free cloning experiment. DNA amplification for the 
plasmid and gene of interest using PCR. DNA products were mixed at a 1 to 1 ratio and heated 
up to 98˚C for 2 min. Afterwards, Samples were cooled down for 2 min. the heating/ cooling 
step was repeated 3 times followed by the addition of the RE DpnI to digest the DNA 
templates. Three hours later, E. coli competent cells were transformed with the whole mix. 
Microfuge tube image was adopted from StarLab webpage. The heat-block picture adopted 
from Benchmark Scientific webpage. The bacteria clipart was adapted from pinterest.co.uk 
Plasmid
PCR PCR
1:1 mix of PCR 
products
Heat up to 98˚C 
then cool down 
DpnI RE digest for    
3 h at 37˚C
DpnI
Transform into 
E. coli cells
Gene of 
interest
5’ 
oligonucleotide
3’ 
oligonucleotide
42 
For the second method, plasmid DNA and PCR fragments were digested with the same RE 
enzymes and ligated as previously described (Section 2.3.5 and 2.3.7). The plasmid pDR111 
was used for the construction of strains JS01 and JS04. The plasmid pAPNC213 was used for 
the construction of strains JS02 and JS03. The oligonucleotides used to amplify the DNA 
fragments mentioned above can be found in Table S1. 
 
Table 2.7 Oligonucleotides and restriction enzymes used for the construction of plasmids 
 
 
 
 
 
 
 
 
 
 
 
2.6.3 Construction of strains 
Gene knockouts were achieved by replacing the gene coding sequence with an antibiotic 
resistance cassette (Fabret et al., 2002). The sequence upstream and downstream (2 kb) of the 
gene of interest were amplified by PCR. Restriction sites were introduced in the 3’ end of the 
upstream amplicon and the 5’ end of the downstream amplicon. A resistance cassette was 
amplified with the same restriction sites aforementioned. The products were digested and 
ligated with equimolar concentrations (1.5 µg of each) then transformed into B. subtilis 
competent cells. Successful transformants grew on plates with antibiotics and a further PCR 
check was performed for the confirmation of mutants in addition to sequencing if necessary. 
BSB1 or 168CA genomic DNA were used for the amplification of B. subtilis coding sequences. 
Plasmids 
Restriction 
enzymes 
oligonucleotides Description/comments 
pJS01  
SalI JS05  5’ ugtP 
SphI JS06 3’ ugtP 
pJS02  
BamHI JS07  5’ pgcA 
SacI JS08 3’  pgcA 
pJS03  
SalI JS09  5’ gtaB 
EcoRI JS10 3’  gtaB 
pJS04 
SalI JS05 5’ ugtP 
SphI JS104 3’ ugtP S827 
pJS05 
NdeI JS59  5’ pbpC 
BamHI JS60 3’  pbpC 
pJS06 
NdeI JS63  5’  pbpC 
BamHI JS60 3’  pbpC 
pJS07 
NheI JS84  5’  pbpB 
BamHI JS85 3’  pbpB 
pJS08 
NheI JS94  5’  pbpB 
BamHI JS85 3’  pbpB 
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The plasmids pMUTIN4 and pCotC-GFP were used for the amplification of erythromycin and 
chloramphenicol cassettes, respectively.   
JS03 was transformed with pJS01 creating the strain JS05. JS04 was transformed with pJS02 
creating the strain JS07. JS09 was transformed with pJS03 creating the strain JS12. To confirm 
double cross-over insertion, cells were grown on nutrient agar plates with starch and exposed 
to iodine. Cells with a double crossover cannot digest starch due to AmyE inactivation and 
failed to produce a halo around the colonies when exposed for 2 min to iodine vapour. 
 
Table 2.8 Oligonucleotides and restriction enzymes used for the construction of strains 
 
 
 
 
Strains 
Restriction 
enzymes 
Oligonucleotides Description/comments 
168CA 
gtaB::erm 
- JS43 5’ gtaB upstream 
XbaI JS69 3’ gtaB  upstream 
XbaI JS67 5’ Erm 
EcoRI JS68 3’ Erm 
EcoRI JS70 5’ gtaB downstream 
- JS046 3’ gtaB  downstream 
BSB1 
S827::erm 
- JS101 5’ S827  upstream 
XbaI JS102 3’ S827  upstream 
XbaI JS67 5’ Erm F 
EcoRI JS100 3’ Erm R 
EcoRI JS103 5’ S827  downstream 
- JS93 3’ S827  downstream 
BSB1 
ponA::cat 
- JS35 5’ ponA  upstream 
XbaI JS57 3’ ponA  upstream 
XbaI JS51 5’ Cm F 
EcoRI JS53 3’ Cm R 
EcoRI JS56 5’ ponA  downstream 
- JS36 3’ ponA  downstream 
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2.7 Microscopy 
2.7.1 Microscopic imaging  
Microscopic images were taken using inverted Nikon eclipse Ti microscope coupled to a Sony 
Cool-Snap HQ2 CCD camera (Roper scientific) operated by Metamorph 6 imaging software 
(Universal imaging). Cell were grown in LB media and images were taken during exponential 
phase (OD600 0.5) unless otherwise mentioned. Samples (0.5 µl) were mounted on 1% agarose 
and imaging was performed with brightfield illumination with 300 ms exposure time. For 
membrane or nucleoid staining, cells were mounted on agarose with Nile red dye (1 µg/ml, 
Molecular Probes) or DAPI (1 µg/ml, Sigma), respectively (Figure 2.2). All images were 
analysed with ImageJ (Schneider et al., 2012). 
 
 
 
 
 
 
2.7.2 Immunofluorescence  
Microscopic images were taken using a spinning disk microscope coupled to a Sony Cool-Snap 
HQ2 CCD camera operated by Metamorph 6 imaging software (Universal imaging). Cells were 
grown to OD600 0.5 followed by the addition of an equal volume of fix buffer (5% 
paraformaldehyde in PBS). The mixture was cooled down on ice for at least 30 min. Cells were 
washed 3 × in PBS and resuspended in GTE buffer (50 mM glucose, 25 mM Tris/HCl, 10 mM 
EDTA, pH 8.0). Cells were spotted on a dry multiwell slide and allowed to stand for up to 5 
min. The solution was aspirated off and the slide left to dry. Polylysine (0.01%) was spotted 
onto the cells for 2 min, aspirated off and cells were allowed to dry. Cell spots were treated with 
lysozyme (10 mg/ml), washed with PBS, and allowed to dry. Cells were rehydrated with PBS 
for 2 min then blocked with PBS buffer with 2% BSA for 15 min. The primary antibody was 
added to the cells and left for overnight at 4°C. Cell spots were washed 10 × with PBS. The 
secondary antibody was added and the slide was incubated at room temperature in the dark for 
1.5 h. Cells washed 10 × with PBS, DAPI (0.2 µg/ml in antifade) was added, and slides were 
Figure 2.2 Nile red membrane dye for BSB1 cell.  
Fluorescent microscope for BSB1 cells with membrane dye during exponential phase.  Bar = 4 µm. 
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ready for imaging. All images were analysed with Metamorph 6 imaging software. 
Fluorescence data were sorted using Python7 and Heat maps were created using ImageJ.  
 
 2.7.3 Transmission electron microscopy  
A Philips CM 100 Compustage (FEI) Transmission Electron Microscope coupled to an AMT 
CCD camera (Deben) was used to collect images for several mutant cells. The growth and 
fixation of cells and the imaging were done by myself, whereas the dehydration and the 
processing of the samples were done by Kathryn White at the electron microscopy unit at 
Newcastle University. Cells were grown in LB media to OD600 0.5 at 37˚C, mixed in a 1:1 ratio 
with fix buffer I (2% glutaraldehyde, 0.1 M sodium cacodylate) and incubated at 4˚C for 
overnight. Cells were pelleted then washed with 0.1 M sodium cacodylate buffer followed by 
a secondary fixation step with 1% osmium tetroxide in water for 1 h. Cells were dehydrated 
using graded acetone (25%, 50%, 75% and 100%). Subsequently, cells were impregnated 
sequentially in 25%, 50%, 75% and 100% resin (in methanol). A final embed was performed 
in 100% resin at 60˚C for 24 to 36 h. to check if cells were not present, sections of 0.5 µm 
thickness were cut and stained with 1% toluidine blue in 1% borax. Ultrathin sections of 70 nm 
were then cut with a diamond knife using a Leica EM UC7 ultramicrotome. Sections were 
stretched with chloroform to eliminate compression, transferred to a Pioloform-filmed copper 
grids and stained on a Leica EM AC20 automatic staining machine with 2% aqueous uranyl 
acetate 3% lead citrate. 
 
2.8 Protein Methods 
2.8.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was used to estimate the molecular weight of the proteins and their purity. It was 
used in protein purifications, western blots, and bocillin assays. BIO-RAD equipment was used 
with 12% acrylamide gels submerged in Tris buffer (20 mM Tris/HCl, 192 mM glycine, 0.1% 
SDS, pH 8.3). Protein samples (20 μl) were mixed with 10 μl of the loading buffer, boiled for 
10 min at 100˚C and centrifuged for 30 s at 18000 g. The supernatant (20 μl) was loaded to the 
gel wells and the gel was run at 100 V to completion. Gels were stained with Coomassie brilliant 
blue for 8 min on a shaker, then destained with (30% ethanol, 60% H2O, 10% acetic acid) for 
8 min. Sufficiently destained gels were scanned using an EPSON perfection V350 scanner and 
the accompanying software.  
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2.8.2 Western Blot 
A BIO-RAD wet-blot system was used for this experiment. Proteins were separated by SDS-
PAGE and transferred to a nitrocellulose membrane. The transfer was done in buffer I (20 mM 
Tris/HCl, 192 mM glycine, 0.1% SDS, 10% methanol, pH 8.3) with a current of 0.35 A for 1 
h. The membrane was submerged in Tris-buffered saline (TBS, 10 mM Tris/HCl, 0.09% NaCl, 
pH 7.4) supplemented with 0.5% casein (blocking buffer) overnight and stored at 4˚C. The 
buffer was discarded and the membrane was submerged in 10 ml TBS with a protein specific 
antibody and incubated at room temperature for 90 min. The membrane was washed with 3 × 
10 ml TBST buffer (10 mM Tris/HCl, 0.09% NaCl, 0.08% Tween, pH 7.4) for 10 min. TBS 
buffer (10 ml) containing a secondary antibody was added to the membrane followed by 
incubation for 90 min at RT. Another membrane wash using 3 × 10 ml TBST buffer was 
performed for 10 min/wash and an enhanced chemiluminescence ECL Prime kit (GE 
Healthcare) was used for antibody labelling as per the manufacturer’s instruction. Blots were 
visualized using ImageQuant LAS4000mini biomolecular imager (GE Healthcare) with 
accompanying software. 
 
2.8.3 Determination of protein concentration in solution 
The concentration of proteins in buffers containing Triton X-100 were measured using a BCA 
protein assay kit (Thermo scientific) as per the manufacturer’s instruction. Concentrations of 
soluble proteins were measured using a Nano-drop spectrophotometer with ND1000 V3.7.1 
software.  
 
2.9 Protein purification methods 
2.9.1 Purification of PBP1  
The PBP1 purification protocol was adopted from (Rismondo et al., 2016) and modified. 
BL21(DE3) pET28a (+)::ponA cells were grown in 2 × 50 ml LB for 4 h at 37˚C. LB medium 
(5 × 1 l) with 50 μg/ml kanamycin and 20 ml/l auto-induction medium (250 mg/l glycerol, 100 
g/L α-lactose and 25 g/L glucose) was inoculated with 50 ml of the previous culture and cells 
were grown at 30˚C for 18 h. Cells were harvested then resuspended in 130 mL lysis buffer (50 
mM Hepes/NaOH, 500 mM NaCl, 3 mM MgCl2, 0.3 mM DTT, pH 7.5) and supplemented with 
1/1000 protease inhibitor cocktail (PIC), phenylmethylsulfonylfluoride (PMSF, 100 mM stock) 
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and desiccated DNase (≈ 1 mg). Cells were sonicated for 3 × 20 seconds at 5, 16, 22, 33, 44 
and 60 W. Cell membranes were pelleted by ultracentrifuge at 133907 g for 1 h at 4˚C. 
Membrane pellets were resuspended in 120 ml resuspension buffer (50 mM Hepes/NaOH, 500 
mM NaCl, 3 mM MgCl2, 2% Triton X-100, 15% glycerol, 10 mM β-mercaptoethanol, pH 7.5) 
supplemented with PIC and PMSF as before and stirred for 3 h at 4˚C. Membrane extracts were 
ultracentrifuged at 100000 g for 1 h at 4°C and the supernatant was supplied with 20 mM 
imidazole.  The first purification step was done with a 5 ml HisTrap HP column by using an 
ÄKTAprime plus FPLC. The column was equilibrated with 50 ml running buffer (50 mM 
Hepes/NaOH, 500 mM NaCl, 3 mM MgCl2, 0.2% reduced Triton X-100, 15% glycerol, 20 mM 
imidazole, pH 7.5). The protein mixture was loaded to the column via a 50 ml superloop at a 
flow rate of 1 ml/min, followed by column washing with the same running buffer. Proteins were 
eluted at a flow rate of 1 ml/min with elution buffer (same as running buffer with 250 mM 
imidazole). Protein samples were mixed with restriction grade thrombin and dialysed overnight 
at 4˚C against 3 × 1 l dialysis buffer (25 mM Hepes/NaOH, 300 mM NaCl, 10% glycerol, 0.2% 
Triton X-100, pH 8.5). Afterwards, an ion exchange chromatography was performed using Äkta 
Prime FPLC with a HiTrap SP HP column. The column was washed with 50 ml distilled water 
followed by 50 ml of dialysis buffer supplemented with 0.2% Triton X-100 (buffer I). The 
dialysed protein samples were injected into the column at a 1 ml/min flow rate. The column 
was washed with 30 ml buffer I and proteins were eluted in a 200 ml gradient with buffer II (10 
mM Hepes/NaOH, 1 M NaCl, 3 mM MgCl2, 0.2% Triton X-100, 12% glycerol, pH 7.5). The 
third purification step consisted of a size exclusion chromatography using a Superdex 75 
HR16/60 ml column that was washed with water and then equilibrated with SEC buffer (10 
mM Hepes/NaOH, 300 mM NaCl, 3 mM MgCl2, 0.2% Triton X-100, 12% glycerol, pH 7.5). 
Protein samples were injected into the column at 0.5 ml/min flow rate and 4 ml fractions were 
collected. Collected samples were analysed by SDS-PAGE.  
 
2.9.2 Purification of PBP2B  
BL21(DE3) pET28a (+)::pbpB cells were grown in 2 × 50 ml LB overnight at 30˚C. Fresh LB 
medium (3 × 1 l) with 50 μg/ml kanamycin was inoculated with 30 ml of the overnight culture 
and cells were grown at 37˚C to an OD578 of 0.5. The expression of PBP2B was induced with 
1 mM IPTG for 3 h at 30˚C. Cells were pelleted by centrifugation (6371 g / 4˚C/ 15 min) and 
resuspended in 40 ml buffer I (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, pH 7.5). 1/1000 
PIC and PMSF were added and desiccated DNase (≈ 1 mg). Cells were sonicated for 3 × 20 s 
at 5, 16, 22, 33, 44 and 60 W. Membrane proteins were pelleted by ultracentrifuge (133907 g / 
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4˚C/1 h) and the soluble fraction was discarded. The pellet was resuspended in 50 ml running 
buffer (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 20 mM imidazol, 10% glycerol, 2% Triton 
X-100, pH 7.5). Nickel beads were washed with 30 ml distilled water and 30 ml running buffer. 
Solubilised proteins were added to the equilibrated beads and mixed gently for 24 hr at 4˚C. 
The mixture was applied to a gravity column where unbound protein flowed through the filter. 
The beads were washed with 40 ml running buffer. Bound proteins were eluted using elution 
buffer (25 mM Tris/HCl, 10 mM MgCl2, 400 mM imidazole, 1 M NaCl, 0.2% Triton X-100, 
pH 7.5) and 3 ml fractions were collected. Restriction grade thrombin (1 µl per 1 ml protein) 
was added to the appropriate elution fractions that were dialysed against 2 × 2 L of dialysis 
buffer I (25 mM Tris/HCl, 500 mM NaCl, pH 6.0) and 2 × 2 l of dialysis buffer II (25 mM 
Tris/HCl, 100 mM NaCl,  pH 6) overnight at 4˚C. Ion exchange chromatography was performed 
using an Äkta Prime FPLC with a HiTrap SP HP column, which was washed with 50 ml 
distilled water followed by 50 ml of buffer I (25 mM Tris/HCl, 100 mM NaCl, 0.2% Triton X-
100, pH 6). The dialysed proteins were injected into the column and bound proteins were eluted 
in a gradient buffer II (25 mM Tris/HCl, 1 M NaCl, 0.2% Triton X-100, pH 7.5). Collected 
samples were analysed for purity by SDS-PAGE. 
  
 
2.9.3 Purification PBP2B(S309A)  
BL21(DE3) pET28a (+)::pbpB(S309A) cells were grown in 2 × 50 ml LB for overnight at 30˚C. 
LB medium (5 × 1 l) with 50 μg/ml kanamycin was inoculated with 30 ml of the overnight 
culture and cells were grown at 37˚C to OD578 of 0.5. The expression of pbpB(S309A) (pbpB*)  
was induced with 1 mM IPTG for 3.5 h at 30˚C. Cells were pelleted by centrifugation (6371 g 
/ 4˚C/ 15 min), and resuspended in 80 ml buffer I (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 
pH 7.5). 1/1000 PIC and PMSF were added and desiccated DNase (≈ 1 mg). Cells were 
sonicated for 3 × 20 s at 5, 16, 22, 33, 44 and 60 W. Membrane proteins were pelleted by 
ultracentrifuge (133907 g / 4˚C/1 h) and the soluble fraction was discarded. The pellet was 
resuspended in 100 ml running buffer (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 20 mM 
imidazole, 10% glycerol, 2% Triton X-100, pH 7.5). The subsequent steps consisted of affinity 
chromatography using nickel beads (1.5 ml) and ion exchange chromatography using a HiTrap 
SP HP column. The two chromatography experiments were performed as described in section 
2.9.2.  
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2.9.4 Purification of PBP3  
BL21(DE3) pET28a (+)::pbpC cells were grown in 50 ml LB for overnight at 30˚C. LB medium 
(3×1 l) with 50 μg/ml kanamycin was inoculated with 30 ml of the overnight culture and cells 
were grown at 37˚C to an OD578 of 0.5. The expression of pbpC was induced with 1 mM IPTG 
for 3 h at 30˚C. Cells were pelleted by centrifugation (6371 g / 4˚C/ 15 min), and resuspended 
in 40 ml buffer I (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, pH 7.5). 1/1000 PIC and PMSF 
were added and desiccated DNase (≈ 1 mg). Cells were sonicated for 3 × 20 s at 5, 16, 22, 33, 
44 and 60 W. Membrane proteins were pelleted by ultracentrifuge (133907 g / 4˚C/1 h) and the 
soluble fraction was discarded. The pellet was resuspended in the appropriate amount of 
running buffer (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 20 mM imidazol, 10% glycerol, 
2% Triton X-100, pH 7.5). Nickel beads (3 ml) were washed with 30 ml distilled water and 30 
ml running buffer. Solubilised proteins were added to the equilibrated beads and mixed gently 
for 24 h at 4˚C. The mixture was applied to a gravity column where unbound protein flowed 
through the filter. The beads were washed with 40 ml running buffer. Bound proteins were 
eluted using elution buffer (25 mM Tris/HCl, 10 mM MgCl2, 400 mM imidazole, 1 M NaCl, 
0.2% Triton X-100, pH 7.5) and 3 ml fractions were collected. Restriction grade thrombin was 
added to the appropriate elution fractions that were dialysed against 2 × 2 l of dialysis buffer I 
(25 mM Tris/HCl, 500 mM NaCl, pH 8.3) and 2 × 2 l of dialysis buffer II (25 mM Tris/HCl, 
100 mM NaCl, pH 8.3) overnight at 4˚C. Ion exchange chromatography was then performed 
using an Äkta Prime FPLC with a HiTrap monoQ column, which was washed with 50 ml 
distilled water followed by 50 ml of buffer I (25 mM Tris/HCl, 100 mM NaCl, 0.2% Triton X-
100, pH 6). Dialysed protein was injected into the column and bound proteins were eluted in a 
200 ml gradient buffer II (25 mM Tris/HCl, 1 M NaCl, 0.2% Triton X-100, pH 6). Collected 
samples were analysed by SDS-PAGE.  
 
2.9.5 Purification of PBP3(17-668)  
BL21(DE3) pET28(a)+ pbpCΔ1-51 cells were grown in 20 ml LB for overnight at 30˚C. LB 
medium (3×1 l) with 50 μg/ml kanamycin was inoculated with 30 ml of the overnight culture 
and cells were grown at 37˚C to an OD578 of 0.5. Plasmid expression was induced with 1 mM 
IPTG for 3 h at 30˚C. Cells were harvested by centrifugation (6371 g/ 15 min/ 4˚C) and 
resuspended in 40 ml of buffer I (25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, pH 7.5). 1/1000 
PIC and PMSF were added and desiccated DNase (≈ 1 mg). Cells were sonicated for 3 × 20 s 
at 5, 16, 22, 33, 44 and 60 W. Cell membranes were pelleted by ultracentrifuge (133907 g/ 1 h/ 
4˚C). Nickel beads were washed with 30 ml distilled water and 30 ml running buffer (25 mM 
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Tris/HCl, 20 mM imidazole, 10 mM MgCl2, 1 M NaCl, pH 7.5). The soluble fraction of the 
pelleted cell membrane was mixed with the equilibrated beads. Imidazole was added to the mix 
to a final concentration of 20 mM and the mixture was gently mixed for 24 h at 4˚C. The mixture 
was applied to a gravity column where unbound protein flowed through the filter. The beads 
were washed with 40 ml running buffer. Bound proteins were eluted using elution buffer (25 
mM Tris/HCl, 400 mM imidazole, 10 mM MgCl2, 1 M NaCl, pH 7.5) and 3 ml fractions were 
collected. Restriction grade thrombin was added to the appropriate elution fractions that were 
dialysed against 2 × 2 l of dialysis buffer (25 mM Tris/HCl, 100 mM NaCl, pH 8.3) overnight 
at 4˚C. Ion exchange chromatography was then performed using an Äkta Prime FPLC with a 
HiTrap monoQ column, which was washed with 50 ml distilled water followed by 50 ml of 
buffer I (25 mM Tris/HCl, pH 8.3, 100 mM NaCl). The dialysed protein sample was injected 
into the column. The protein didn’t bind to the column and was collected in the flow through. 
The column was washed with Buffer II (25 mM Tris/HCl, pH 7.5, 1 M NaCl). PBP3 containing 
samples were concentrated to a volume < 5 ml by centrifugation (3893 g/ 4˚C / 15 min). The 
third purification step consisted of a size exclusion chromatography using a superdex 75 16/60 
ml column that was washed with water and then equilibrated with SEC buffer (25 mM Tris/HCl, 
500 mM NaCl, pH 7.5). Protein samples were injected into the column and 4 ml fractions were 
collected. Collected samples were analysed for purity by SDS-PAGE.  
 
2.9.6 Purification of PBP3(S410A)  
PBP3(S410A) (PBP3*) was purified according to the PBP3 purification protocol using 
BL21(DE3) pET28a+::pbpC* cells. The difference was that PBP3* was dialysed to pH 8.5 
instead 8.3, allowing the binding of the protein to the HiTrap monoQ column followed by the 
elution of PBP3* using a gradient of buffer II (25 mM Tris/HCl, 1 M NaCl, 0.2% Triton X-
100, pH 7.5). 
 
2.9.7 Purification of YrrL  
YrrL was purified following the same protocol for the purification of PBP2B. 
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2.9.8 Purification of PBP3 antibody 
Affinity chromatography was performed for the purification of antibodies from serum with 
immobilised antigen. The purification consisted of 2 steps: 
Step 1.  
CNBr-activated sepharose beads (desiccated) (0.8 g) were placed into a gravity column and 
washed with 200 ml of 1 mM HCl for 15 min. PBP3 protein, diluted to 0.5 mg/ml using coupling 
buffer (100 mM NaHCO3, 10 mM MgCl2, 500 mM NaCl, 0.1% Triton X-100, pH 8.3), was 
applied to the sepharose beads and incubated overnight at 4˚C with mixing. The beads were 
washed with 25 ml coupling buffer. The remaining active groups of the beads were blocked 
with 10 ml blocking buffer (200 mM Tris/HCl, 500 mM NaCl, 10 mM MgCl2, 0.1% Triton X-
100, pH 8.0). The mix was incubated overnight at 4˚C with mixing. The gravity column was 
washed 3 × 20 ml with acetate buffer (100 mM sodium acetate, 500 mM NaCl, 10 mM MgCl2, 
0.1% Triton X-100, pH 4.8) and blocking buffer. The beads were washed with 5 ml binding 
buffer (10 mM Tris/HCl, 10 mM MgCl2, 50 mM NaCl, 0.1% Triton X-100, pH 6.8) and stored 
in 5 ml binding buffer ready for use.  
 
Step 2.  
The beads were first washed with 1 × 5 ml elution buffer I (100 mM glycine/HCl, 0.1% Triton 
X-100, pH 2.0).  then washed with 30 ml buffer I (10 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 
0.1% Triton X-100, pH 7.2). The serum (10 ml) was diluted with 35 ml diluent (10 mM 
Tris/HCl, 0.1% Triton X-100, pH 7.4) and centrifuged (4500 rpm / 4˚C / 10 min). The 
supernatant was then incubated with the PBP3-sepharose material for 20 hours at 4°C with 
gentle mixing. The mixture was transferred back to the gravity column, the solution flowed 
through, and the bead material was collected. Beads were washed with 20 ml buffer I followed 
by 20 ml buffer II (10 mM Tris/HCl, 10 mM MgCl2, 150 mM NaCl, 0.1% Triton X-100, pH 
7.2). Bound antibodies were eluted with 10 × 1 ml of elution buffer I (100 mM glycine/HCl, 
0.1% Triton X-100, pH 2.0) into tubes containing 200 μl of elution buffer II (2 M Tris/HCl, pH 
8.0). Glycerol (300 μl) was added to each 1.2 ml sample, which was analysed by SDS-PAGE 
and stored at -80˚C. 
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2.10 Other protein methods  
2.10.1 In vitro cross-linking pulldown assay 
This method was adapted from (Egan et al., 2015). Proteins (1 µM) were mixed in 200 μl 
binding buffer (10 mM Hepes/NaOH, 10 mM MgCl2, 150 mM NaCl, 0.05% Triton X-100, pH 
7.5). Samples were incubated for 10 min at room temperature followed by the addition of 0.2% 
w/v formaldehyde (Sigma, USA) and further incubation at 37˚C for 10 min. Blocking buffer 
(100 mM Tris/HCl, pH 7.5) was added to block the excess cross-linker and samples were 
incubated for 10 min at room temperature.  Samples were applied to 100 µl of washed and 
equilibrated Ni-NTA superflow beads (Qiagen, The Netherlands) and incubated overnight at 
4˚C with gentle mixing. In the absence of cross-linker, proteins were mixed straight away with 
the Ni-NTA beads. The beads were then washed with 8 × 1 ml wash buffer (10 mM 
Hepes/NaOH, 10 mM MgCl2, 500 mM NaCl, 50 mM imidazole, 0.05% Triton X-100, pH 7.5) 
and boiled in SDS–PAGE loading buffer. Beads were then pelleted by centrifugation and 
samples analysed by SDS–PAGE. Gels were stained with Coomassie brilliant blue (Roth, 
Germany). 
 
2.10.2 Surface Plasmon Resonance (SPR) assay 
Immobilization of PBPs to ampicillin-coated sensor chips.  
This method was adapted from (Vollmer et al., 1999). A ProteOn XPR36 system and associated 
software (BioRad) were used for this experiment. Ampicillin has a free amino group in the side 
chain that was immobilised to a GLC sensor chip via amino coupling following the standard N-
ethyl-N9-(3-dimethylaminopropyl)-carbodimide hydrochloride/N-hydroxysuccinimide 
procedure recommended by BioRad. The chip temperature was set to 35˚C then initialised with 
air or glycerol. Buffer lines were put in immobilization buffer (10 mM Tris/maleate, 150 mM 
NaCl, 0.05% Triton X-100, pH 7.5) and the chip was preconditioned by injecting 0.5% SDS, 
50 mM NaOH then 100 mM HCl. The chip was activated by injecting 70 µl of a 1:1 mixture of 
400 mM N-ethyl-N9-(3-dimethylaminopropyl)-carbodimide hydrochloride and 100 mM N-
hydroxysuccinimide. Ampicillin solution (10 mg/ml in 100 mM sodium acetate buffer, pH 4.6) 
was applied for 5 min and immobilized to the chip surface giving a response of approximately 
80 to 120 RU. Ethanolamine (1 M) was used to block the free remaining activated functional 
groups on the chip surface. PBPs were injected at optimum μg/ml concentration to the 
ampicillin matrix (optimal response signal is 1000 to 2000 RUs) at a rate of 30 μl/min for 5 
min. As a control, immobilisation buffer with no protein was injected onto the ampicillin 
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surface. The surface was then rinsed with regeneration buffer (10 mM Tris/maleate, 1 M NaCl, 
2% Triton X-100, pH 6.8). β-lactamase solution (0.1 unit/µl, Merck) was injected at to digest 
the remaining free ampicillin.  
 
Protein-protein interaction studies 
Binding assays were performed at 25˚C in running buffer (10 mM Tris/Maleate, 250 mM NaCl, 
0.05% Triton X-100, pH 7.5). Proteins to be injected (analyte) were dialysed into 2 × 1 l of 
dialysis buffer (10 mM Tris/Maleate, 250 mM NaCl, pH 7.5) then centrifuged using a Beckman 
TLA120.2 rotor (90000 rpm, 30 min, 4˚C) to remove aggregates. The concentration of the 
protein was measured again and the analytes were diluted in running buffer to 6 concentration 
ranges from 0 to 2 μM. It was important to make sure the Triton X-100 level in the analyte was 
as close to the running buffer as possible. Immobilized protein surfaces were regenerated with 
regeneration buffer (10 mM Tris/maleate, 1 M NaCl, 2% Triton X-100 and pH 7.5) injected for 
3 min at 100 μl/min.   
 
Estimation of kinetic parameters 
SigmaPlot software (windows version 13.0) was used for kinetic calculations. Several repeats 
(at least 3) were required across a range of analyte concentrations. The KD (nM) of ligand 
binding was based on the assumption of a one site saturation with the use of the equation y =
Bmax × x
(Kd+x)
  where y is the response (RU) for an analyte concentration in (nM), and Bmax is the 
maximum response recorded (RU).  
 
2.10.3 In vitro glycosyltransferase activity assay 
This method was performed as published with modifications (Banzhaf et al., 2012; Offant et 
al., 2010; Schwartz et al., 2002) (Figure 2.3). The experiment was performed in a FLUOstar 
OPTIMA microplate reader (BMG Labtech, Offenburg, Germany) using a medium-binding 
black 96-well microplate (Greiner Bio-One ref. 655076, Freickenhausen, Germany). Samples 
(60 µl each) consisted of 0.5 µM of each protein and lysine-dansylated lipid II (10 µM) in 50 
mM Hepes/NaOH, 10 mM CaCl2, 20 mM NaCl, 0.5 µg/µl cellosyl, 0.02% Triton X-100 pH 
7.5. Samples were prepared without the addition of lipid II, transferred to the microplate and 
incubated at 30˚C for 3 min. Reactions were initiated by adding lipid II (dissolved in H2O) to 
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samples and the GTase activity was measured over the time course of 20 min at 30˚C. The 
fluorophore was excited with 340 nm wavelength and the emission was recorded at a 
wavelength of 520 nm. The experiment consisted of 60 cycles of 20 s with orbital shaking. The 
data shown represent the mean florescence presented as a percentage of initial fluorescence at 
a given time-point.  The gradient of the curve at its steepest point correspond to the rate of 
reaction. 
 
 
 
 
 
 
 
 
2.10.4 In vitro peptidoglycan synthesis assay 
This method was adapted from (Bertsche et al., 2005) (Figure 2.4). The reaction was performed 
in standard buffer condition (10 mM Hepes/NaOH, 10 mM CaCl2, 20 mM NaCl, 0.02% Triton 
X-100, pH 7.5). Appropriate amount of [14C]-GlcNAc labelled mDap Lipid II was used to 
obtain a final concentration of 15 µM in 100 µl. A volume of Lipid II was first dried then 
resuspended in 5 μl on 0.1% Triton X-100. Protein solution (95 μl total volume) was prepared 
in a standard buffer condition and left on ice for 10 min. Lipid II was then added to the protein 
mix which was briefly vortexed and incubated at 37˚C with shaking (850 rpm) in a thermomixer 
for 1 h. Samples were heated for 4 min at 100˚C to stop the reaction before digestion with 
muramidase to produce muropeptides for HPLC analysis (Section 2.11.3).  
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Figure 2.3 In vitro glycosyltransferase assay 
Fluorescently labelled lipid II is used to monitor the GTase activity of PBPs in vitro. In the presence of 
GTase activity lipid II is polymerised into glycan chains, which are digested by muramidases into 
muropeptides. Labelled muropeptides has lower level of fluorescence than labelled lipid II. Such 
decrease in the levels of fluorescence is monitored over time and the data is presented as a percentage 
of the initial fluorescence.  
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2.10.5 Bocillin binding assay  
This assay was used to test the binding of β-lactams to the TPase domain of PBPs. The method 
was adopted from a published protocol (Zhao et al., 1999) with minor modification. PBPs (10 
µg) were mixed with 1 ng/µl of the fluorescently labelled β-lactam bocillin (Molecular Probes, 
Life Technologies, UK) and incubated for 10 min at 37˚C. As a control, the same amount of 
PBPs were mixed with 1 ng/µl penicillin G and incubated at 37˚C for 10 min prior to the 
addition of bocillin. Samples were analysed by SDS-PAGE and the final gel was scanned with 
a Typhoon scanner using a blue FAM channel at 488 nm. 
 
2.11 Cell wall analysis methods 
2.11.1 Cell wall purification  
This method was adopted from (Atrih et al., 1999) and modified as per (Bisicchia et al., 2011). 
Culture (1 l) of B. subtilis cells was grown to OD600 0.5 then cooled down in an ice bath to 
4˚C. Cells were pelleted (10,000 g/ 4˚C/ 15 min) then resuspended in 30 ml ice-cold 50 mM 
Figure 2.4 In vitro peptidoglycan synthesis assays  
Radio labelled lipid II is used to test the GTase and TPase activities of PBPs in vitro. Lipid II is 
polymerised into glycan chains by GTase activity and peptides are crosslinked by TPase activity. After 
1 hour, the reaction is stopped by boiling followed by digestion of the PG with muramidase generating 
muropeptides that are subsequently reduced and analysed by HPLC.  
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Tris/HCl, pH 7. Cell suspension was dropped into 120 ml of slightly boiling 5% SDS, left to 
boil for an additional 15 min, and then the lysate was cooled down at room temperature 
overnight. Lysates were transferred to PPCO Nalgene 50 ml round bottom tubes and centrifuged 
(12000 g/ 30 min/ room temperature). The supernatant was discarded, and the pellet was 
resuspended in 20 ml of 1 M NaCl. The lysate was centrifuged again as above with 1 M NaCl 
and then with H2OMilliQ until the suspension was free of SDS (6 to 8 times). The pellet was 
resuspended in H2OMilliQ (6 ml) and transferred to 2 ml screw cap tubes filled to 1/3 with glass 
beads. Cells were broken down using a bead beater (Thermo FastPrep FP120) with 12 cycles 
of 3 × 6.5 pulse speed for 20 s. After each cycle the tubes were cooled on ice for a few minutes 
before the subsequent cycle starts. The broken cells were filtered through a glass frit to remove 
the glass beads, which were washed with 10 ml H2OMilliQ. The filtrate was then transferred to a 
50 ml Falcon tube and centrifuged (2000 g/ 5 min/ room temperature). The supernatant was 
transferred to a PPCO Nalgene tube while the pellet was resuspended in 25 ml H2OMilliQ, 
centrifuged as before and the supernatant was added to the PPCO Nalgene tube, which was 
centrifuged for 30 min at 25000 g. The pellet was resuspended in 10 ml Tris buffer (100 mM 
Tris/HCl, 20 mM MgSO4, pH 7.5) to which DNase I (10 μg/ml [Sigma]) and RNase (50 μg/ml 
[Sigma]) were added. The sample was stirred at 37˚C for 2 h followed by the addition of CaCl2 
(10 mM) and trypsin (Novagen/Merck), porcine pancreas (100 μg/ml) and stirred for another 
18h at 37˚C. 20 ml of 1% SDS was added and the tube was incubated for 15 min at 80˚C in a 
water bath. The mix was then centrifuged (25000 g/ 30 min/ room temperature) and the pellet 
was resuspended in 10 ml LiCl (8 M). The sample was incubated for 15 min at 37˚C then 
Centrifuged as above. The pellet was resuspended in 10 ml EDTA (100 mM and pH 7.0), 
incubated for 15 min at 37˚C then centrifuged as above. The pellet was washed, resuspended 
and centrifuged twice with 30 ml H2O MilliQ, then centrifuged and resuspended in 3 ml H2O 
MilliQ. The suspension was transferred to a glass container and frozen at -80˚C for at least 1 h 
then lyophilized for 2 days using an Alpha 1-2 freeze dryer (Biopharma).  
 
2.11.2 Isolation of peptidoglycan from cell wall 
Cell wall (5 mg) was transferred to a polyallomer tube for the 100.3 rotor (desktop-UZ) and 
dissolved in 3 ml hydrofluoric acid at 4˚C for 48 h with stirring. Next, the tube was centrifuged 
in a precooled TL 100 rotor (90000 rpm, 4˚C, and 30 min). The supernatant was discarded and 
the pellet was washed, resuspended and centrifuged twice with 3 ml with ice-cold H2O MilliQ, 
once with 3 ml with ice-cold 100 mM Tris/HCl pH 7.0 and twice with 3 ml with ice-cold 
H2OMilliQ, respectively. After washing, the murein was resuspended in 500 μl of ice-cold 
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H2OMilliQ and transferred to a 2 ml screw-cap tube. Sodium azide (0.05%) was added and 
samples were kept at 4˚C. 
 
2.11.3 Muropeptide preparation and analysis  
Muropeptides were generated from the digestion of peptidoglycan with cellosyl (Hoechst, 
Germany) following an established protocol (Glauner et al., 1988). Peptidoglycan was either 
isolated from cells (Section 2.11.1) or produced in the in vitro peptidoglycan synthesis assay 
(Section 2.10.4). Cellosyl buffer (80 mM NaH2PO4, pH 4.8) was added to samples for a final 
concentration of 20 mM NaH2PO4 with 8 μg of cellosyl. Samples were incubated for 2 h at 
37°C with shaking (850 rpm) for in vitro synthesised PG, or overnight for isolated sacculi.  
Samples were incubated at 100°C for 7 min and centrifuged at 14,000 rpm for 10 min. An equal 
volume of sodium borate (0.5 M, pH 9.0) was added to samples in addition to a full small 
spatula of solid sodium borohydride and centrifuged at 4000 rpm for 30 min. The pH was 
adjusted between 3 and 4 with 20% phosphoric acid and the sample was transferred to HPLC 
tubes ready for analysis. 
The HPLC analysis was performed using Agilent Technologies Series 1200 HPLC system with 
a reverse phase column (Prontosil 120-3-C18-AQ 3 µM, Bischoff). For PG isolated from B. 
subtilis cells a linear gradient was used from 100% solvent A (40 mM sodium phosphate pH 
4.5 + 0.0003% NaN3) to 100% solvent B (40 mM sodium phosphate, 20% methanol, pH 4.0) 
at 55˚C, for 5 h. For PG isolated from the in vitro peptidoglycan synthesis assay a linear gradient 
was used from 100% solvent A (50 mM sodium phosphate pH 4.31 + 0.0002% NaN3) to 100% 
solvent B (75 mM sodium phosphate, 15% methanol, pH 4.75) at 55˚C, for 90 min.  
Muropeptides were detected by a UV detector at 205 nm and [14C]-labelled muropeptides were 
detected by an online scintillation counter (Agilent Technologies). Laura software v4.1.7.70 
(LabLogic Systems Ltd) was used for the data analysis. The detected muropeptides are shown 
in figure S2. The levels of peptides in crosslink (x) was calculated using the formula x = 100 - 
(%TetraTetra + %TetraPenta). 
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Figure 2.5 Chemical structure of muropeptides detected by HPLC 
The chemical structures of muropeptides from in vitro PG synthesis assays. 1, Penta-P, the product of 
glycan chain ends and/or unreacted substrate. 2, Penta-P-P, produced after boiling lipid II for a 
prolonged time. 3, Tetra-peptide, the product of both GTase and the CPase activities. 4, Penta-peptide, 
the product of GTase alone. 5, TetraTetra-, the product of GTase, TPase and CPase activities. 6, 
TetraPenta-, product of GTase and TPase activities.  
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3 The impact of carbon metabolism on the synthesis of PG 
3.1 Effects of glucolipid absence on cell growth and morphology  
3.1.1 Introduction  
Changes in the glucose and magnesium ion concentrations of the culture medium ameliorated 
the growth of several mutants with cell wall defects probably by changing their metabolic status 
(Formstone and Errington, 2005; Murray et al., 1998a). The focus of this part of the work was 
to study the effect of carbon metabolism on cell wall synthesis in B. subtilis. It was suggested 
that proteins involved in the synthesis of the LTA glucolipid anchor, such as UgtP, PgcA and 
GtaB, link nutrient availability to cell division, however, the impact of these proteins on the cell 
wall is still unclear (Weart et al., 2007). In this work, we studied the effect of the absence of 
UgtP, PgcA or GtaB on cell growth and morphology. We also studied the effect of glucolipid 
absence on PG synthesis. As part of the AMBER-ITN consortium, we used the BSB1 strain as 
the wild type for these experiments (Nicolas et al., 2012).  
 
3.1.2 Strains with single deletions in ugtP, gtaB and pgcA do no exhibit growth defects  
To study the effect of the absence of UgtP, GtaB or PgcA on cell growth and morphology, we 
replaced the coding sequence of these genes with neomycin, tetracycline and erythromycin 
resistance cassettes, respectively. Copies of the deleted genes were introduced in the amyE or 
aprE loci to create complementation strains (Section 2.6.3). For ΔugtP complementation, a 
copy of the ugtP gene was introduced in the amyE locus under the control of a hyper-spank 
IPTG inducible promoter. For ΔpgcA or ΔgtaB complementation, a copy of the gene was 
introduced in the aprE locus under a Pspac IPTG inducible promoter. The growth and 
morphology of strains with single deletions in ugtP, gtaB and pgcA were studied and compared 
to wild type. Complementation strains were characterised in presence or absence of inducer. 
The ugtP, gtaB and pgcA mutants in addition to the complementation strains showed similar 
growth curves to wild-type cell (Figure 3.1). 
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3.1.3 The absence of UgtP, GtaB or PgcA causes short cells  
The morphology of cells lacking UgtP, GtaB or PgcA during exponential phase was studied 
using fluorescence microscopy and Nile red membrane dye was used to visualise possible cell 
membrane defects (section 2.7.1). The white spots that were observed at the cell periphery (in 
<1% of the cells) are artefacts of the dye. The cell widths and cell lengths for all mutants were 
quantified using ImageJ. The absence of UgtP caused shorter and wider cells than wild type 
(Figure 3.2). The ugtP complementation strain showed longer cells than the ugtP mutant in the 
absence of inducer which was probably due to the leaky expression of the ectopic ugtP. The 
presence of 0.1 mM IPTG was sufficient to cause longer and thinner cells than wild type, in 
addition to a chaining morphology (Figure 3.2 and 3.5). Septum mislocalisation was also 
observed occasionally (≈ 5% of cells had septal mislocalisation), and the frequency of such 
mislocalisation increased in presence of 1 mM IPTG (≈ 20%). This morphology was probably 
caused by the inhibition of FtsZ polymerization by UgtP (Weart et al., 2007).  
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Figure 3.1 Growth curves for the ugtP, gtaB, pgcA mutants and complementation strains 
The growth curves for mutants and corresponding complemented strains in LB media at 37˚C. UgtP, 
gtaB or pgcA complementation strains were grown in the presence or absence of IPTG. All mutants 
had similar growth curves to BSB1.   
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Figure 3.2 Morphology and complementation of cells lacking UgtP 
Phase contrast and cell membrane stained images of BSB1, BSB1ΔugtP, and BSB1ΔugtP Pspank ugtP 
mutants. The ugtP complementation mutant was grown in the presence or absence of IPTG. Cell 
dimensions represent the mean cell length ± standard deviation of 100 cells. The lack of UgtP caused 
short and wide cells. The overexpression of ugtP resulted in long and chained cells. NA, not assigned 
due to the high variations in cell length caused by septum mislocalisation. Scale bars: 4 µm. 
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The absence of GtaB caused similar cell morphology to the absence of UgtP. Microscopic 
analysis of the gtaB mutant showed shorter and slightly wider cells during exponential phase 
when grown in nutrient rich medium (Figure 3.3 and 3.5). The complementation of gtaB 
restored the cell length and decreased the cell width almost back to wild type values.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Morphology and complementation of cells lacking GtaB 
Phase contrast and cell membrane stained images of BSB1, BSB1ΔgtaB, and BSB1ΔgtaB Pspac gtaB 
cells. The gtaB complementation mutant was grown in the presence or absence of IPTG. Cell 
dimensions represent the mean cell length or width ± standard deviation of 100 cells. The lack of GtaB 
caused short cells. The complementation of GtaB increased the cell length and decreased the cell width. 
Scale bars: 4 µm. 
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The replacement of the pgcA gene with a tetracycline resistance cassette resulted in short and 
chained cell morphology during exponential phase in nutrient rich medium (Figure 3.4 and 3.5). 
The lack of PgcA also caused slightly wider cells than wild type, a similar morphology to the 
gtaB mutant. The complementation of pgcA increased the length and decreased the width of the 
cells almost back to wild type values. The chaining effect was not seen in either ugtP or gtaB 
mutant cells suggesting that PgcA may have an additional unknown function in BSB1.  
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Figure 3.4 Morphology and complementation of cells lacking PgcA 
Phase contrast and cell membrane stained images of BSB1, BSB1ΔpgcA, and BSB1ΔpgcA Pspac pgcA 
cells. The pgcA complementation mutant was grown in the presence or absence of 1 mM IPTG. Cell 
dimensions represent the mean cell length and width ± standard deviation of 100 cells. The lack of 
PgcA caused shorter and wider cells than BSB1. The complementation of PgcA increased cell length 
and decreased cell width. Scale bars: 4 µm. 
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Figure 3.5 Summary of cell dimensions for wild type and mutant cells 
The diagrams represent the cell length (A) or cell width (B) of wild-type and mutant cells. The 
dimensions for the ugtP, gtaB or pgcA complementation strains were quantified when cells were grown 
with or without IPTG. Each column represents the mean cell length or width ± standard deviation of 
100 cell. All values significantly differed to that of BSB1 with P<0.01. 
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3.1.4 The absence of the PG synthase PBP1 in ugtP mutant causes thin and chained cells  
Morphological studies of cells lacking UgtP, GtaB or PgcA showed changes in cell dimensions 
compared to wild type. To investigate the effects of these deletions on cell wall synthesis, the 
levels of cell wall precursors were quantified by Joana Sousa at the University of Greifswald 
using LC-MS. In ΔugtP, ΔgtaB or ΔpgcA cells, the levels of LTA or WTA precursors such as 
UDP-glucose, glycerol-phosphate or CDP-glycerol were similar to wild type. Interestingly, the 
levels of several cytosolic PG precursors were higher in ΔugtP, ΔgtaB and ΔpgcA mutants 
compared to wild type (Figure 3.6). The level of precursors increased up to 3-fold for these 
mutant cells compared to BSB1; the highest precursor level was present in cells lacking UgtP, 
suggesting an upregulation of PG synthesis. To further investigate this hypothesis, PG synthesis 
in ΔugtP, ΔgtaB or ΔpgcA cells was disrupted and the growth and morphology of these strains 
were characterized. Bacillus subtilis has 4 bi-functional PBPs, PBP1, PBP2C, PBP4 and 
PBP2D (Bhavsar and Brown, 2006). PBP1, encoded by ponA, is the highest expressed PBP and 
plays an important role in PG synthesis during cell division (Pedersen et al., 1999). Cells 
lacking PBP1 were thinner and grew more slowly than BSB1 in nutrient rich medium (Popham 
and Setlow, 1995). The deletion of PBP1 in the BSB1ΔugtP mutant was lethal, however, it was 
possible to delete ponA in the ugtP complementation strain (BSB1ΔugtP Pspank ugtP). All 
mutants grew on NA plates with or without IPTG at 37˚C, however, the ΔponA mutant and the 
ΔponA ΔugtP Pspank ugtP mutant did not grow on PAB plates in the absence of IPTG at 37˚C 
(Figure 3.7). Interestingly, the ΔponA mutant recovered the growth defect on PAB plates when 
incubated at 45˚C but the ΔponA ΔugtP Pspank ugtP mutant did not when grown in the absence 
of IPTG. The reasons behind these different phenotypes are unclear due to the unknown effects 
of high temperature on cell wall synthesis. Nevertheless, these results show that the partial 
complementation of ugtP was sufficient to rescue cell growth. 
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Figure 3.6 Quantification of peptidoglycan precursors  
Relative quantification of cell wall precursors using LC-MS. The bars represent the mean ± standard 
deviation of three independent experiments. ΔugtP, ΔgtaB or ΔpgcA mutants showed higher levels of 
peptidoglycan precursors compared to wild type cells. *, values significantly differed to that of BSB1 
with P<0.01 
 
0
0.05
0.1
0.15
0.2
0
1
2
3
4
5
6
0
0.2
0.4
0.6
0.8
1
1.2
0
0.1
0.2
0.3
0.4
0.5
0
0.05
0.1
0.15
0.2
0.25
R
el
at
iv
e 
co
n
ce
n
tr
at
io
n
R
el
at
iv
e 
co
n
ce
n
tr
at
io
n
R
el
at
iv
e 
co
n
ce
n
tr
at
io
n
R
el
at
iv
e 
co
n
ce
n
tr
at
io
n
R
el
at
iv
e 
co
n
ce
n
tr
at
io
n
BSB1 ΔugtP ΔgtaB ΔpgcA
BSB1 ΔugtP ΔgtaB ΔpgcA
BSB1 ΔugtP ΔgtaB ΔpgcA
BSB1 ΔugtP ΔgtaB ΔpgcA BSB1 ΔugtP ΔgtaB ΔpgcA
N-acetylglucosamine-P UDP-GlcNAc 
UDP-MurNAc UDP-MurNAc-L-Ala 
UDP-MurNAc-L-Ala-Glu
* *
* * ** * *
* * *
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ΔponA ΔugtP Pspank ugtP mutant grown without IPTG exhibited cell chains that were 
thinner than the ponA mutant and longer than the ugtP mutant (Figure 3.8 and 3.9). The addition 
of 0.1 mM IPTG had no significant effect on the cell shape. The increase in IPTG concentration 
did not increase the width of the cells (Figure 3.9) and caused the formation of spots along the 
cell periphery (data not shown). These results suggest that the complementation is partial upon 
ugtP induction.   
 
 
 
 
 
 
ΔponA
ΔugtP
Pspank ugtP
- IPTGΔponABSB1
ΔponA
ΔugtP
Pspank ugtP
+ IPTG
37˚C
45˚C
Figure 3.7 Growth of several mutants lacking the PG synthase PBP1 on PAB plates 
PAB plates showing the growth of several mutants at 37 or 45˚C. The ΔponA mutant and the ΔponA 
ΔugtP Pspank ugtP mutant showed grow at 37˚C on PAB plates in the absence of IPTG. At 45˚C, the 
ΔponA mutant grew sufficiently on PAB plates whereas the ΔponA ΔugtP Pspank ugtP mutant was not 
able to grow in the absence of inducer.  
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Figure 3.8 Morphology of BSB1ΔugtP cells lacking the PG synthase PBP1 
Phase contrast and cell membrane stained images for vegetative cells grown in LB media. BSB1ΔponA 
and BSB1ΔugtP ΔponA Pspank ugtP mutants had thin cell morphology in the absence of IPTG. The 
addition of IPTG had no effect on the cell shape. Scale bars: 4 µm. 
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3.1.5 The effect of the S827 RNA on the cell width 
Based on the microarray data published by (Nicolas et al., 2012), the Subtiwiki web server 
(http://subtiwiki.uni-goettingen.de) suggested the presence of an anti-sense transcript called 
S827 that overlaps with the ugtP locus (Figure 3.10). In the BSB1ΔugtP mutant as well as in 
all published ugtP mutants the S827 transcript was disrupted (Matsuoka et al., 2011a; Salzberg 
and Helmann, 2008; Weart et al., 2007). In order to investigate if the S827 RNA is a reason for 
the partial complementation of ugtP, the S827 RNA was included in the ectopic expression of 
ugtP. Hence, ugtP was inserted into the amyE locus under the expression of an IPTG inducible 
promoter and the 3’ end of ugtP was extended to include the S827 RNA and its putative 
promoter. The complementation of S827 in BSB1ΔugtP ΔponA Pspank ugtP did not support cell 
growth on PAB plates at 37˚C or 45˚C (Figure 3.11 A), but it resulted in wider cells in the 
presence or absence of the inducer (Figure 3.9 and 3.11 B). These results suggest that the 
complementation of S827 did not rescue the growth of the BSB1ΔugtP ΔponA Pspank ugtP 
Figure 3.9 Cell width of mutant cells  
The diagram represents the mean cell width of several mutants. The ΔugtP ΔponA Pspank ugtP mutant 
was shorter than both BSB1 and the ΔponA mutant. The complementation of UgtP did not recover the 
cell width. Complementation of the S827 antisense RNA caused wider cells than ΔugtP ΔponA Pspank 
ugtP mutants. The ectopic expression of GtaB in ΔponA ΔgtaB Pspac gtaB mutant resulted in wider 
cells but not as wide as the ΔponA mutant. The complementation of PgcA in ΔponA ΔpgcA Pspac pgcA 
mutant had no effect on the cell width. Each column represents the mean cell width ± standard deviation 
of 100 cells. All values significantly differed to that of BSB1 with P<0.01. 
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mutant at high temperature but the RNA is probably partially responsible for the thin cell 
morphology of the latter mutant. The promoter sequence of the RNA was replaced with an 
erythromycin cassette to investigate the effect of S827 on cell growth and morphology. 
However, cells lacking S827 had similar growth and morphology to BSB1 indicating that the 
RNA dispensable for growth and morphology in wild-type cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Transcriptome data for ugtP and S827 
(A) The diagram represent microarray results adopted from (Nicolas et al., 2012). The diagram shows 
the double stranded DNA for the operon that ugtP is part of.  
(B) Gene mapping for ugtP and S827 RNA complementation construct. 
The coding genes and the RNA genes are represented as white or grey arrows, respectively. The 
direction of the arrows indicates the direction of the transcription. The small arrow bars in black 
represent the promoters.  
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Figure 3.11 Complementation of the S827 RNA in the ΔugtP ΔponA Pspank ugtP mutant  
Phase contrast and cell membrane stained images for vegetative cells grown in LB media. The 
BSB1ΔS827 mutant exhibited similar cell morphology to wild type cells. Cells with complemented 
ugtP and S827 had similar growth (A) and cell morphology (B) to the ΔugtP ΔponA Pspank ugtP mutant. 
Scale bar: 4 µm. 
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3.1.6 The absence of PBP1 in gtaB mutant causes thin and chained cells    
GtaB produces UDP-glucose which is a constituent of the LTA and WTA in the cell. UgtP 
catalyses the transfer of UDP-glucose to diacylglycerol. Thus the absence of GtaB should 
presumably have the same effect on the LTA structure/composition as the absence of UgtP. 
Furthermore, the absence of GtaB altered the localisation of UgtP from midcell during 
exponential phase (Weart et al., 2007). Thus GtaB is assumed to regulate cell growth and 
division by controlling substrate availability for UgtP (Weart et al., 2007). The double deletion 
of gtaB and ponA (PBP1 gene) was lethal, suggesting that the LTA glucolipid precursor is 
crucial for cells lacking PBP1. The deletion of ponA in the gtaB complementation mutant was 
viable and cells grew sufficiently in the presence or absence of IPTG. This mutant allowed us 
to further investigate whether the S827 RNA has a role in the partial complementation of the 
cell width in the BSB1ΔponA ΔugtP Pspank ugtP mutant since the BSB1ΔponA ΔgtaB Pspac gtaB 
mutant contains UgtP and S827 but lacks the LTA glucolipids and PBP1. Interestingly, the 
BSB1ΔponA ΔgtaB Pspac gtaB mutant was able to grow on PAB plates at 37˚C or 45˚C in the 
presence or absence of inducer (Figure 3.12 A). The ΔponA ΔgtaB Pspac gtaB mutant was 
thinner than the BSB1ΔponA ΔugtP Pspank ugtP mutant in the absence of inducer and the 
complementation of GtaB increased the cell width by 7% (Figure 3.9 and 3.12 B). The cell 
width measurements were also obtained for the BSB1ΔponA ΔpgcA Pspac pgcA mutant grown 
in LB with or without IPTG (Figure 3.9). These measurements showed that BSB1ΔponA ΔpgcA 
Pspac pgcA cells were wider than BSB1ΔponA ΔugtP Pspank ugtP cells and almost as wide as 
BSB1ΔponA. These results suggested that the S827 RNA has a role in controlling the cell width, 
but the mechanism of this regulation is unclear. Next, we studied the localisation of PBP1 in 
cells lacking UgtP or PgcA.  
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Figure 3.12 Growth and Morphology of BSB1ΔgtaB cells lacking the PG synthase PBP1 
(A) The BSB1ΔponA ΔgtaB Pspac gtaB mutant grown on PAB plates in the presence or absence of IPTG 
at 37 or 45˚C. The growth of the latter mutant was independent of the temperature or the inducer. 
(B) Phase contrast and cell membrane stained images for BSB1 and the ΔponA ΔgtaB Pspac gtaB mutant 
grown in LB with or without IPTG. The latter mutant exhibited thin and chained cell morphology 
independent of the presence of IPTG. Scale bar: 4 µm. 
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3.1.7 The localisation PBP1 in the ugtP mutant is similar to wild-type 
The localisation of PBP1 was studied in BSB1, ΔugtP and ΔpgcA mutants. A gfp gene under 
the control of a xylose inducible promotor was introduced at the 5’ end of the native ponA locus 
in BSB1, ΔugtP and ΔpgcA mutants. Cells were grown in LB with 0.5% xylose and the 
localisation of PBP1 was studied using fluorescence microscopy. The localisation pattern in 
both mutants was similar to wild type cells where PBP1 seemed to be localised at the septum 
during vegetative growth and occasionally at the cell periphery (Figure 3.13). These results 
suggests that the absence of LTA glucolipids has no effect on the localisation of Gfp-PBP1 in 
the cell.  
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Brightfield GFP Combined
Figure 3.13 Localisation of PBP1 in ugtP or pgcA mutant cells 
BSB1 ponA::(Pxyl gfp-ponA), BSB1ΔpgcA ponA::(Pxyl gfp-ponA) and BSB1ΔugtP ponA::(Pxyl gfp-
ponA) mutants were grown in LB media in the presence of 0.5% xylose. Phase contrast and GFP 
fluorescence images showed similar localisation pattern for PBP1 in BSB1, ΔugtP and ΔpgcA mutants. 
Scale bars: 4 µm.   
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3.1.8 TEM images indicated altered cell wall structure for the ugtP mutant 
Cells lacking LTA glucolipids exhibit higher sensitivity to lysozyme and salt compared to wild 
type cells (Fedtke et al., 2007; Matsuoka et al., 2011a). Fluorescence microscopy allowed us to 
study the morphology of the strains, but high resolution images were required to better 
characterize the cell wall. Therefore, ΔponA, ΔugtP and ΔugtP ΔponA Pspank ugtP mutants were 
analyzed by transmission electron microscopy (TEM), at the electron microscopy facility, 
Newcastle University. The effect of ponA deletion on the cell morphology was previously 
described as thin cells with membrane invaginations and occasional aberrant septa (Pedersen et 
al.,1999). However, TEM analysis for the BSB1ΔponA mutant indicated thin cells with normal 
septa (Figure 3.14). Interestingly, BSB1ΔponA cells had thinner cell walls (CW) than BSB1 
cells (≈ 15% thinner). The absence of UgtP caused rough cell surfaces compared to wild type 
cells but had no effect on the thickness of the CW. The BSB1ΔugtP ΔponA Pspank ugtP mutant 
had thinner cell walls compared to both the parent BSB1 and the ΔponA mutant (≈ 30% thinner 
than wild type) in addition to a similar rough cell wall structure to the ugtP mutant. 
Consequently, the altered cell wall structure might be a reason behind the higher susceptibility 
of the ugtP-null mutant to lysozyme.  
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Figure 3.14 TEM analysis for several mutants 
TEM images for BSB1, ΔponA, ΔugtP and ΔugtP ΔponA Pspank ugtP mutants during exponential phase 
using three different magnifications. The ugtP mutant had altered cell wall structure. The ΔponA and 
ΔponA ΔugtP Pspank ugtP mutants had thinner cell wall than BSB1 cells. Scale bars: (A) 500 nm, (B) 
100 nm and (C) 30 nm 
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3.2 The role of the PG hydrolases in ugtP, gtaB or pgcA mutants 
3.2.1 Introduction 
Cells lacking UgtP had LTA with longer glycerol-phosphate chains (Aurelie Guyet, 
unpublished data). Changes in the LTA structure were implicated with higher susceptibility to 
antimicrobial peptides and an increase in the autolysis activity in the cells (Perego et al., 1995; 
Wecke et al., 1997; Wecke et al., 1996). TEM images for cells lacking UgtP showed rough cell 
wall structure suggesting higher or uncontrolled PG hydrolase activity. To investigate this 
phenomenon, we quantified muropeptides from BSB1, ΔugtP and ΔpgcA cells. Subsequently, 
we constructed mutants lacking UgtP, GtaB or PgcA and cell wall hydrolases and the 
morphology of these mutants was analysed by fluorescence microscopy.  
 
3.2.2 Quantification of muropeptides from ugtP or pgcA mutants 
To test if the absence of UgtP or PgcA had any effect on peptidoglycan structure or composition, 
we analysed the muropeptide profiles for the ΔugtP and ΔpgcA single mutants. First, the PG of 
these strains was purified (Section 2.11.2), digested with cellosyl to muropeptides and analysed 
by HPLC using a reversed phase column (Section 2.11.3). The HPLC chromatograms for the 
ΔugtP and ΔpgcA mutants were comparable to that of BSB1 (Figure 3.15). However, looking 
at more subtle differences, it was evident that both ΔpgcA and ΔugtP mutants had increased 
levels of “Di” (peak 5) and “Tri-Ala-mDap (NH2)2” (peak 8) (Table 3.1). Such an increase in 
these two muropeptides was reported previously in strains where higher autolytic enzymes 
activity was present, specifically  CwlO or LytE activities (Bisicchia et al., 2007). The 
percentages of Di or Tri-Ala-mDap(NH2)2 were 30% or 37% higher in the ΔugtP mutant 
compared to BSB1, respectively (Table 3.1) (Figure 3.16). The ΔpgcA mutant had an increase 
of 43% and 51% in the Di or Tri-Ala-mDap(NH2)2 MP compared to BSB1, respectively. The 
percentage of the other muropeptides did not change with the loss of UgtP or PgcA compared 
to BSB1. Thus there is a strong suggestion that CwlO or LytE are either upregulated or have 
higher activity in cells lacking UgtP or PgcA.  
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Figure 3.15 RP-HPLC analysis of muropeptides from BSB1, ΔugtP and ΔpgcA mutants 
The peaks 1-38 have been assigned according to Bisicchia et al.,2011. BSB1, ΔugtP or ΔpgcA mutants 
showed comparable muropeptide profiles except that the peaks number 5 and 8 (red arrows) 
corresponding to the levels of the muropeptides Di- and Tri-Ala-mDap(NH2)2, respectively, were bigger 
in the ΔugtP and ΔpgcA mutants compared to BSB1.  
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Table 3.1 Muropeptide identities and quantification for BSB1, ΔugtP and ΔpgcA mutants 
BSB1, ΔugtP and ΔpgcA mutants had similar muropeptide levels except that the muropeptides Di and 
Tri-Ala-mDap (NH2)2 from pgcA or ugtP mutants were higher compared to BSB1, respectively. The 
chemical structure for the identified muropeptides are presented in Figure 3.16. Values represent the 
mean ± standard deviation from two independent PG preparations.          
1 Nomenclature of muropeptides according to Glauner et al., (1988)                                         
2 calculated according to Glauner et al., (1988)             
3 calculated as 100% - % monomers. 
Peak area  (%)
Muropeptides 1 Peak no BSB1 pgcA ugtP
Tri 1 2.2  0.2 1.9  0.0 1.8  0.1
Tri (NH2) (PO4) 2 1.0  0.3 0.7  0.2 1.0  0.3
Tri (NH2) 3 14.2  1.4 11.8  0.5 12.1  0.9
Tri (NH2) (deAc) 4 0.0  0.0 0.1  0.1 0.1  0.0
Di 5 2.3  0.3 4.0  0.2 3.2  0.2
Tri-Ala-mDap (NH2) 6 1.4  0.4 1.5  0.2 1.2  0.2
tetra (NH2) 7 0.5  0.2 0.3  0.0 0.2  0.0
Tri-Ala-mDap (NH2)2 8 1.4  0.2 2.9  0.2 2.2  0.3
penta (Gly5) (NH2) 9 0.3  0.0 0.3  0.0 0.2  0.0
TriTetra (-GM) (NH2)2 10 0.6  0.1 0.6  0.1 0.7  0.3
penta (NH2) 11 0.4  0.0 0.6  0.1 0.6  0.2
TriTetra (-G) 12 0.7  0.2 0.4  0.1 0.4  0.1
TriTetra (NH2) (PO4) 13 0.8  0.4 1.5  0.6 1.6  0.7
TetraTetra (-GM) (NH2)2 14 1.4  0.4 0.6  0.1 0.7  0.0
TriTetra (NH2) 15 13.5  1.9 10.9  3.0 11.3  3.0
TriTetra (NH2) (deAc) 18 2.1  0.6 1.1  0.2 1.1  0.5
TriTetra (NH2) (deAc) 19 1.7  0.5 0.8  0.2 0.9  0.4
TriTetra (NH2) 20 3.0  0.5 2.8  0.0 2.7  0.1
TriTetra (NH2)2 21 26.0  0.1 28.3  0.9 29.2  2.2
TriTetra (NH2)2 (deAc) 22 0.2  0.2 0.1  0.1 0.1  0.1
TriTetra (NH2)2 (deAc) 23 0.4  0.0 0.3  0.1 0.2  0.0
Penta (Gly5) Tetra 24 0.3  0.1 0.6  0.0 0.5  0.1
Penta (Gly5) Tetra (NH2)2 25 0.7  0.3 0.7  0.0 0.6  0.0
TetraTetra (NH2)2 26 0.6  0.2 1.4  0.0 1.3  0.2
PentaTetra (NH2)2 27 0.6  0.1 0.5  0.2 0.4  0.1
TriTetraTetra (NH2)2 28 0.4  0.1 0.4  0.1 0.3  0.1
TriTetraTetra (-G) 29 1.1  0.1 1.0  0.2 1.0  0.3
TriTetraTetra (NH2)2 30 0.5  0.1 0.7  0.0 0.7  0.1
TriTetraTetra (NH2)3 31 2.6  0.4 2.5  0.6 2.3  0.6
TriTetraTetra (NH2)3 (deAc) 32 2.5  0.1 3.3  0.2 3.3  0.4
TriTetraTetra (NH2)3 (deAc) 33 0.6  0.0 0.6  0.2 0.6  0.1
Penta(Gly5)TetraTetra (NH2)2-3 34 0.3  0.0 0.3  0.1 0.3  0.0
TriTetraTetraTetra (NH2)2-3 35 0.3  0.1 0.4  0.1 0.3  0.0
TriTetra(Anh) (NH2)2 36 0.7  0.1 0.8  0.3 0.7  0.3
TriTetraTetraTetra (NH2)4 37 0.9  0.0 1.4  0.0 1.5  0.2
TriTetraTetra(Anh) (NH2)2 38 0.0  0.0 0.0  0.0 0.0  0.0
Sum monomers 25.9  0.3 24.8  0.8 23.9  0.3
Sum dimers 61.8  0.4 59.6  1.1 61.4  0.8
Sum trimers 9.3  0.1 10.2  0.2 9.9  0.2
Sum tetramers 1.4  0.0 2.1  0.0 2.1  0.3
Sum dipeptides 2.6  0.2 4.7  0.4 3.8  0.3
Sum tripeptides 56.0  0.4 53.9  0.4 54.4  0.5
Sum tetrapeptides 39.2  0.3 38.8  0.5 39.7  0.1
Sum pentapeptides 1.9  0.3 2.3  0.4 1.9  0.3
Degree of Crosslinkage 2 38.1  0.3 38.1  0.6 38.9  0.3
% Peptides in Crosslinkage 3 74.1  0.3 75.2  0.8 76.1  0.3
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Figure 3.16 Chemical structure of identified muropeptides 
Proposed basic structure for muropeptides from B. subtilis according to (Atrih et al., 1999). Numbers 
refer to peaks in table 3.1.   
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3.2.3 The deletion of lytE in cells lacking UgtP causes sever growth and shape defects 
The analysis of muropeptides form ΔugtP or ΔpgcA mutants suggested that the levels or 
activities of CwlO or LytE might be affected. Furthermore, ugtP, pgcA and ltaS mutants have 
higher levels of LytE and not CwlO (Kasahara et al., 2016). LytE and CwlO both have DL-
endopeptidase activity. LytE is suggested to be involved in cell elongation and division due to 
its localisation at the septum and the lateral cell wall (Kasahara et al.,2016; Yamamoto et al., 
2003), whereas, CwlO is suggested to be more involved in cell elongation based on its lateral 
cell wall localisation (Hashimoto et al., 2012). To better understand the roles of these DL-
endopeptidases in the absence of LTA glucolipids, BSB1ΔugtP ΔlytE and BSB1ΔugtP ΔcwlO 
mutants were constructed and characterised. Since the absence of CwlO or LytE has not been 
described before in the BSB1 background, these strains were also constructed as controls.   
The loss of LytE in BSB1 cells did not have an effect on cell growth on PAB plates at 37˚C or 
45˚C. However, ΔugtP cells lacking LytE showed smaller colonies than BSB1 on both PAB 
and NA plates at 37˚C suggesting slower growth. No growth was observed for the ΔugtP ΔlytE 
double mutant on PAB plates at 45˚C suggesting lethality at permissive temperature (Figure 
3.17 A). The morphology of the mutants was studied using fluorescence microscopy. BSB1 
cells lacking LytE were bent slightly when grown in LB media (Figure 3.17 B). The ΔugtP 
ΔlytE mutant cells had severe shape defects featuring short bent cells with a high number of 
mini cells. These results suggest that LytE may have an important role in maintaining the rod 
shape in cells lacking UgtP.  
The lytE gene was also deleted in the ugtP complementation mutant, subsequently the growth 
and morphology of the constructed mutant were characterized in the presence or absence of 
inducer. ΔugtP ΔlytE Pspank ugtP cells grew on PAB at 45˚C with or without IPTG, suggesting 
that the leaky expression of the ectopic ugtP was sufficient to support growth (Figure 3.17 A). 
ΔugtP ΔlytE Pspank ugtP colonies were smaller when grown on PAB without IPTG. However, 
in the presence of IPTG, the latter mutant had similar growth to BSB1. In the absence of IPTG, 
the mutant partially recovered the rod morphology and fewer mini cells were observed (Figure 
3.17 B). However, the cells were shorter than wild type and bent. In the presence of IPTG, the 
cells completely recovered their rod shape and no bending was observed. However, mini cells 
and mislocalisation of the septum were still present (Figure 3.17 B). 
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Figure 3.17 Growth and morphology of BSB1ΔugtP cells lacking the DL-endopeptidase LytE  
(A) Growth of BSB1, ΔlytE, ΔugtP ΔlytE and ΔugtP ΔlytE Pspank ugtP cells on PAB plates with or 
without IPTG at 45˚C. 
(B) Phase contrast or membrane stained images for ΔlytE, ΔugtP ΔlytE or ΔugtP ΔlytE Pspank ugtP 
mutants. The ΔugtP ΔlytE mutant had severe shape defects compared to the ΔlytE mutant. The 
complementation of ugtP partially rescued the ΔugtP ΔlytE morphological defect. Scale bars: 4 µm.  
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3.2.4 The deletion of cwlO in cells lacking UgtP causes short and wide cells 
The absence of LytE in the ΔugtP mutant caused a severe shape defect. CwlO and LytE have 
the same enzymatic activity and they both play a role in cell elongation (Bisicchia et al., 2007; 
Hashimoto et al., 2012). The absence of CwlO in BSB1 or ΔugtP mutants had no effect on cell 
growth. Fluorescence microscopy analysis for BSB1ΔcwlO showed shorter and wider cells than 
BSB1 (Figure 3.18). Interestingly, the ΔugtP ΔcwlO mutant was wider than cwlO or ugtP single 
mutants and had a similar short cell morphology to ΔugtP cells. These results show that the 
ΔugtP ΔcwlO mutant had worse morphological defect compared to the ΔugtP mutant, however, 
LytE seems to have a greater contribution in maintaining proper cell morphology than CwlO in 
cells lacking UgtP. 
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3.2.5 The deletion of lytF in cells lacking UgtP causes chaining and shorter cells 
Cells lacking LytE but not CwlO showed severe growth and shape defects. Unlike CwlO that 
is involved in cell elongation only, LytE is assumed to play a role in both cell elongation and 
division. LytF, a DL-endopeptidase, has a role in PG hydrolysis during cell division (Yamamoto 
et al., 2003). BSB1ΔugtP ΔlytF was constructed and characterised to test if this DL-
endopeptidase is as important as LytE in the absence of UgtP. BSB1ΔlytF was also constructed 
and studied as a control. BSB1ΔlytF and BSB1ΔugtP ΔlytF had similar growth as BSB1 on 
NA plates (data not shown). Fluorescence microscopy analysis for the ΔlytF mutant cells 
showed chain formation that is probably caused by delay in cell separation (Figure 3.19). Cells 
lacking both UgtP and LytF were shorter than wild-type cells and formed chains. This 
morphology is a combination of those of the single mutants, suggesting that LytE has a bigger 
role in maintaining rod shape than LytF in the ugtP mutant.  
Figure 3.18 Morphology of BSB1ΔugtP strains lacking the DL-endopeptidase CwlO 
Phase contrast or cell membrane stained images for BSB1, ΔcwlO or ΔugtP ΔcwlO mutants grown in 
LB media at 37˚C.  ΔcwlO mutant had shorter and wider cells than BSB1. ΔugtP ΔcwlO mutant had 
shorter and wider cells than both BSB1 and the ΔcwlO mutant. Scale bars: 4 µm.  
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3.2.6 The deletion of lytABC in cells lacking GtaB causes chaining and short cells 
We initially considered to construct a strain lacking the LTA glucolipid precursor and the 
amidase LytC using the available strains. LytC is involved in cell separation by hydrolysing the 
bond between the N-acetylmuramic acid and the L-Ala of PG (Rogers et al., 1984). lytC is 
encoded in the lytABC operon where LytA and LytB are suggested to be chaperons for LytC 
(Lazarevic et al.,1992), hence the use of the lytABC mutant. Both the lytABC and ugtP mutants 
available have neomycin cassettes, thus the strategy was changed to construct a strain lacking 
lytC and gtaB. The double deletion of gtaB and lytABC had no effect on growth. The 
morphology of ΔlytABC and ΔgtaB ΔlytABC mutants was studied using fluorescence 
microscopy. The ΔLytABC mutant cells formed chains suggesting a delay in cell separation 
whereas the ΔgtaB ΔlytABC mutant cells were short and chaining (Figure 3.20). The latter 
morphology is a combination of those of the single mutants. These results suggest that LytE 
contributes more to the cell morphology than LytABC in cells lacking LTA glucolipids. Thus, 
LytE seems to have an unknown important role in cells lacking UgtP. Subsequently, TEM 
Figure 3.19 Morphology of the ugtP mutant lacking the DL-endopeptidase LytF 
Phase contrast and cell membrane stained images for BSB1, ΔlytF and ΔugtP ΔlytF mutants grown in 
LB at 37˚C. The deletion of lytF in BSB1 or the ΔugtP mutant caused similar chaining morphology. 
Scale bars: 4 µm. 
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analysis was performed for several mutant to acquire high resolution images in order to better 
understand the effects of these mutations on the cell wall.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.7 TEM imaging for the ugtP lytE and ugtP cwlO mutants  
The absence of UgtP caused rough cell surface (Figure 3.14). The absence of LytE or CwlO in 
the ugtP mutant worsen the morphology of the cells. Using fluorescence microscopy with or 
without membrane dye was insufficient to observe changes in cell wall morphology, therefore, 
mutants were analysed by TEM to obtain high resolution images. The deletion of both cwlO 
and ugtP caused wider cells, as seen by fluorescence microscopy (Figure 3.18), and a rougher 
cell surface than the ΔugtP mutant (Figure 3.21). The BSB1ΔLytE mutant had similar cell wall 
morphology to wild type cells while the ΔlytE ΔugtP mutant had severe shape defect with the 
loss of rod shape, formation of bulges and loss of cell wall integrity (Figure 3.17 and 3.21). The 
cell wall morphology of the ΔugtP ΔlytE mutant adds evidence to demonstrate the importance 
Figure 3.20 Morphology of ΔgtaB mutants lacking the lytABC operon 
Phase contrast and cell membrane stained images for BSB1, ΔlytABC and ΔgtaB ΔlytABC mutants 
grown in LB media. The absence of LytABC resulted in chained cells whereas the absence of both 
LytABC and GtaB resulted in short and chained cells. Scale bars: 4 µm. 
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of LytE in maintaining shape in the absence of UgtP. This suggests that the DL-endopeptidase 
LytE contributes to CW hydrolysis in the ΔugtP mutant and such activity is required for cells 
to maintain the rod shape.  
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Figure 3.21 TEM images for ΔcwlO, ΔugtP ΔcwlO, ΔlytE and ΔugtP ΔlytF mutants 
The ΔcwlO ΔugtP mutant had wide cells and rough cell wall structure compared to both BSB1 and 
ΔcwlO cells. The ΔlytE ΔugtP mutant had a severe shape defect with loss of cell wall integrity. Scale 
bars: (A) 500 nm, (B) 100 nm. 
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3.2.8 Growth and morphology of the ugtP lytE ponA and ugtP lytE sigM mutants 
The ΔugtP mutant exhibited an altered cell wall structure probably caused by high PG hydrolase 
activity in addition to increased levels of cell wall precursors suggesting an upregulation of PG 
synthesis. Thus, the deletion of ponA or σM genes could rescue the ΔugtP ΔlytE phenotype by 
balancing the PG synthesis and hydrolysis. σM is an ECF sigma factor involved in cell wall 
synthesis and cell shape maintenance through upregulation of genes involved in cell wall 
synthesis (Cao et al., 2002; Jervis et al., 2007).  
The deletion of ponA in the ugtP mutant was lethal (Section 3.1.4), however, the deletion of 
ponA in the ΔugtP ΔlytE double mutant was viable. The triple mutant grew at 37˚C on NA or 
PAB plates but it was not able to grow at 45˚C on PAB plates (Figure 3.22 A). Fluorescence 
microscopy analysis showed that the ΔugtP ΔlytE ΔponA mutant had a comparable morphology 
to the ΔponA mutant (Figure 3.8), in addition to the formation of chained cells (Figure 3.22 B).  
The deletion of sigM in the ΔugtP ΔlytE mutants did not rescue the lethal phenotype of cell 
growth on PAB at 45˚C (Figure 3.22 A). However, the deletion of sigM partially rescued the 
shape defect caused by the deletion of ugtP and lytE (Figure 3.22 B). The triple mutant cells 
were shorter and wider than wild type cells, formed chains, and had occasional (≈ 5%) 
mislocalisation of the septum. These results show that deleting ponA or sigM, rescues the 
morphological defect of the ugtP lytE double knockout.  
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Figure 3.22 Growth and morphology of BSB1ΔugtP ΔlytE strains lacking SigM or PBP1  
(A) BSB1ΔugtP ΔlytE ΔponA or BSB1ΔugtP ΔlytE ΔsigM mutant cells did not grow on PAB plates at 
45˚C. 
(B) Phase contrast and cell membrane stained images for BSB1, ΔponA, ΔugtP ΔlytE ΔponA and ΔugtP 
ΔlytE ΔsigM mutants grown in LB at 37˚C.  BSB1ΔugtP ΔlytE ΔponA cells had thin and chained cell 
morphology.  The ΔugtP ΔlytE ΔsigM mutant had wide, short and chained cell morphology in addition 
to occasional mislocalisation of the septum. Scale bar: 4 µm. 
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3.3 Conclusions and discussion 
The BSB1ΔugtP, ΔgtaB or ΔpgcA mutants grew similarly to wild-type cells but exhibited a 
short and wide cell morphology. UgtP coordinates cell size to growth rate in a nutrient rich 
environment by regulating the polymerization of FtsZ (Chien et al., 2012b; Weart et al., 2007). 
Thus, the overexpression of ugtP in the BSB1ΔugtP Pspank ugtP strain resulted in increased cell 
length and occasional septal mislocalisation (≈20%) which correlates with the function of UgtP 
as an inhibitor of FtsZ polymerization (Weart et al., 2007).  
Microarray experiments for the ugtP mutant indicated an increase in the transcription levels of 
several genes with unknown functions (Salzberg and Helmann, 2008). However, microarray 
studies only reveal the relative amounts of mRNAs in the cell, which might not correlate with 
the expression levels of the gene, or with the activity of the corresponding proteins. Thus, 
metabolomics analysis for the ugtP mutant performed by our collaborators determined the 
levels of several PG precursors were increased up to three fold suggesting upregulation of PG 
synthesis. The double deletion of ugtP, gtaB or pgcA and ponA, encoding the class A PG 
synthase PBP1, was lethal. However, the deletion of ponA in the complementation strain was 
viable even in absence of inducer suggesting that a minimal amount of UDP-glucose is 
sufficient for cell survival in the absence of the PBP1. 
Both ΔponA and ΔponA ΔugtP Pspank ugtP mutants grew poorly at 37˚C on PAB plates without 
magnesium ion supplements. Interestingly, the growth of the ΔponA but not the ΔponA ΔugtP 
Pspank ugtP mutant was improved when cells were grown at 45˚C. The sigma factor SigI, 
required for cell growth at high temperature, responds to heat stress by upregulating the 
expression of lytE, mreBH, bcrC and rsgI (Schirner and Errington, 2009; Tseng and Shaw, 
2008; Tseng et al., 2011). BcrC is an undecaprenyl phosphate phosphatase that produces the 
carrier lipid for cell wall synthesis. Thus, the increase in the expression of bcrC at high 
temperature might be responsible for the alleviated growth of the ponA mutant by increasing 
the availability of lipid II. However, the inability for the cells lacking UgtP and PBP1 to grow 
at 45˚C suggest that the upregulation of the SigI controlled genes are insufficient to support the 
ΔponA mutant growth in the absence of LTA glucolipids.   
The absence of the PG synthase PBP1 caused thin cell morphology. MreB is an actin homolog 
and a shape-determining factor in rod-shaped bacteria (Daniel and Errington, 2003). Previously 
published data proposed that MreB provides a scaffold that organizes the peptidoglycan 
synthesis machinery during cell elongation and thereby directing the lateral cell wall growth 
(Dominguez-Escobar et al., 2011; Garner et al., 2011).  E. coli cells expressing MreB with a 
93 
substitution in the ATP binding domain (MreBD165A/E) exhibited thin cell morphology 
similar to the ponA mutant (Kruse et al., 2003). Moreover, cells with different MreB alleles 
exhibited variations in cell width dimensions which correlated with the MreB helical pitch angle 
and the MreB polymer length (Ouzounov et al., 2016). These results suggests that MreB is a 
key determinant of cell diameter. Therefore, since PBP1 is part of the elongation machinery, 
the absence of the synthase might alter the dynamics of the elongasome complex leading to a 
change in the MreB helical conformation and resulting in thin cell morphology. Additionally, 
the deletion of ugtP resulted in increased expression of MreB and MreBH (Matsuoka et al., 
2011). Therefore, cells lacking both UgtP-S827 and PBP1 might be subject to additional stress 
caused by increased MreB expression and altered cytoskeleton dynamics resulting in thinner 
cell width than the ΔponA mutant.  
Defects in UgtP reduced the size of the cell by 20% during growth in a nutrient rich medium, 
however, the absence of UgtP had no effect on growth when cells were grown in minimal 
medium (Weart et al., 2007). Since cells lacking UgtP had similar growth and viability to wild-
type cells, the defects resulting from the absence of UgtP are probably due to abnormal cell size 
homeostasis (Weart et al., 2007). B. subtilis coordinates cell size with nutrient availability but 
why they do so is unclear. It was suggested that UgtP inhibits FtsZ polymerization when cells 
are grown in nutrient-rich medium resulting in an increase in the cell size which permits the 
accommodation of the extra DNA generated by multifork replication (Chien et al., 2012a). The 
absence of both UgtP and PBP1 caused thin cells but had no significant effect on the cell length 
(Section 3.1.4). These results suggests that the role of UgtP is dispensable in the absence of 
PBP1 even when cells are grown in nutrient rich medium. Thus, we propose that the decrease 
in the dimensions of cells lacking UgtP and PBP1 resulted in a smaller cytoplasm, in which 
case the min and the nucleoid occlusion systems are sufficient to regulate Z–ring 
polymerization thereby cell size (Section 1.3.4).  
Alteration in the LTA structure or composition causes cell shape defects in addition to increased 
autolysis activity and susceptibility to antimicrobial peptides (Matias and Beveridge, 2008; 
Perego et al., 1995; Schirner et al., 2009; Wecke et al., 1996, 1997). UgtP synthesises the LTA 
glucolipid precursor, and the absence of UgtP or the LTA synthase LtaS in S. aureus cells 
resulted in longer LTA strands (Reichmann et al., 2014). TEM analysis for cells lacking UgtP 
showed an altered cell surface suggesting high or uncontrolled hydrolase activity. This 
observation is consistent with previously published data showing increased levels of the 
endopeptidase LytE in cells grown at high temperature or in the absence of UgtP (Kasahara et 
al., 2016). Moreover, the absence of the LtaS2 in B. anthracis resulted in a similar rough cell 
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surface to the B. subtilis ugtP mutant suggesting that the altered LTA structure is responsible 
for the increased autolytic activity in the cells (Garufi et al., 2012). These modifications in cell 
wall structure or composition might be one of the reasons for the increased susceptibility to 
lysozymes and antimicrobials and for the induction of the stress response sigma factors sigM, 
sigV and sigX (Hashimoto et al., 2013; Matsuoka et al., 2011; Salzberg and Helmann, 2008). 
The TEM analysis also showed a decrease in cell wall thickness for cells lacking PBP1 and a 
further decrease in thickness for cells lacking both PBP1 and UgtP in addition to a rough cell 
surface. Therefore, the thin cell wall structure and the increased hydrolase activity might be 
creating weak points in the cell wall structure leading to cell lysis which might explain the 
lethality of the ponA ugtP double deletions.  
PG analysis for the ugtP and pgcA mutants showed increased levels of Di- and Tri-Ala-
mDap(NH2)2 muropeptides suggesting an increased DL-endopeptidase activity. B. subtilis has 
two redundantly essential lateral cell wall endopeptidases LytE and CwlO, important for cell 
elongation (Bisicchia et al., 2007; Hashimoto et al., 2012). The absence of both UgtP and LytE 
resulted in severe growth and shape defects whereby cells were short and twisted with a high 
number of mini-cells. The ugtP cwlO mutant showed shorter and wider cells than the cwlO 
single mutant suggesting that the loss of UgtP aggravates the shape defect caused by the absence 
of CwlO due to the increased cell requirement for DL-endopeptidase activity at the lateral wall 
(Hashimoto et al., 2012). The depletion of CwlO in the lytE mutant resulted in similar twisted 
cell morphology to the ugtP lytE double mutant. In addition, the labelling of cells lacking both 
CwlO and LytE with fluorescent vancomycin showed no fluorescence along the cell periphery 
suggesting a halt in lateral wall PG synthesis (Bisicchia et al., 2007). Therefore, we 
hypothesised that either CwlO is only partially active in cells lacking the LTA glucolipids 
making LytE essential for cell survival or that LytE has a crucial unknown role in cells lacking 
UgtP.  
The expression of lytE, which is controlled by SigI, significantly increased in cells either 
lacking UgtP or grown at high temperatures (Kasahara et al., 2016; Zuber et al., 2001). 
Moreover, the overexpression of lytE in the absence of sigI rescued cell growth at high 
temperature (Tseng et al., 2011). However, cells lacking both UgtP and LytE were viable at 
37˚C but were not able to grow at 45˚C probably due to the lack of LytE activity.  
The absence of ugtP resulted in increased autolysin activity and an upregulation of PG 
synthesis. The combined deletion of ugtP with lytE or ponA caused severe shape defects or 
lethality, respectively. Interestingly, cells with triple deletions in ugtP, lytE and ponA exhibited 
normal rod shape cells with a moderate chaining morphology. Moreover, the absence of SigM, 
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which responds to cell wall defects by upregulating genes involved in cell wall synthesis, in the 
ugtP lytE sigM triple mutant recovered the rod morphology but cells were short, wide and 
chaining (Cao et al., 2002; Jervis et al., 2007). The morphology of both triple mutants suggests 
that alteration in PG synthesis in the ugtP lytE mutant helps the cells to partially recover their 
rod shape. Taken together, these results suggest that a balanced PG synthesis and hydrolysis is 
important in cells lacking the LTA glucolipid precursor. 
These results provided evidence for the importance of LytE in cells lacking the LTA 
glucolipids, however, the reasons behind the upregulation of this endopeptidase or the PG 
synthesis are not clear. Hence, the isolation of mutants that suppress the growth and shape 
defects of the ugtP lytE mutant might be helpful to further understand the role of LTA in the 
cell. 
 
The impact of LTA on PG synthesis and hydrolysis  
In rod-shaped bacteria and in B. subtilis in particular, the elongation of the cell wall occurs by 
the homogenous incorporation of newly synthesised PG in the lateral surface of the sacculus 
(den Blaauwen et al., 2008; Daniel and Errington, 2003). The PG is also continuously modified 
and hydrolysed to maintain integrity and avoid thickening (Hayhurst et al., 2008). Therefore, 
the activity of both synthases and hydrolases must be coordinated during synthesis to avoid 
weak points in the sacculus that might lead to bursting by turgor. UgtP was suggested to play a 
role in modulating cell size by regulating the assembly of the master regulator for cell division 
FtsZ (Chien et al., 2012; Weart et al., 2007). UgtP is also responsible for the synthesis of the 
LTA glucolipid precursor (Jorasch et al., 1998). In S. aureus, the deletion of ugtP or ltaS 
resulted in increased LTA size suggesting longer glycerol phosphate chains (Reichmann et al., 
2014). Such changes in the LTA structure was coupled with increased LytE levels which was 
shown in this work to be important for cell growth and morphology in absence of glucolipids 
(Kasahara et al., 2016). The increased lytE expression in the ugtP mutant was paralleled with 
rough cell surface and altered muropeptide composition suggesting high DL-endopeptidase 
activity. These modification in the cell wall structure are probably one of the reasons causing 
the induction of the extracellular sigma factor SigM, which responds to cell wall synthesis and 
cell shape maintenance (Cao et al., 2002; Jervis et al., 2007; Matsuoka et al., 2011a). 
Interestingly, the loss of SigM or PBP1 was lethal in the absence of UgtP but not in the absence 
of both UgtP and LytE. Moreover, the ugtP lytE sigM and the ugtP lytE ponA mutants partially 
recovered the normal rod morphology. These results show that several dispensable proteins in 
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wild-type cells involved in PG synthesis, such as SigM and PBP1, seem to be crucial in the 
absence of UgtP when uncontrolled hydrolase activity occurs. Consequently, maintaining 
balanced PG synthesis and hydrolysis is essential for cells with altered LTA structure. 
Considering the above, this work enhanced our knowledge about the impact of ugtP deletion 
not only on FtsZ polymerization but also on PG synthesis (Figure 3.23). However, the reasons 
for the lytE upregulation in the cell with altered LTA structure is still unclear and the generation 
of suppressor mutants for the ugtP lytE phenotype might help in understanding the causes 
behind these complex genetic interactions.  
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Figure 3.23 Simplified scheme showing the effects of ugtP deletion on the cell wall 
To the left, the cartoon represents the synthesis and the structure of the PG and LTA in wild-type cells. 
To the right, the deletion of ugtP causes in the loss of the LTA UDP-Glucose resulting in longer LTA 
structure. The latter changes in the LTA resulted in higher LytE expression leading to altered cell wall 
structure. The absence of UDP-Glucose also caused increased expression of the extracellular sigma 
factor σM, which is probably resulting in the upregulation of PG synthesis.  
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4 Coordination of peptidoglycan synthesis during cell division  
4.1 In vitro and in vivo characterization of the role of PBP3 in PG synthesis 
4.1.1 Introduction 
B. subtilis has 16 PBPs but only PBP2B (encoded by pbpB) is essential for cell division. PBP2B 
is a class B PBP with a catalytic TPase domain and a non-catalytic domain. Interestingly, in 
cells expressing PBP2B with a substitution of the TPase active site serine to an alanine residue 
(PBP2B*), PBP3, which is a non-essential PBP2B homologue, becomes essential (Richard 
Daniel, unpublished data). Further work showed that the inactivation of the TPase domain of 
PBP3 is lethal in the pbpB* mutant suggesting enzymatic redundancy. In this work, the role of 
PBP3 in the pbpB* mutants was characterized by studying the localisation of both PBPs using 
immunofluorescence microscopy. The effect of the PBP2B* mutation on the cell morphology 
was investigated using TEM. Interactions and activities of PBP2B and PBP3 were characterised 
in vitro in assays with the class A PBP1.  
 
4.1.2 Similar localisation of PBP3 in 168CA and PBP2B* mutant cells 
Previously, the localisation of PBP3 was studied using a GFP-PBP3 construct (Scheffers et al., 
2004). In wild-type cells GFP-PBP3 predominantly localised in dots or foci at the cell periphery 
and more frequently at the cell poles after division was completed, but with relatively little 
enrichment at the division site (Scheffers et al., 2004). In the PBP2B* mutant, the localisation 
pattern of GFP-PBP3 was similar to that in the wild type cells. An alternative approach was 
also used to study the localisation of PBP3 by using immunofluorescence microscopy (IFM) 
(section 2.7.2). Full length PBP3 was purified and used to produce α-PBP3 antibodies from 
guinea pigs. Subsequently, affinity chromatography was used with immobilised PBP3 to purify 
the antibody from the serum (section 2.9.8). Western blot analysis using the α-PBP3 antibody 
for cells expressing GFP-PBP3 (168CA pbpC::(Pxyl gfp-pbpC) showed two strong and two 
weak bands. The upper strong band correspond to GFP-PBP3 whereas the lower strong one 
correspond to PBP3. The weak bands presumably correspond to degradation products. This 
result suggests that the GFP was removed from the N-terminal of some GFP-PBP3 molecules 
(Figure 3.24). Immunofluorescence microscopy (IFM) with the α-PBP3 antibody was used to 
localise PBP3 in 168CA and PBP2B* cells. The α-PBP2B antibody from Daniel et al., (2000) 
was used for the localisation of PBP2B in 168CA or PBP2B* cells as a control and the DNA 
was stained with DAPI. The localisation pattern of PBP3 in the PBP2B* mutant was 
comparable to that in 168CA cells, with PBP3 being slightly more enriched at the septum and 
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the cell poles (Figure 3.25). The differences in PBP3 localisation between wild-type cells and 
the PBP2B* mutant were difficult to quantify, thus an alternative method was required to 
investigate possible localisation differences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24 Cellular level of PBP3 (encoded by pbpC gene) 
Western blot using α-PBP3 antibody for 168CA, the pbpC and the pbpC::(Pxyl gfp-pbpC) mutants grown 
in LB with or without xylose. The blot shows 2 bands that correspond to PBP3 and GFP-PBP3 in 
addition to degradation products, suggesting the removal of the GFP from some of the PBP3 molecules.  
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Figure 3.25 Cellular localisation of PBP3 or PBP2B using α-PBP3 or α-PBP2B antibodies, 
respectively 
(A) PBP3 localisation in 168CA and PBP2B* mutant cells was determined by IFM using α-PBP3 
antibody and a secondary antibody bound to FITC. PBP3 localised at midcell and occasionally at the 
lateral cell wall in foci. The DNA was stained with DAPI. Scale bar: 5 µm.  
(B) PBP2B localisation in 168CA and PBP2B* mutant cells was determined by IFM using α-PBP2B 
antibody and a secondary antibody bound to a red fluorescent probe (Alexa 594). PBP2B localised at 
midcell in vegetative cells. The DNA was stained with DAPI. Scale bar: 5 µm.  
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4.1.3 PBP3 showed enhanced septal localisation in PBP2B* mutant cells 
IFM images were not sufficient to visualize the possible changes of PBP3 localisation during 
the cell cycle in cells with inactive PBP2B (Figure 3.26). To obtain quantitative data on the 
localisation of PBP3 and PBP2B, profile maps were generated for both PBPs in 168CA and the 
PBP2B* mutant. The profile maps represent the fluorescence intensity profile of individual 
cells normalized to the cell average fluorescence and sorted horizontally by cell length. For the 
PBP2B* mutant cells, the profile maps showed longer cell length than wild type cells at all 
stages of the cell cycle (Figure 3.26 A). In young 168CA cells PBP3 localised at the cell poles 
and periphery but later in the cell cycle PBP3 was mostly recruited to midcell with the exception 
of some PBP3 molecules that showed occasional cell periphery localisation. In the PBP2B* 
mutant, PBP3 exhibited similar cell pole localisation to young 168CA cells, however, a 
decrease in the level of fluorescence at the cell periphery was detected at the early and middle 
stages of the cell-cycle. Moreover, the localisation of PBP3 at midcell was observed earlier in 
the PBP2B* mutant cell cycle compared to wild-type (Figure 3.26 A). For comparison, the 
same analysis using α-PBP2B antibodies showed similar localisation of PBP2B at mid-cell in 
both 168CA and PBP2B* cells (Figure 3.26 B). This localisation pattern was observed at early 
stages of the cell cycle in both 168CA or in PBP2B* cells suggesting early recruitment of 
PBP2B to the septum. These results suggests that the early and enhanced localisation of PBP3 
at midcell in the PBP2B* mutant is presumably to complement the lack of PBP2B TPase 
activity.  
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Figure 3.26 Profile maps for the localisation of PBP3 and PBP2B in 168CA and the PBP2B* 
mutant  
(A) Profile maps representing the localisation of PBP3 by IFM using α-PBP3 antibody (n=450 cells). 
(B) Profile maps representing the localisation of PBP2B using α-PBP2B antibody (n=150 cells). The 
level of fluorescence was normalized to the mean cell fluorescence. The data was sorted using Python7 
and the profile maps were created with ImageJ. PBP3 showed early and enhanced midcell localisation 
in the PBP2B* mutant compared to 168CA. The DNA was stained with DAPI. 
α-PBP3 DAPI
168CA
PBP2B*
α-PBP2B DAPI
168CA
PBP2B*
A
B
L
ife cy
cle 
103 
4.1.4 PBP2B* cells have aberrant septum morphology 
Microscopic images of the PBP2B* mutant showed an increase in cell length compared to 
168CA. We proposed that cells with inactive PBP2B have a delay in building the septal PG 
which is causing an increase in cell length. However, fluorescence microscopy was insufficient 
to observe any changes in the septum morphology. Thus, we analysed 168CA, ΔPBP3 or 
PBP2B* cells by TEM to obtain high resolution images which gave us more insight into septum 
morphology. Most of the PBP2B* mutant cells (83%) exhibited aberrant septum (n=50) (Figure 
3.27). The ΔPBP3 mutant had a similar septum morphology to 168CA cells suggesting a 
dispensable role for PBP3 in septal PG synthesis. These results suggest that although cells with 
active PBP3 TPase domain can compensate for the lack of TPase activity of PBP2B, the latter 
has a more important role in cell division.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ΔPBP3 PBP2B*168CA
Figure 3.27 TEM images of 168CA, ΔPBP3 or PBP2B* mutant cells 
The absence of PBP3 had no effect on the cell morphology whereas the inactivation of the TPase domain 
of PBP2B caused aberrant septa. Scale bar: 100 nm.  
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4.1.5 HPLC analysis of muropeptides from 168CA, ΔPBP3 and PBP2B* cells 
B. subtilis has 16 PBPs that have redundant roles in PG synthesis, however, the inactivation of 
PBP2B alone distorted the septum of the cell. Next we analysed muropeptides isolated from 
ΔPBP3 or PBP2B* mutant cells to study the effect of such mutations on the PG composition. 
Cell wall material was harvested from exponentially growing cells (Section 2.11.1). The cell 
wall was purified from cell lysate followed by the PG purification (Section 2.11.2).  The PG 
was digested with cellosyl to muropeptides by cutting the β-1,4-glycosidic bond between the 
N-acetylmuramic acid and the N-acetylglucosamine. Muropeptides were reduced and analysed 
by HPLC using a reversed-phase column. The RP-HPLC muropeptide elution patterns of PGs 
from 168CA, ΔPBP3 and PBP2B* mutants showed comparable muropeptide profiles with only 
two minor differences for the PBP2B* mutant (Figure 3.28). First, a small unknown peak, 
observed in one of the experiments, had a retention time of 96 min and appeared in 168CA and 
ΔPBP3 muropeptide profiles but not in the PBP2B* muropeptide profile. Second, a mild 
reduction in the peak area for the muropeptide number 15 for the PBP2B* mutant was observed 
compared to wild-type. The relative quantification of the muropeptides identified a 2% decrease 
in the TriTetra(NH2) for the PBP2B* mutant compared to wild-type (Table 3.2). The lower 
levels of TriTetra(NH2) correlated with a 3.1% decrease in percentage of peptides in crosslinks 
and a 3.1% increase in the sum of monomeric muropeptides from PBP2B* compared to 168CA 
cells. The changes in muropeptide levels are probably caused by the expression of inactive 
PBP2B in the cell (Table 3.2). No changes were identified between muropeptides from 168CA 
or ΔPBP3 cells. To get more insights about the function of these PBPs, biochemical assays were 
used to characterize the activities and interactions of PBP2B, PBP3 and the class A PBP1.  
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Figure 3.28 RP-HPLC analysis of muropeptides from 168CA, ΔPBP3 and PBP2B* cells 
Muropeptide profiles for 168CA, ΔPBP3 and PBP2B* cells. The peaks 1-38 have been assigned 
according to Bisicchia et al., 2011. 168CA, ΔPBP3 or PBP2B* mutant cells have similar muropeptide 
profiles except two minor differences, the mild decreased peak area for the muropeptide number 15 in 
the PBP2B* mutant and the unknown peak (red arrow) detected in only one of the experiments for 
168CA and ΔPBP3.  
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Table 3.2 Muropeptide identities and quantification from 168CA, ΔPBP3 and PBP2B* cells  
BSB1, ΔPBP3 or PBP2B* mutants showed similar levels of muropeptides except for a 3.1% decrease 
in muropeptides in crosslink from the PBP2B* mutant compared to 168CA. Peak areas shown represent 
the mean ± standard deviation of two independent PG preparations.               
1 Nomenclature of muropeptides according to Glauner et al., (1988)                                         
2 calculated according to Glauner et al., (1988)             
3 calculated as 100% - % monomers. 
 
Peak area (%)
Muropeptides 1 Peak no 168CA ΔPBP3 PBP2B*
Tri 1 2.0  0.1 1.7  0.2 1.9  0.1
Tri (NH2) (PO4) 2 1.4  0.3 1.3  0.2 1.3  0.0
Tri (NH2) 3 14.1  0.1 14.1  0.1 14.1  0.1
Tri (NH2) (deAc) 4 0.1  0.1 0.1  0.1 0.1  0.1
Di 5 2.2  0.1 2.3  0.4 2.3  0.4
Tri-Ala-mDap (NH2) 6 1.3  0.3 1.3  0.2 1.3  0.4
tetra (NH2) 7 0.2  0.1 0.4  0.2 0.4  0.1
Tri-Ala-mDap (NH2)2 8 1.2  0.0 1.5  0.3 1.4  0.4
penta (Gly5) (NH2) 9 0.4  0.0 0.3  0.0 0.4  0.1
TriTetra (-GM) (NH2)2 10 0.8  0.1 0.7  0.1 0.7  0.0
penta (NH2) 11 0.4  0.1 0.4  0.0 0.6  0.0
TriTetra (-G) 12 0.6  0.1 0.6  0.0 0.6  0.1
TriTetra (NH2) (PO4) 13 1.6  0.8 1.7  0.5 0.6  0.3
TetraTetra (-GM) (NH2)2 14 1.2  0.3 1.0  0.0 1.0  0.1
TriTetra (NH2) 15 14.0  1.7 13.1  1.4 12.0  1.3
TriTetra (NH2) (deAc) 18 2.1  0.5 1.3  0.2 1.4  0.2
TriTetra (NH2) (deAc) 19 1.8  0.5 1.0  0.2 1.1  0.2
TriTetra (NH2) 20 2.8  0.0 2.4  0.0 2.5  0.2
TriTetra (NH2)2 21 25.6  3.1 27.7  0.6 24.2  1.0
TriTetra (NH2)2 (deAc) 22 0.1  0.1 0.1  0.1 0.1  0.1
TriTetra (NH2)2 (deAc) 23 0.3  0.1 0.3  0.1 0.4  0.0
Penta (Gly5) Tetra 24 0.5  0.1 0.4  0.2 0.4  0.1
Penta (Gly5) Tetra (NH2)2 25 0.4  0.2 0.6  0.4 0.5  0.1
TetraTetra (NH2)2 26 1.1  0.4 0.9  0.1 0.7  0.3
PentaTetra (NH2)2 27 0.5  0.2 0.5  0.1 0.5  0.0
TriTetraTetra (NH2)2 28 0.4  0.2 0.4  0.1 0.6  0.4
TriTetraTetra (-G) 29 1.2  0.1 1.1  0.2 0.7  0.3
TriTetraTetra (NH2)2 30 0.6  0.1 0.5  0.1 1.5  1.1
TriTetraTetra (NH2)3 31 2.7  0.3 2.5  0.4 2.1  0.1
TriTetraTetra (NH2)3 (deAc) 32 2.7  0.3 2.6  0.2 1.2  1.0
TriTetraTetra (NH2)3 (deAc) 33 0.5  0.1 0.4  0.1 0.3  0.2
Penta(Gly5)TetraTetra (NH2)2-3 34 0.3  0.1 0.2  0.1 0.3  0.0
TriTetraTetraTetra (NH2)2-3 35 0.2  0.0 0.3  0.1 0.5  0.3
TriTetra(Anh) (NH2)2 36 0.8  0.2 0.8  0.1 0.5  0.1
TriTetraTetraTetra (NH2)4 37 0.9  0.2 1.2  0.2 1.0  0.1
TriTetraTetra(Anh) (NH2)2 38 0.1  0.1 0.0  0.0 0.0  0.0
Sum monomers 25.3  0.0 25.7  0.9 28.4  0.3
Sum dimers 62.2  0.0 61.9  0.2 59.5  0.4
Sum trimers 9.8  0.2 8.9  0.6 8.6  0.2
Sum tetramers 1.4  0.1 1.7  0.3 1.8  0.5
Sum dipeptides 2.5  0.1 2.7  0.3 2.9  0.3
Sum tripeptides 55.8  0.6 56.2  0.3 57.0  0.2
Sum tetrapeptides 39.7  0.1 39.2  0.3 37.9  0.2
Sum pentapeptides 1.9  0.3 1.8  0.3 2.2  0.2
Degree of Crosslinkage 2 38.7  0.0 38.2  0.5 36.8  0.0
% Peptides in Crosslinkage 3 74.7  0.0 74.3  0.9 71.6  0.3
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4.1.6 Purification of full length PBPs 
In vivo work performed in Richard Daniel’s lab showed that the activity of PBP3 is essential to 
complement the lack of PBP2B TPase activity in the cell suggesting partial functional 
redundancy. The deletion of PBP2B is lethal suggesting that the protein has a non-catalytic role 
that cannot be replaced even by the overexpression of PBP3 in the cell. To test if PBP3 interacts 
with PBP2B, we adopted an in vitro approach using affinity chromatography and SPR. Thus, 
we first established the purification of PBP2B and PBP3 and we characterized their enzymatic 
activities in the presence of PBP1. PBP2B* and PBP3* featuring substitutions in the active site 
serine residues to alanine were also purified for control experiments.  
 
4.1.6.1 Purification of PBP2B 
PBP2B was purified using affinity chromatography and ion exchange chromatography (section 
2.9.2). PbpB (PBP2B gene) was cloned into pET28(a)+ (section 2.6.2). E. coli BL21(DE3) cells 
were used for the expression of PBP2B with an N-terminal hexahistidine tag (His-PBP2B). 
Cells were harvested and PBP2B was purified from the solubilised membrane fraction. Affinity 
chromatography was first performed to purify His-PBP2B from the membrane fraction (Figure 
3.29 A). The hexahistidine tag was removed using thrombin. The second purification step 
consisted of ion exchange chromatography. Using the protein calculator software 
(http://protcalc.sourceforge.net/), His-PBP2B was predicted to have a positive charge +19 at 
pH 6.0. Thus, a HiTrap SP HP column was used to further purify PBP2B. Samples containing 
PBP2B were dialysed to pH 6 which promoted the binding of the protein to the column followed 
by elution of PBP2B using a gradient of elution buffer with 1 M NaCl and pH 7.5. Collected 
fractions from the two chromatography experiments were analysed by SDS-PAGE (Figure 3.29 
A and B). Typically, 1.46 mg of PBP2B per litre of culture was obtained.  
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Figure 3.29 Purification of PBP2B 
SDS-PAGE analysis shows the fractions of the PBP2B purification steps. Gels were stained with 
Coomassie blue.  
(A) IMAC purification of His-PBP2B. App, applied fraction; FT, flow-through; M, Protein size marker 
(Fermentas PageRuler); W1-W4, wash fractions; E1-E3, elution fractions. The theoretical molecular 
weight of His-PBP2B is 81 kDa. 
(B) IEX of the purified PBP2B after thrombin cleavage. M, Protein size marker; the bands in F7, F8, 
F9 and F10 fractions with an apparent molecular weight of 79 kDa correspond to PBP2B.  
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4.1.6.2 Optimization of PBP2B* purification 
PbpB* gene, encoding PBP2B*, was cloned into pET28(a)+ expression plasmid using ligase 
free cloning (section 2.6.2). PBP2B* was expressed and solubilized in a similar way to PBP2B 
(section 4.1.6.2). Affinity chromatography was first performed to purify His-PBP2B* (section 
2.9.3) (Figure 3.30 A). Despite the correct DNA sequence for the thrombin recognition site, the 
enzyme did not cleave of the hexahistidine tag due to an unknown reason (Figure 3.30 C). 
Although the tag was still attached to PBP2B*, we proceeded to the second purification step to 
improve protein purity. Ion exchange chromatography was performed with a HiTrap SP HP 
column. PBP2B* was dialysed to pH 6.0, which promoted the binding of the protein to the 
column, followed by the elution of PBP2B* using elution buffer with 1 M NaCl and pH 7.5. 
Fractions collected from the two chromatography experiments were analysed by SDS-PAGE 
(Figure 3.30 A and B). Typically, 0.24 mg of PBP2B* per litre of culture was obtained. Western 
blot experiment using α-PBP2B antibody confirmed that the purified protein is PBP2B (Figure 
3.31 A). Several bands with smaller sizes than PBP2B were detected by SDS-PAGE and were 
also identified by the α-PBP2B antibody suggesting that these bands correspond to PBP2B 
degradation products. The bocillin-binding assay for PBP2B* showed no fluorescence when 
PBP2B* was incubated with bocillin or with both bocillin and PenG suggesting the inactivation 
of the TPase domain (Figure 3.31 C).  
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Figure 3.30 Purification of PBP2B* 
SDS-PAGE analysis showing the fractions of PBP2B* purification steps. Gels were stained with 
Coomassie blue.  
(A) IMAC purification of His-PBP2B*. Ap, applied fraction; FT, flow-through; M, protein size marker 
(Fermentas PageRuler); W1-W3, wash fractions; E1-E3, elution fractions. The theoretical molecular 
weight of His-PBP2B* is 81 kDa. 
(B) IEX of the purified PBP2B* after thrombin digest. M, protein size marker; the bands in E2-E9 
fractions with an apparent molecular weight of 79 kDa correspond to His-PBP2B*.  
(C) Hexahistidine-tag removal using Thrombin. M, protein size marker; B, before thrombin digest; Mi, 
a mixture of samples containing His-PBP2B with and without thrombin digest; A, after thrombin digest. 
No decrease in the apparent molecular weight of His-PBP2B* was observed suggesting that the 
Hexahistidine tag is still attached to PBP2B*.  
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4.1.6.3 Purification of PBP3  
PBP3 was purified using affinity and ion exchange chromatography (section 2.9.4). E. coli 
BL21(DE3) cells were used for the expression of PBP3 with an N-terminal Hexahistidine tag 
(His-PBP3). His-PBP3 was purified from the solubilised membrane fraction. Affinity 
chromatography was performed to purify His-PBP3 (Figure 3.32 A) and the hexahistidine tag 
was removed by thrombin. A second purification experiment was performed using ion 
exchange chromatography. PBP3 was predicted to have negative charge -7.0 at pH 8.3. 
Therefore, a HiTrap monoQ column was used to further purify PBP3. Samples containing PBP3 
were dialysed to pH 8.3 and injected into the column. PBP3 was eluted using a gradient of 
elution buffer with 1 M NaCl and pH 7.5. Collected samples from the two purification 
experiments were analysed by SDS-PAGE (Figure 3.32 A and B). Typically, 1 mg of PBP3 per 
litre of culture was obtained.  
PBP3* was purified in a similar way to PBP3 except that PBP3* was dialysed to pH 8.5 
permitting the binding of the protein to the HiTrap monoQ column followed by the elution of 
PBP3* (section 2.9.6) (Figure 3.33 A and B). Typically, 1.33 mg of PBP3* per litre of culture 
Figure 3.31 Western blot and bocillin-binding assay for PBP2B and PBP2B* 
(A) SDS-PAGE, (B) Western blot (using α-PBP2B antibody) and (C) bocillin binding assay for purified 
PBP2B and PBP2B*. M, Protein size marker (NEB); B, proteins incubated with bocillin; P+B, proteins 
incubated with PenG then bocillin. The bands in (A) and (B) with an apparent molecular weight of 79 
kDa correspond to PBP2B or PBP2B*. (C)  Only PBP2B molecules treated with bocillin showed 
fluorescence suggesting inability of PBP2B* to bind bocillin. PBP2B samples treated with PenG then 
bocillin showed no fluorescence suggesting a specific binding of bocillin to the TPase domain of 
PBP2B.  
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was obtained. Bocillin-binding assay for the purified PBP3* showed no fluorescence 
suggesting that the TPase domain of PBP3 is inactive (Figure 3.34).  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32 Purification PBP3 
SDS-PAGE analysis shows fractions from PBP3 purification steps. Gels were stained with Coomassie 
blue.   
(A) IMAC purification of His-tagged PBP3. App, applied fraction; FT, flow-through; M, Protein size 
marker (Fermentas PageRuler); W1-W4, wash fractions; E1-E3, elution fractions. The theoretical 
molecular weight of His-PBP3 is 74 kDa. 
(B) IEX of the purified PBP3 after thrombin cleavage. Collected samples were diluted four-fold to 
avoid overloading the gel. M, Protein size marker; the bands in E1, E2, F3 and F4 fractions with an 
apparent molecular weight of 73 kDa correspond to PBP3.  
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Figure 3.33 Purification of PBP3* 
SDS-PAGE analysis shows fractions from PBP3* purification steps. Gels were stained with Coomassie 
blue.   
(A) IMAC purification of His-tagged PBP3*. App, applied fraction; FT, flow-through; M, Protein size 
marker (NEB); W1-W4, wash fractions; E1-E5, elution fractions. The theoretical molecular weight of 
His-PBP3* is 74 kDa. 
(B) IEX of the purified PBP3* after thrombin cleavage. M, Protein size marker; the bands in E2-E4 
fractions with apparent molecular weight 73 KDa correspond to PBP3 however overloading the gel 
caused this smearing. 
B P+B B P+B
A
M M
B
Ap FT M W1 W2 W3 E1 E2 E3W4kDa
30
26
180
80
58
46
25
E4 E5
F1kDa
30
26
180
80
58
46
25
M F2 F3 F4 F5 F6 E1 E2 E3 E4 E5 E6
C
30
180
80
58
46
25
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.6.4 Purification of PBP3(17-668) 
PbpC gene (encoding PBP3) without the transmembrane coding sequence [PBP3(17-668)] was 
introduced into the expression plasmid pET28(a)+. E. coli BL21(DE3) cells were transformed 
with the latter plasmid and used for the expression of PBP3(17-668) with a hexahistidine-tag 
(Section 2.9.5). Affinity chromatography was first performed to purify His-PBP3(17-668) 
(Figure 3.35 A) and the hexahistidine tag was removed using thrombin. Second, ion exchange 
chromatography was performed using a HiTrap monoQ column to separate PBP3 from the 
hexahistidine -tag and to obtain a purer PBP3 product. The IEX was performed as described 
previously for full length PBP3. However, PBP3 did not bind to the column and was eluted in 
the flow through fractions (Figure 3.35 B). The third step was a gel filtration chromatography 
to further purify the protein by using a Superdex size exclusion column (Figure 3.35 C). 
Figure 3.34 Western blot and bocillin-binding assay for PBP3, PBP3(17-668) and PBP3* 
(A) SDS-PAGE, (B) Western blot (using α-PBP3 antibody) and (C) bocillin binding assay for purified 
PBP3, PBP3(17-668) and PBP3*. M, Protein size marker (NEB); B, proteins incubated with bocillin; 
P+B, proteins incubated with PenG then bocillin. The bands in (A) and (B) with an apparent molecular 
weight of 72 kDa correspond to PBP3, PBP3(17-668) or PBP3*. (C) Only PBP3 and PBP3(17-668) 
molecules treated with bocillin showed fluorescence suggesting the inability of PBP3* to bind bocillin. 
PBP3 and PBP3(17-668) samples treated with PenG then bocillin didn’t show a band suggesting a 
specific binding of bocillin to the TPase domain of PBP3. 
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Collected samples from all purification experiments were analysed by SDS-PAGE (Figure 3. 
35 A and B). Typically, 1.5 mg of PBP3 per litre of culture was obtained.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35 Purification of PBP3(17-668) 
SDS-PAGE analysis shows the fraction of PBP3(17-668) purification steps. Gels were stained with 
Coomassie blue.   
(A) IMAC purification of His-tagged PBP3(17-668). Ap, applied fraction; FT, flow-through; M, Protein 
size marker (Fermentas PageRuler); W1-W3, wash fractions; E1-E3, elution fraction. The theoretical 
molecular weight of His-PBP3(17-668) is 74 kDa. 
(B) IEX of the purified PBP3(17-668). F1-F9, flow-through; M, Protein size marker; the bands in F2, 
F3, F4 and F5 fractions with a size of 72 kDa correspond to PBP3(17-668).  
(C) SEC of the protein. The bands with an apparent molecular weight of 72 kDa in all fractions 
correspond to PBP3(17-668). 
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4.1.7 PBP3 interacts with PBP2B  
The interaction between PBP2B and PBP3 was studied using pull-down assay and Surface 
Plasmon Resonance (SPR). In a pull-down assay we tested if PBP2B interacts with a 
hexahistidine-tagged PBP3 (His-PBP3) (section 2.10.1). His-PBP3 and PBP2B were mixed 
with Ni-NTA beads in an interaction buffer. His-PBP3 had a hexahistidine tag which promoted 
the binding of PBP3 to the beads. SDS–PAGE analysis of the applied and bound fractions 
shows whether His-PBP3 was able to pull-down PBP2B (Figure 3.36 A). Both the applied and 
bound fractions for His-PBP3 showed a band with an apparent molecular weight corresponding 
to His-PBP3 showing that it was successfully pulled down by the Ni-NTA. PBP2B in the 
absence of His-PBP3 only appeared in the applied fraction suggesting that PBP2B was not 
pulled down by the beads. PBP2B in the presence of His-PBP3 appeared in both the applied 
and bound fractions suggesting that His-PBP3 was able to pull down some of the PBP2B 
molecules indicating an interaction between the two proteins.   
SPR was used to further analyse the interaction between PBP3 and PBP2B and to determine 
the dissociation constant (KD) of this interaction (section 2.10.2). First, ampicillin was 
immobilized to the sensor chip followed by the binding of PBP2B via its TPase domain. This 
method allows a homogeneous orientation of PBP2B proteins with their N-terminus accessible 
for interaction. The remaining free ampicillin was digested with β-lactamase. The chip was 
washed with NaCl buffer (1 M) to remove non-covalent bound protein. In parallel, the control 
surface was prepared in a similar way without the immobilized PBP2B. PBP3 was injected over 
the PBP2B surface and the control surface at concentration 400, 200, 100, 50 and 25 nM (Figure 
3.36 B). The binding of the injected protein (analyte) to the chip surface or the immobilized 
protein causes an increase in the SPR curves (Bravman et al., 2006). These SPR curves are 
called sensorgrams and represent the changes in response unite (RU) plotted against time (s). 
PBP3 was injected at a flow rate of 75 µl/min. The surface with immobilized PBP2B showed 
an increase in signal during association (from 0 to 300 s) compared to the control surface 
(Figure 3.36 B). The response almost reached saturation or equilibrium towards the end of the 
association (from 200 to 300 s). Subsequently, running buffer was injected after 300 s causing 
the dissociation of analytes. The increase in response unit for the control surface indicates 
unspecific binding of the analyte (PBP3) to the chip surface. A higher signal for the PBP2B-
surface compared to the control surface during association and equilibrium indicates a specific 
interaction between PBP2B and PBP3. The subtraction of the control signal from the PBP2B-
surface signal is represented in figure 3.36 C. The signal corresponding to analytes with 
concentration of 100 nM or higher overlapped suggesting a saturation of binding (Figure 3.36 
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C). The KD of the interaction was calculated using Sigma Plot software, based on a one site 
interaction with PBP3. The average response of PBP3 during equilibrium was calculated for 
every concentration and used for KD determination. The binding curve was generated by 
plotting the response in (RU) against analyte concentration in nM (Figure 3.36 D). The KD of 
the interaction of PBP2B with PBP3 was 8.7 ± 1.2 nM calculated from three independent 
experiments. 
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Figure 3.36 Interaction of PBP2B with PBP3 by in vitro pull-down and SPR   
(A) Pull-down assay performed to test if PBP2B and PBP3 interact. Coomassie stained SDS-PAGE 
analysis showing His-PBP3 and PBP2B. His-PBP3 and PBP2B were detected in both the applied and 
the bound fractions suggesting that His-PBP3 pull-down PBP2B. A, Applied; B, bound fractions.  
(B) SPR sensorgrams showing the response for PBP3 when injected over a surface with immobilized 
PBP2B or a control surface at concentration 20, 50, 100, 200 and 400 nM plotted against time (s). The 
signal for the PBP2B-surface was higher than the control surface upon PBP3 injection.   
(C) SPR sensorgram showing the response for the PBP2B-surface minus control. The signals 
corresponding to 100, 200 and 400 nM PBP3 overlapped suggesting ligand saturation.  
(D) The response values during equilibrium were plotted against the injected PBP3 concentrations. 
The KD of the PBP2B-PBP3 interaction was determined by non-linear regression using Sigma Plot 
software. The KD value is the mean ± standard deviation of three independent experiments. 
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A similar SPR experiment was performed with PBP2B immobilised to the chip surface as above 
except that PBP3 lacking its transmembrane domain (PBP3(17-668)) was injected as an analyte 
over the PBP2B-surface and a control surface at concentrations 1000, 500, 250, 125 and 62.5 
nM. The response over the PBP2B-surface was similar to the control surface upon the injection 
of PBP3(17-668) suggesting the absence of specific binding between the two proteins (Figure 
3.37 A). The subtraction of the control response from the PBP2B-surface response showed no 
saturation of signal upon increasing the concentration of the analyte supporting the premise of 
the absence of interaction between the two proteins (Figure 3.37 B). 
These results suggest that the interaction between PBP2B and PBP3 is specific and the N-
terminal region of PBP3 is required for interaction with PBP2B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.37 PBP2B does not interact with PBP3(17-668) by SPR   
(A) SPR sensorgrams showing the response for PBP3(17-668) when injected over a surface with 
immobilized PBP2B or a control surface at concentration 62.5, 125, 250, 500 and 1000 nM plotted 
against time (s). The signal for the PBP2B-surface was similar to the control surface upon analyte 
injection. 
(B) SPR sensorgram showing the response for PBP3(17-668) minus the control response. The response 
for PBP3(17-668) at various concentrations was similar and did not result in a binding curve or signal 
saturation suggesting absence of interaction between the two proteins. 
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4.1.8 Interaction between PBP3 and PBP1 
B. subtilis has four bi-functional class A PBPs with PBP1, encoded by the ponA gene, involved 
in septal PG synthesis (Scheffers and Errington, 2004). PBP1 was purified (Section 2.10.1) and 
tested for interaction with PBP3 using in vitro pull-down assay and surface plasmon resonance. 
First, we used Ni2+-NTA pull down to test whether His-PBP3 would retain PBP1. SDS–PAGE 
analysis for the applied and bound fractions of His-PBP3 showed a band with an apparent 
molecular weight corresponding to His-PBP3 showing that it was successfully pulled down by 
the Ni-NTA (Figure 3.38 A). PBP1 in the absence of His-PBP3 only appeared in the applied 
fraction suggesting that PBP1 was not pulled down by the beads. PBP1 in the presence of His-
PBP3 appeared only in the applied fraction suggesting that His-PBP3 did not retain PBP1. To 
stabilize a possible weak interaction, formaldehyde (0.2%) was used to crosslink interacting 
proteins. Nevertheless, His-PBP3 did not retain PBP1 suggesting that PBP1 and PBP3 do not 
interact by pull-down assay. 
SPR was also used to test if PBP1 and PBP3 directly interact. Ampicillin was first immobilized 
to the sensor chip followed by the covalent binding of PBP1 via its TPase domain. A control 
surface was prepared in the same way without PBP1. The remaining free ampicillin was 
digested with β-lactamase. The chip was washed with NaCl buffer (1 M) followed by the 
injection of PBP3 at concentration 200, 100, 50, 25 and 12.5 nM. The sensorgram for the PBP1-
surface showed a higher signal during association and equilibrium compared to the control 
surface followed by a decrease in the signal for both surfaces during dissociation. To test if the 
PBP1-surface was saturated upon the injection of PBP3, the control signal was subtracted from 
the PBP1-surface (Figure 3.38 C). The binding levels saturated at 50 nM injected PBP3. This 
result suggests that PBP1 and PBP3 interact. Whilst three independent experiments have been 
performed for the interaction of PBP1 and PBP3, only 2 showed an increase in signal suggesting 
an interaction between PBP1 and PBP3.  
A similar experiment was performed with PBP3 being immobilized to the chip surface and 
PBP1 being injected as an analyte. However, the signal for the control surface when PBP1 was 
injected as an analyte was high suggesting unspecific binding of PBP1 to the chip surface. These 
results suggest that PBP3 is presumably interacting with PBP1 but additional experiments are 
required to confirm such interaction. Next, we proceeded to characterize the enzymatic 
activities of PBP3 or PBP3* in the presence of PBP1 in vitro using established methods in our 
lab.  
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Figure 3.38 Interaction of PBP1 with PBP3 by in vitro crosslink / pull-down and SPR 
(A) Ni-NTA affinity chromatography used to test if PBP1 and PBP3 directly interact. Coomassie stained 
SDS-PAGE analysis showing His-PBP3 and PBP1. PBP1 in the presence of His-PBP3 appeared only 
in the applied fraction suggesting that His-PBP3 did not retain PBP1. A, Applied; B, bound fractions. 
(B) SPR sensorgrams showing the response for PBP3 when injected over a surface with immobilized 
PBP1 or a control surface at concentration 12.5, 25, 50, 100 and 200 nM. The signal for the PBP1-
surface was higher than the control surface during association suggesting that PBP1 interacts with 
PBP3.  
(C) SPR sensorgram showing the response for the PBP1-surface minus control. The binding levels 
saturated at 50 nM injected PBP2B.  
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4.1.9 PBP3 has DD-transpeptidase and DD-carboxypeptidase activities  
The enzymatic activities of the class B PBP3 alone or together with the bifunctional synthase 
PBP1, were tested using radioactive Lipid II, which is the precursor for peptidoglycan synthesis. 
To test whether PBP3 contributes to the synthesis of peptides in cross-link, PBP3 with an 
inactive TPase domain (PBP3*) was also purified (section 2.10.6) and tested. The detection of 
monomeric muropeptides suggest that lipid was polymerized into a glycan chain by the GTase 
activity of PBPs and the levels of oligomeric muropeptides (peptides in crosslink) correlate 
with the TPase activity of the synthases. PBP3 alone had no activity against lipid II (Figure S1). 
PBP1 alone has GTase and TPase activities, consequently PBP1 polymerised lipid II into glycan 
strands with crosslinked peptides (Cleverley et al., 2016; Lebar et al., 2014). PBP3 and PBP3* 
tested together with PBP1 had similar levels of peptides in crosslinks suggesting that PBP3 did 
not contribute to this activity (Figure 3.39). A mild but significant (4.8%) decrease in levels of 
peptides in crosslinks was detected for PBP1 with PBP3 compared to PBP1 alone. A similar 
decrease (6.0%) was noticed for PBP1 with PBP3* suggesting that PBP3 caused a mild 
reduction in the TPase activity of PBP1 (Figure 3.39). The activity of PBPs was also tested in 
the presence of sacculi isolated from wild type B. subtilis (tripeptide rich) or ΔdacA mutant 
(pentapeptide rich). Samples were incubated for 1 h at 37˚C then the reaction was stopped by 
boiling the samples for 5 min. The mixture of old and newly synthesised PG was digested with 
cellosyl overnight, reduced and analysed by HPLC. Muropeptides identified by the HPLC 
radioactivity detector represented the newly synthesised PG material. An insignificant decrease 
in the levels of peptides in cross-link was identified for PBP1 with PG compared to PBP1 alone 
(figure 3.39). PBP1 alone or together with PBP3 in the presence of 168CA or ΔdacA PG had 
similar levels of peptides in crosslink. However, PBP3* with PBP1 had a significant decrease 
in levels of peptides in crosslink when tested in the presence of 168CA or ΔdacA PG (Figure 
3.39). These results suggest that PBP3 contributes to the level of peptides in crosslink and has 
a transpeptidase activity. The decrease in the level of peptides in crosslink for PBP1 with PBP3* 
compared to PBP1 alone in presence of 168CA or ΔdacA PG suggested that PBP3 inhibits the 
TPase activity of PBP1 in presence of PG.  
DD-carboxypeptidase (CPase) activity causes the removal of the fifth D-Ala residue from the 
GlcNAc-MurNAc-pentapeptide. Thus, the CPase activity of PBPs is quantified by measuring 
the levels of GlcNAc-MurNAc-tetrapeptide (Tetra) and of the crosslinked bis-GlcNAc-
MurNAc-tetrapeptide (TetraTetra) muropeptides. PBP1 alone had 18.7% of CPase products 
suggesting that PBP1 has a CPase activity which is consistent with previously publish data 
(Figure 3.40) (Cleverley et al., 2016). PBP3 and not PBP3* together with PBP1 showed 15.8% 
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increase in the levels of CPase products suggesting that PBP3 has a CPase activity. PBP1 alone 
had similar levels of CPase products when tested in the presence of 168CA or ΔdacA PG 
suggesting that PBP1 has a CPase activity independent of the presence or absence of PG. PBP3 
with PBP1 had 14.5% and 10.3% increase in CPase products when tested in the presence of 
168CA or ΔdacA PG, respectively. The decrease in CPase products for PBP1 with PBP3 in the 
presence of PG was complemented by an increase in levels of peptides in crosslink. These 
results suggest that PBP3 has a CPase activity in the absence of PG and a TPase and a CPase 
activity in the presence of PG. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.39 TPase activities of PBP1 and PBP3  
The percentage of cross-linked peptides in PG produced by PBP1 alone, PBP1 and PBP3 or PBP1 
and PBP3*, with or without PG. In the absence of PG, PBP1 with PBP3 or PBP3* had similar levels 
of peptides in crosslink. In samples containing PG, PBP3 and not PBP3* contributed to the levels of 
peptides in crosslink. PBP3* caused a mild decrease in the levels of peptides in crosslink produced by 
PBP1 in presence of 168CA or ΔdacA PG. *, P<0.05; **, P<0.01 
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4.1.10 PBP3 has no effect on the GTase activity of PBP1 
The effect of PBP3 on the GTase activity of PBP1 was tested in vitro using fluorescently 
labelled dansyl-lipid II (Section 2.10.3). Class A PBPs have a GTase activity that polymerizes 
dansyl-lipid II into glycan strands. This polymerization causes a decrease in the fluorescence 
signal, which is detected by a spectrophotometer and recorded over time. Figure 3.41 shows the 
mean florescence presented as a percentage of initial fluorescence at a given time-point. 
Consistent with the TPase assay shown in section 4.1.9, PBP3 showed no decrease in 
fluorescence detected over time suggesting that PBP3 has no activity against dansyl-lipid II 
(Figure 3.41). The fluorescence signal detected for PBP1 alone decrease over time suggesting 
that the dansyl-lipid is polymerised into a glycan chain by a GTase activity which is consistent 
with previously published data (Cleverley et al., 2016). PBP3 together with PBP1 showed a 
Figure 3.40 DD-Carboxypeptidase activity of PBP1 and PBP3 
The percentage of CPase products (Tetra and TetraTetra) produced by PBP1 alone, PBP1 and PBP3 
or PBP1 and inactive PBP3*, with or without PG. PBP1 alone with or without PG exhibited an 
increase in the levels of CPase products suggesting a CPase activity. PBP3 and not PBP3* together 
with PBP1 showed a significant increase in the levels of CPase products compared to PBP1 alone 
suggesting that PBP3 has CPase activity. *, P<0.05; **, P<0.01 
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similar decrease in the fluorescence signal over time compared to PBP1 alone suggesting that 
PBP3 has no effect of the GTase activity of PBP1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.41 The effect of PBP3 on the GTase activity of PBP1 
The diagram represent the GTase activity of PBP1 and PBP3. A decrease in relative fluorescence 
suggests the presence of a GTase activity. PBP3 alone had no activity against dansyl-lipid II. PBP3 had 
no effect on the GTase activity of PBP1. Values represent the mean ± standard deviation of three 
independent experiments. 
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4.2 Characterization of PBP2B in vitro  
4.2.1 Introduction 
PbpB (encoding PBP2B) is the only essential PBP gene in B. subtilis (Yanouri et al., 1993). 
PBP2B is highly conserved across bacterial species and plays a crucial role in cell division 
(Daniel et al., 1996, 2000; Yanouri et al., 1993). PBP2B is recruited to the septum at the early 
stages of cell division followed by other PG synthases and hydrolases. PBP2B is the first PBP 
to be recruited to midcell during cell division and the depletion of PBP2B caused 
mislocalisation of GFP-PBP1 (Scheffers and Errington, 2004). To further characterise the 
interaction and biochemical roles of PBP1 and PBP2B in cell division, both proteins were 
purified and tested in vitro.  
 
4.2.2 Dimerization of PBP2B 
Bacterial two-hybrid experiments suggested that PBP2B dimerizes in vivo (Daniel et al., 2006). 
In this work, we studied the dimerization of PBP2B by SPR. First, ampicillin was immobilized 
to the sensor chip followed by the binding of PBP2B via its TPase domain. The remaining free 
ampicillin was digested with β-lactamase. The chip was washed with NaCl buffer (1 M) to 
remove non-covalently bound protein. A control surface was prepared in the same way without 
PBP2B. PBP2B molecules were injected over the PBP2B surface and the control surface at ten 
different concentrations ranging from 0 to 350 nM. The sensorgrams in figure 3.42 A and B for 
the PBP2B-surface showed an increase in signal during association compared to the control 
surfaces. The signal almost reached equilibrium for all PBP2B injected concentrations during 
association followed by a continuous decrease during the dissociation phase (Figure 3.42 A). 
The signal for the PBP2B-surface minus the control showed saturation of binding at 80 nM 
injected PBP2B (Figure 3.42 B). These results suggest that PBP2B dimerises under the tested 
conditions. The KD of the interaction was calculated using SigmaPlot software, based on a one 
site interaction with PBP2B. The average response of PBP2B during equilibrium was calculated 
for every concentration and used for KD determination. The binding curve was generated by 
plotting the response in (RU) against analyte concentration in nM (Figure 3.42 C). The KD of 
the dimerization of PBP2B was 21.7 ± 11.4 nM calculated from three independent experiments. 
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4.2.3 Interaction of PBP2B and PBP1 by SPR 
PBP1 was tested for interaction with PBP2B using SPR. PBP1 showed substantial unspecific 
binding to the chip surface when it was injected as an analyte in previous SPR experiments. 
Thus, PBP1 was immobilized to the surface and PBP2B was injected as an analyte. First, 
ampicillin was immobilized to the sensor chip followed by the binding of PBP1. The remaining 
free ampicillin was digested with β-lactamase and the chip was washed with NaCl buffer (1 M). 
A control surface was prepared in a similar way without the immobilized PBP1. PBP2B was 
Figure 3.42 Dimerization of PBP2B by SPR 
(A) SPR sensorgrams showing the response for PBP2B when injected over the PBP2B-surface and the 
control surface. The interaction was tested using ten different concentrations of PBP2B and the 
sensorgrams suggest dimerization of PBP2B. 
(B) SPR sensorgram showing the response for the PBP2B-surface minus the control response. The 
binding levels saturated at 80 nM injected PBP2B. 
(C) The response values during equilibrium were plotted against injected PBP2B concentrations. 
The KD of the dimerization of PBP2B was determined by non-linear regression using Sigma Plot. The 
value shown is the mean KD ± standard deviation of three independent experiments. 
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injected over the control surface and the PBP1-immobilized surface at concentrations 500, 250, 
125, 62.5 and 31.25 nM. The sensorgrams showed higher signal for the PBP1-surface compared 
to the control surface during association (Figure 3.43 A). The SPR signals reached equilibrium 
towards the end of the association phase followed by a decrease in signal during dissociation 
phase upon the injection of running buffer (Figure 3.43 A). The curves for the PBP1-surface 
minus the control overlapped upon the injection of PBP2B at 250 nM concentration and above 
suggesting a saturation of binding (Figure 3.43 B). This result suggests that PBP2B directly 
interacts with PBP1. This interaction has been observed in two independent experiments for 
five PBP2B concentrations however, more experiments are required for the calculation of the 
interaction KD of PBP1 with PBP2B. Following the observed interaction between PBP1 and 
PBP2B, we characterized the enzymatic activities of PBP1 and PBP2B using radioactive or 
fluorescently labelled lipid II 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.43 Interaction of PBP1 with PBP2B by SPR 
(A) SPR sensorgrams showing the response for PBP2B when injected over a surface with immobilized 
PBP1 or a control surface at concentration 31.2 , 62.5, 125, 250 and 500 nM. The signal for the PBP1-
surface was higher than the control surface during association suggesting that PBP1 interacts with 
PBP2B.  
(B) SPR sensorgram showing the response for the PBP1-surface minus control. The binding levels 
saturated at 250 nM injected PBP2B. 
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4.2.4 PBP2B has DD-transpeptidase and DD-carboxypeptidase activities 
The GTase and TPase activities of PBP1 and PBP2B were tested using in vitro PG synthesis 
assay (section 2.10.4). To test whether PBP2B contributes to the synthesis of peptides in cross-
link, PBP2B with an inactive TPase domain (PBP2B*) was also purified (section 2.9.3) and 
tested with PBP1. PBP2B* featured a substitution of the active site serine residue to alanine 
making the TPase domain non-functional. PBP2B alone had no activity against lipid II (Figure 
S3).  The TPase and GTase activity of PBP1 was previously described in section 4.1.9. PBP2B 
together with PBP1 had a mild increase of 4.6% in the levels of peptides in crosslinks compared 
to PBP1 alone (Figure 3.44 A) and an increase of 8.5% compared to PBP1 with PBP2B*. This 
suggested that PBP2B contributed to the formation of peptides in crosslinks and has TPase 
activity. PBP1 and PBP2 were also tested in the presence of 168CA and ΔdacA PG. In the 
presence of 168CA PG, no significant changes were observed for PBP1 alone, PBP1 with 
PBP2B or PBP1 with PBP2*. In presence of ΔdacA PG, PBP1 with PBP2B showed an mild 
but significant increase in the levels of peptides in crosslink compared to PBP1 alone or PBP1 
with PBP2B*, supporting previous results about the TPase activity of PBP2B.  
The CPase activity of PBP1 alone in the presence or absence of PG was previously described 
in section 4.1.9. PBP1 with PBP2B showed a significant increase of 7.1 and 6.5% in the levels 
of CPase products compared to PBP1 alone or PBP1 with PBP2B*, respectively. These results 
suggests that PBP2B contributed to the levels of CPase products and has a CPase activity 
(Figure 3.44 B). In the presence of 168CA or ΔdacA PG, no significant differences were 
detected in the levels of CPase products for PBP1 alone, with PBP2B or with PBP2* suggesting 
that PBP2B has a CPase activity only in the absence of PG. Taken together, these results 
suggested that PBP2B has DD-carboxypeptidase and DD-transpeptidase activities. The levels 
of peptides in crosslink for PBP1 alone or with PBP2B* were similar suggesting that PBP2B* 
has no effect on the TPase activity of PBP1. 
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Figure 3.44 Enzymatic activities of PBP1 and PBP2B 
(A) The percentage of cross-linked peptides in PG produced by PBP1 alone, PBP1 and PBP2B or PBP1 
and inactive PBP2B*, with or without PG. PBP1 with PBP2B had higher levels of peptides in crosslinks 
compared to PBP1 alone or PBP1 with PBP2B* in the absence of PG or in the presence of ΔdacA PG. 
PBP2B and not PBP2B*, contributed to the levels of peptides in crosslinks suggesting a TPase activity.  
(B) The percentage of CPase products produced by PBP1 alone, PBP1 and PBP2B or PBP1 and 
PBP2B*, with or without PG. PBP1 with PBP2B and not PBP2B* showed increased levels of CPase 
products only in the absence of PG suggesting that PBP2B has CPase activity.    
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4.2.5 PBP2B stimulates the GTase activity of PBP1 
The In vitro PG synthesis assay showed that PBP2B had no GTase activity and no effect on the 
TPase activity of PBP1. Here, PBP1 and PBP2B were tested for activity against dansyl-lipid II 
by an in vitro glycosyltransferase assay. Supporting previous results (section 4.2.4), there was 
no decrease in fluorescence for samples with PBP2B alone suggesting that PBP2B has no 
activity against lipid II (Figure 3.45). PBP1 with PBP2B had a moderately faster decrease in 
the fluorescence signal compared to PBP1 alone. This suggests that the polymerization of lipid 
II into glycan strands is occurring at a faster rate when PBP2B is added to PBP1. The GTase 
rate was 2.0 ± 0.02 fold higher in the presence of PBP2B compared to PBP1 alone, suggesting 
that PBP2B stimulates the GTase activity of PBP1.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.45 PBP2B stimulates the GTase activity of PBP1  
In vitro glycosyltransferase assay performed for PBP1, PBP2B or PBP1 with PBP2B. PBP2B alone 
had no effect on the substrate. PBP1 with PBP2B had a faster decrease in fluorescence compared to 
PBP1 alone. The rate of the GTase reaction for PBP1 increased by 2.0 ± 0.02 fold in presence of 
PBP2B. Values represent the mean ± standard deviation of three independent experiments. 
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4.2.6 In vitro pull-down for His-PBP3, PBP1 and PBP2B  
The interactions of PBP1, PBP2B and PBP3 were characterized previously using various 
interaction assays. The formation of multi-protein complexes during cell division is well 
established in other bacterial species such as E. coli (Egan et al., 2015). Therefore, to test 
whether PBP1, PBP2B and PBP3 form a ternary complex, Ni-NTA crosslink/pull down assay 
was performed with His-PBP3, PBP1 and PBP2B. Formaldehyde was used as a crosslinker to 
stabilise possible weak interactions. SDS–PAGE analysis for the applied and bound fractions 
of His-PBP3 showed a band with an apparent molecular weight corresponding to His-PBP3 
showing that it was successfully pulled down by the beads (Figure 3.46). PBP2B and PBP1 in 
the absence of His-PBP3 appeared only in the applied fraction suggesting that PBP1 and PBP2B 
were not pulled down by Ni-NTA. The elution fraction of the mixture PBP1, PBP2B and His-
PBP3 showed only two bands in the elution fraction corresponding to PBP2B and His-PBP3 
suggesting that His-PBP3 was able to pull down PBP2B but not PBP1. These results suggest 
that the formation of a ternary complex between PBP1, PBP2 and His-PBP3 is doubtful. The 
KD of the interaction between PBP2B and PBP3 was 8.7 nM suggesting a strong interaction 
between the two proteins. Thus, we hypothesised that the presence of PBP3 destabilises the 
interaction of PBP2B with PBP1. To test this hypothesis we used the in vitro GTase assay to 
monitor the activity of PBP1 in the presence of PBP2B and PBP3.  
 
 
 
 
 
 
 
 
 
 
Figure 3.46 In vitro crosslink / pull-down assay of His-PBP3 with PBP1 and PBP2B 
Ni-NTA pull-down for His-PBP3, PBP1 and PBP2B. Coomassie stained SDS-PAGE analysis showing 
His-PBP3 and PBP2B but not PBP1 in the bound fraction suggesting that His-PBP3 pulled down 
PBP2B but not PBP1. A, Applied; B, bound fractions. 
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4.2.7 GTase activity of PBP1 in the presence of PBP2B and PBP3 
The pull-down experiment proposed that PBP1, PBP2B and PBP3 do not form a ternary 
complex. PBP2B, unlike PBP3, stimulated the GTase activity of PBP1 (Sections 4.1.10 and 
4.2.5). The GTase activity of PBP1 was tested in the presence of both PBP2B and PBP3. PBP1 
in the presence of both PBP2B and PBP3 had a similar decrease in fluorescence to PBP1 alone 
(Figure 3.47), suggesting that the stimulation of the GTase activity of PBP1 by PBP2B was 
diminished upon the addition of PBP3. This effect was probably caused by the destabilization 
of the interaction between PBP1 and PBP2B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.47 The GTase activity of PBP1 in the presence of PBP2B and PBP3  
In vitro glycosyltransferase assay for PBP1 alone or PBP1 with PBP2B and PBP3. PBP1 with PBP2B 
and PBP3 had a similar decrease in the fluorescence signal to PBP1 alone. Values represent the mean 
± standard deviation of three independent experiments. 
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4.3 Conclusions and discussion  
The depletion of the essential PBP2B (BsPBP2B) resulted in a block in cell division followed 
by lysis (Daniel et al., 2000). Work done by Meizhu Xu showed that cells expressing a 
catalytically inactive BsPBP2B were viable, but they required functional PBP3 (BsPBP3), a 
homologue of BsPBP2B that is dispensable in wild-type cells (Unpublished data). These results 
suggests that BsPBP2B has a crucial non-catalytic and a dispensable catalytic roles. In young 
wild-type cells BsPBP3 localised at the cell poles or in foci at the cell periphery (Scheffers et 
al., 2004). At later stages of the cell cycle most BsPBP3 molecules were recruited to mid-cell, 
however distinct foci along the cell periphery were still detected. The depletion of BsPBP2B or 
FtsZ in the cell resulted in a scattered localisation of BsPBP3 along the cell periphery, 
suggesting that BsPBP3 is part of the septal PG synthesis machinery and requires the presence 
of BsPBP2B to find the mid-cell (Richard Daniel, unpublished). Moreover, BsPBP2B and 
BsPBP3 interact, which supports that the physical presence of PBP2B is essential for PBP3 to 
find the divisome. Why two class B PBP homologues are needed together for septal PG 
synthesis is not known. The absence of BsPBP3 had no effect on cell growth, morphology or 
sporulation (Murray et al., 1996). The amino acid sequence analysis and the crystal structure of 
BsPBP3 revealed the presence of a MecA domain, which is also present in the SaPBP2a from 
S. aureus (Unpublished data) (Wei Wu et al., 2001). SaPBP2a is responsible for the methicillin-
resistance phenotype in S. aureus however, since B. subtilis cells are sensitive to methicillin, 
the role of BsPBP3 remains unclear (Matsuhashi et al., 1986). Cells expressing BsPBP2B* 
exhibited an earlier and enhanced recruitment of PBP3 to mid-cell possibly to complement the 
lack of TPase activity.  However, the BsPBP2B* mutant exhibited longer cell morphology and 
aberrant septa suggesting a lower efficiency in septal PG synthesis despite the enhanced 
presence of BsPBP3.  
BsPBP2B is a monofunctional transpeptidase presumably catalysing cross-links in the murein 
(Daniel et al., 1996; Yanouri et al., 1993). However, BsPBP2B alone cannot synthesize the 
murein net during cell division and requires a synthetic glycosyltransferase activity to 
polymerize the murein glycan strands. BsPBP2B is the first PBP recruited to the assembling 
divisome and the depletion of BsPBP2B resulted in the loss of the class A BsPBP1 septal 
localisation (Scheffers and Errington, 2004). Moreover, BsPBP2B interacts with BsPBP1 by 
bacterial two-hybrid (Richard Daniel, unpublished) and by SPR suggesting that BsPBP1 is 
recruited to midcell through its interaction with BsPBP2B. The interaction between class A and 
B PBPs have been studied previously in E. coli where the essential cell division class B PBP3 
(EcPBP3) interacts with the class A synthase PBP1B (Bertsche et al., 2006). These results 
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support a consistent model of murein synthesis between E. coli and B. subtilis rods where class 
A PBPs are recruited by class B PBPs for septal PG synthesis.  
An interaction between BsPBP3 and BsPBP1 was also detected in vitro and in vivo (this work 
and Richard Daniel, unpublished), however the loss of BsPBP3 in cells lacking BsPBP1 didn’t 
not have any additional effect on cell growth or morphology (Murray et al., 1996). This is an 
evidence of a redundancy between PBPs in B. subtilis which produces a robust system for cell 
wall synthesis. Furthermore, since the cooperation between class A and B PBPs is important 
for PG synthesis, perhaps the interaction of the class B BsPBP3 with BsPBP1 is important for 
murein synthesis and it is one on the reasons why BsPBP3 was able to complement the inactive 
BsPBP2B*.  
Purified BsPBP2B and BsPBP3 bound the β-lactam antibiotic bocillin indicating that the TPase 
domain was folded and potentially active. BsPBP2B and BsPBP3 both had mild transpeptidase 
and carboxypeptidase activities in assays with BsPBP1. Consequently, both BsPBP2B and 
BsPBP3 require ongoing PG synthesis by BsPBP1 for activity. The cell division class B 
SpPBP2x from S. pneumoniae is also required for the GTase activity of the class A SpPBP2A 
to produce PG (Zapun et al., 2013). However, EcPBP3 showed no TPase activity despite the 
presence of EcPBP1B, FtsN, and/or PG (Waldemar Vollmer, unpublished). The presence of a 
tripeptide rich PG or a pentapeptide rich PG had no effect on the activity of BsPBP2B, similar 
to SpPBP2x, which did not require the presence of PG from S. pneumoniae for activity (Zapun 
et al., 2013). In contrast, BsPBP3 from B. subtilis showed a TPase activity only in the presence 
of PG similar to the class B PBP2 from  E. coli (EcPBP2), which is involved in cell elongation 
(Banzhaf et al., 2012). These results suggests that BsPBP2B is able to crosslink two nascent 
glycan strands synthesised by BsPBP1 while BsPBP3 is more involved in attaching newly 
synthesised PG to the sacculi. The subtle differences between the activities of BsPBP2B and 
BsPBP3 could be a reason for the partial complementation of the BsPBP2B* mutant by 
BsPBP3.   
PBP2B moderately stimulated the GTase activity of BsPBP1. Since the N-terminals of both 
synthases are anchored in the membrane, it is possible that the non-catalytic domain of 
BsPBP2B interacts with the GTase domain of BsPBP1 near to the cytoplasmic membrane 
resulting in the stimulation of the GTase activity (see section 1.3.1). On the other hand, EcPBP3 
had no effect on the GTase or TPase activity of its cognate EcPBP1B [(Egan et al., 2015) and 
Khai Bui, unpublished]. Despite the homology between BsPBP2B and BsPBP3, the latter 
modulated the activity of BsPBP1 differently in vitro, where BsPBP3 had no effect on the GTase 
activity but reduced the TPase activity of BsPBP1. Taken together, class B PBPs may have 
136 
dissimilar roles in the PG synthesis process by differentially modulating the activity of the class 
A BsPBP1.  
The formation of a multi-protein complex in E. coli was previously described between cell 
division proteins (Egan et al., 2015; Trip and Scheffers, 2015). Thus, we tested if a ternary 
complex exists in B. subtilis between PBP1, PBP2B and PBP3 since binary interactions 
between each protein was observed. Pull down experiments suggested that His-PBP3 only 
interacted with PBP2B despite the presence of PBP1 in the mixture. Moreover, the GTase 
activity of PBP1 increased 2 fold in the presence of PBP2B. However, the GTase activity of 
the synthase with PBP2B and PBP3 together was similar to that of PBP1 alone suggesting that 
stimulatory effect of PBP2B on the activity of PBP1 is blocked in the presence of PBP3. The 
loss of the stimulation could be caused by the destabilization of the PBP1-PBP2B interaction 
by PBP3 supported by the pull-down experiment, or by a direct effect of the PBP3 interaction 
on PBP1. However, more experiments are required to verify these suggestions. 
 
PG synthesis in B. subtilis 
Cells lacking the FtsZ regulators SepF and EzrA do not recruit the essential PG synthase 
BsPBP2B to the divisome, resulting in cell death (Hamoen et al., 2006). Moreover, EzrA 
interacts with GpsB and BsPBP1 and coordinates the recruitment of the synthase to the division 
site (Claessen et al., 2008; Cleverley et al., 2014; Tavares et al., 2008). Therefore, the 
recruitment of cell wall synthase seems to be regulated by cytosolic proteins that act as a 
scaffold to assemble the cell division machinery. In this work, we have shown an interaction 
between BsPBP1 and BsPBP2B in vitro suggesting that the recruitment of BsPBP1 to mid-cell 
is dependent on the physical presence and interaction of BsPBP1with the class B BsPBP2B, a 
model that has been observed as well in E. coli cells between EcPBP3 and its cognate EcPBP1B 
(Bertsche et al., 2006; Scheffers and Errington, 2004). BsPBP3 was recruited at later stages in 
the cell cycle and its recruitment was dependent on BsPBP2B. However, the biochemical 
characterization of BsPBP3 in vitro suggests three criteria for BsPBP3. First, BsPBP3 showed 
a significantly higher CPase than TPase activity in assays with BsPBP1. CPases are thought to 
have a role in the regulation of cell shape by limiting the availability of pentapeptides as donor 
substrates for TPase reactions, hence regulating the extent of cross-linking in PG (Potluri et al., 
2010). Second, PBP3 reduced the TPase activity of BsPBP1. Third, BsPBP3 diminished the 
stimulatory effect of BsPBP2B on the GTase activity of BsPBP1. Taken together, we propose 
that BsPBP3 is recruited late to mid-cell to finalise the septal PG synthesis by reducing the 
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activity of the main synthase and dissociating the BsPBP2B-PBP1 complex. This hypothesis 
correlates with partial complementation of BsPBP3 to the BsPBP2B*, however, it does not take 
into account the presence of other proteins in the divisome complex that might be modulate PG 
synthesis. Therefore, for future work, if BsPBP3 is indeed playing a role in the termination of 
the septal PG synthesis then the overexpression of BsPBP3 should cause a delay or a block in 
cell division leading to the formation of longer cells.   
The lipid II flippase EcFtsW interacts with EcPBP3 and recruits it to mid-cell during cell 
division (Derouaux et al., 2008; Fraipont et al., 2011; Mohammadi et al., 2014). EcPBP3 also 
interacts with EcPBP1B and recruits it (Bertsche et al., 2006). Therefore, EcPBP3 is possibly 
recruiting the synthase EcPBP1B to the lipid II substrate at midcell by interacting with EcFtsW 
and EcPBP1B. The interaction between MtPBP3 and MtFtsW in Mycobacterium tuberculosis 
was also observed suggesting that the interaction of the lipid II flippase with a cognate PBP is 
conserved across several bacterial species. In B subtilis, the recruitment of BsFtsW to midcell 
is interdependent on the localisation of BsPBP2B and FtsL (Gamba et al., 2016). Moreover, 
BsPBP2B interacts with BsFtsW (Richard Daniel, unpublished). Therefore, perhaps the non-
catalytic domain of BsPBP2B is essential in B. subtilis due to its role in the recruitment of cell 
division proteins to midcell where the lipid II is being delivered by BsFtsW. Hence, the inability 
of BsPBP3 to complement the loss of BsPBP2B may be caused by the absence of interaction 
with the flippase BsFtsW or other essential cell division proteins such as FtsL or DivIC.   
B. subtilis has four class A PBPs, PBP1, PBP2c, PBP4 and PBP2d (Section 1.3.1). Cells lacking 
the four class A PBP were viable and an unknown GTase activity in this quadruple mutant was 
detected (McPherson and Popham, 2003). Recently, RodA, a presumed lipid II flippase, was 
suggested to be the missing GTase and responsible for PG synthesis in the quadruple mutant 
(Meeske et al., 2016). This hypothesis was based on the ability of the RodA overexpression to 
alleviate the growth and morphology defects of the quadruple mutant. Partially purified RodA 
showed weak PG polymerization activity, however, the purity of the protein was low which 
makes it unclear whether the detected activity was from RodA or a contaminant. Another paper 
by the same group suggested that EcFtsW has a similar GTase activity to RodA and proposed 
the cytoskeleton-directed SEDS/bPBP (class B PBPs) model for PG synthesis highlighting the 
separation of labour between the class A PBP system and the SEDS/bPBP system in E. coli 
(Cho et al., 2016). In B. subtilis, the localisation of BsPBP1 is dependent on the presence of  
BsPBP2B and our results shows that class A BsPBP1 interacts with two class B BsPBP2B and 
BsPBP3 (Scheffers and Errington, 2004). Therefore, these results suggest a collaboration 
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between class A and B PBPs and SEDS proteins to synthesise the PG regardless of being SEDS 
being glycosyltransferases or not.  
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5 Characterization of the role of YrrL  
5.1 Introduction 
A synthetic lethal screen for regulators of the PG synthase PBP1B in E. coli identified a 
membrane bound potential lytic transglycosylase, MltG (Yunck et al., 2016). MltG interacted 
with PBP1B by bacterial two-hybrid assay and was described as a terminase for peptidoglycan 
polymerization in E. coli (Yunck et al., 2016). Since MltG is suggested to be part of a conserved 
lytic transglycosylase enzyme family, a sequence comparison was conducted using the 
SubtiList web address (http://genolist.pasteur.fr/SubtiList/) in search for a B. subtilis 
homologue. A hypothetical protein, named YrrL, with a YceG-like superfamily domain was 
identified with 32% amino acid sequence identity and 50% similarity to MltG (Figure 3.53). To 
characterize the role of YrrL the corresponding gene was deleted and the effect of such deletion 
on cell morphology was studied using fluorescence microscopy. A homologue for YrrL, YocA, 
was also identified within the B. subtilis proteome and was suggested to have the YceG-like 
superfamily domain. YocA showed 23.8% amino acid sequence identity and 55.8% similarity 
to YrrL. To characterise the potential role of YrrL in PG synthesis or hydrolysis, the full length 
protein was purified and tested in vitro. YrrL was tested for interaction with PBP1 or PBP2B 
using in vitro crosslink/pull-down assays and SPR. The effects of such interactions on the 
GTase and TPase activities of PBP1 were also characterised using various enzymatic assays.  
 
5.2 The effect of yrrL or yocA deletions on cell morphology 
To study the effect of the absence of YrrL on cell morphology, the yrrL gene was replaced with 
an erythromycin resistance cassette in the 168CA strain, and the morphology of the mutant was 
characterised using fluorescence microscopy. The loss of YrrL had no effect on the cell 
morphology during vegetative growth when grown in nutrient rich media at 37˚C (Figure 3.48). 
The effect of yocA deletion on cell morphology was also studied using florescence microscopy. 
The ΔyocA mutant had a similar morphology to 168CA with an occasional mild chaining 
phenotype during exponential phase suggesting a delay in cell separation (Figure 3.48).   
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5.3 The effect of the double deletion of yrrL and yocA on the cell morphology 
Cells lacking either yrrL or yocA had similar morphology to wild type cells. Thus, a strain 
lacking both genes, yrrL and yocA, was constructed and morphologically characterised using 
fluorescence microscopy. Cells lacking both genes were viable and the majority of the cells had 
a similar morphology to wild type cells (Figure 3.49 A). However, a few cells (10% of cells) 
were bloated or wider than 168CA cells (Figure 3.49 B). Bulges were also observed at the cell 
periphery and sometimes even lysis. Using fluorescence microscopy with a membrane stain 
showed white foci along the periphery of the cell (Figure 3.49 B). These results suggest that the 
deletion of yrrL and yocA causes alterations in the membrane integrity which occasionally leads 
to cell lysis.  
 
 
 
 
 
 
ΔyrrL ΔyocA168CA
Figure 3.48 Morphology of 168CA, ΔyrrL or ΔyocA mutants 
Phase contrast and cell membrane stained images of 168CA, ΔyrrL or ΔyocA mutants. ΔyrrL or ΔyocA 
cells had similar morphology to wild type cells, with ΔyocA having a mild chain morphology. Scale 
bars: 4 µm. 
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5.4 Purification of YrrL 
The TMHMM server (http://www.cbs.dtu.dk/services/TMHMM-2.0/) predicted that YrrL, 
similar to MltG, has a transmembrane helix (Sonnhammer et al., 1998). The use of the SignalP 
prediction server (http://www.cbs.dtu.dk/services/SignalP/) did not identify an amino acid 
sequence recognised by peptidases suggesting that YrrL, like MltG, is a membrane bound 
protein (Petersen et al., 2011). Based on this prediction, yrrL was cloned into an expression 
plasmid pET28(a)+ using ligase free cloning (sections 2.6.2). E. coli BL21(DE3) cells were 
used for the expression of YrrL with an N-terminal hexahistidine tag (His-YrrL). Cells were 
harvested and YrrL was purified from the solubilised membrane fraction using affinity 
chromatography and ion exchange chromatography (section 2.10.7). Affinity chromatography 
using Ni-NTA was first performed to purify His-YrrL (Figure 3.50 A). The hexahistidine tag 
was removed using thrombin. The second purification step consisted of ion exchange 
chromatography. Protein Calculator v3.4 predicted YrrL to have a  positive charged of +18.3 at 
pH 6.0. Thus, a HiTrap SP HP column was used to further purify YrrL. Samples were dialysed 
to pH 6.0 which promoted the binding of YrrL to the column followed by the elution of the 
protein using a gradient of elution buffer with 1 M NaCl and pH 7.5. Collected fractions from 
the two chromatography steps were analysed by SDS-PAGE (Figure 2.50 A and B). Typically, 
2.3 mg of YrrL per litre of culture was obtained.  
 
 
ΔyrrL ΔyocA
A B
Figure 3.49 Morphology of 168CA Δyrrl ΔyocA cells 
Phase contrast and cell membrane stained images of 168CAΔyrrl ΔyocA mutant. The majority of cells 
had similar morphology to 168CA (A). However, we observed few cells to have a mildly bloated shape 
(B). Membrane stain showed white foci along the periphery suggesting cell lysis. Scale bars: 4 µm. 
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5.5 YrrL had no activity against PG  
MltG is a potential lytic transglycosylase with a weak endoglycosidase activity (Yunck et al., 
2016). The activity of YrrL was tested against PG from B. subtilis cells at pH 7.5 or 5, in the 
presence of 20 or 150 mM NaCl, and with or without MgCl2 and CaCl2. After overnight 
incubation with PG at 30 or 37˚C, samples were pelleted and the supernatant was reduced and 
analysed by HPLC. However, no muropeptides were detected suggesting that YrrL has no 
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Figure 3.50 Purification of YrrL 
SDS-PAGE analysis shows the fractions of YrrL purification steps. Gels were stained with Coomassie 
blue 
(A) IMAC purification of His-YrrL. S, soluble fraction; Ap, applied fraction; FT, flow-through; M, 
Protein size marker (Fermentas PageRuler); W1-W3, wash fractions; E1-E3, elution fractions. The 
theoretical molecular weight of His-YrrL is 46 kDa. 
(B) IEX of the purified YrrL after thrombin cleavage. M, Protein size marker; the bands in E3 to E10 
fractions with an apparent molecular weight of 44 kDa correspond to YrrL. The bands above the marker 
and YrrL are gel artefacts due to unknown reasons.  
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activity on PG under the conditions tested. Since MltG is potentially interacting with the cell 
division synthase PBP1B in E. coli, the activity of YrrL was tested in the presence of B. subtilis 
PBP1, PBP2B and PBP3. As before, the supernatant from samples containing YrrL and one or 
multiple PBPs with B. subtilis PG were analysed by HPLC. However, no muropeptides were 
detected in all samples tested suggesting the absence of muropeptides released into the 
supernatant. Hence, YrrL showed no activity against tripeptide-rich PG isolated from 168CA 
cells. The activity of YrrL was also tested against pentapeptide rich PG isolated from 168CA 
ΔdacA mutant cells, but no activity was observed. These results suggest that YrrL is inactive in 
vitro against B. subtilis PG under the conditions tested.  
 
5.6 YrrL interacts with PBP1 
MltG presumably interacts with the PG synthase PBP1B in E.coli (Yunck et al., 2016). YrrL 
was tested for interaction with the cell division PG synthase, PBP1, by SPR and pull-down 
experiments using purified PBP1 and YrrL. First, an in vitro pull-down experiment was 
performed using Ni-NTA to test if a hexahistidine-tagged YrrL (His-YrrL) retains PBP1 
(section 2.10.1) and formaldehyde was used to stabilize possible weak interactions. SDS-PAGE 
analysis shows that His-YrrL bound to Ni-NTA and PBP1 was not retained by the beads in the 
absence of His-YrrL (Figure 3.51 A). PBP1 in the presence of His-YrrL appeared in both the 
applied and bound fractions suggesting that His-YrrL was able to pull down PBP1 indicating 
an interaction between the two proteins.   
The interaction between PBP1 and YrrL was investigated using SPR as a second method 
(section 2.10.2). First, ampicillin was immobilized to the sensor chip followed by the covalent 
binding of PBP1 via its TPase domain. The remaining free ampicillin was digested with β-
lactamase followed by a 1 M NaCl buffer wash of the chip surface. A surface without PBP1 
was prepared in the same way as a control. YrrL molecules were injected over the PBP1-surface 
and the control surface at concentration 500, 250, 125, 62.5 and 31.2 nM. Sensorgrams 
representing both surfaces showed a strong increase in signal during association upon YrrL 
injection. The PBP1-surface showed slightly higher signal than the control surface (Figure 3.51 
B). The signals for the PBP1-surface minus the control for YrrL injected at 250 and 500 nM 
overlapped suggesting a saturation of binding (Figure 3.51 C). The high signal over the control 
surface is caused by the unspecific binding of YrrL to the chip surface. Thus, further 
optimization of the condition is essential to decrease the signal generated by YrrL over the 
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control surface. Otherwise, an alternative method need to be used to confirm the interaction 
between the two proteins.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.51 Interaction of PBP1 with YrrL by in vitro crosslink / pull-down and SPR 
(A) Ni-NTA pull-down used to test if PBP1 and YrrL directly interact. Coomassie stained SDS-PAGE 
analysis for the His-YrrL and PBP1 sample shows both proteins in the applied and bound fractions 
suggesting that His-YrrL retained PBP1. His-YrrL efficiently bound to the bead and PBP1 was not 
pulled down in the absence of His-YrrL. A, Applied; B, bound fractions.  
(B) SPR sensorgrams showing the signal generated by the injection of Yrrl over the PBP1-surface or 
the control surface at concentration 31.2, 62.5, 125, 250 and 500 nM. The high signal on the control 
surface is caused by the unspecific binding of YrrL to the chip surface.     
(C) SPR sensorgram showing the response for the PBP1-surface minus control. The binding levels 
saturated at 250 nM injected YrrL concentration. 
BA
His-YrrL
+ PBP1
BA
His-YrrL
BA
PBP1
500 nM
250 nM
125 nM
62.5 nM
31.2 nM
0 nM
Time (s)
R
es
p
o
n
se
 (
R
U
)
Time (s)
R
es
p
o
n
se
 (
R
U
)
B
A
ControlPBP1-surface
200
400
-200 200 400 600 8000
0
200
400
-200 200 400 600 8000
0
PBP1
His-YrrL
Time (s)
R
es
p
o
n
se
 (
R
U
)
40
80
-200 200 400 600 8000
0
PBP1-surface
(Minus control)
C
145 
5.7 YrrL had no effect on the GTase activity of PBP1  
A GTase assay was used to study the activity of YrrL against dansyl-lipid II and the effect of 
YrrL on the GTase activity of PBP1. The fluorescence signal was monitored using a 
spectrophotometer. Based on DNA sequence analysis, YrrL is a lytic-transglycosylase and 
lacks a GTase domain. Consistent with this, no decrease in fluorescence was observed for YrrL 
alone, suggesting the absence of activity against lipid II (Figure 3.52). PBP1 with YrrL showed 
a similar decrease in fluorescence to PBP1 alone suggesting that YrrL has no effect on the 
GTase activity of PBP1.  
 
 
 
 
 
 
 
 
 
 
5.8 YrrL reduces the TPase activity of PBP1  
The activity of YrrL against radio-labelled lipid II and the effect of YrrL on the TPase activity 
of PBP1 was studied using the in vitro PG synthesis assay (section 2.11.4). YrrL alone had no 
activity against lipid II (Figure S5). The relative percentage of peptides in crosslinks decreased 
10.9% in samples containing YrrL and PBP1 compared to samples with PBP1 alone (Figure 
3.53). The activity of PBP1 and YrrL was also studied in the presence of 168CA PG or ΔdacA 
PG. A decrease of 7.5 and 5.0% in levels of peptides in crosslinks was identified for PBP1 with 
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Figure 3.52 The effect of YrrL on the GTase activity of PBP1 
The diagram represents the GTase activity of PBP1, PBP1 with YrrL or YrrL alone. A decrease in 
fluorescence suggests the presence of a GTase activity. YrrL alone has no activity against lipid II and 
has no effect of the GTase activity of PBP1. Values represent the mean ± standard deviation of three 
independent experiments. 
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YrrL compared to PBP1 alone in the presence of 168CA or ΔdacA PG, respectively. These 
results suggest that YrrL reduces the TPase activity of PBP1 in the presence or absence of PG. 
Moreover, the HPLC chromatogram representing the radioactive signal for muropeptides 
produced by PBP1with YrrL showed a small unknown peak (Figure S5). The peak eluted at 64 
min on a reversed phase column and represented 9.6% ± 0.5 of the total muropeptides. A similar 
peak was identified for PBP1 with YrrL in the presence of 168CA or ΔdacA PG. Due to the 
low levels of the unknown product in the aforementioned reactions, we were not able to identify 
the chemical structure of this component by mass spectrometry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.53 YrrL reduces the TPase activity of PBP1  
The level of cross-linked peptides in PG produced by PBP1 alone or PBP1 with YrrL in the presence 
or absence of 168CA or ΔdacA PG. The levels of muropeptides in crosslinks for PBP1 with YrrL 
significantly decreased compared to PBP1 alone suggesting that YrrL reduces the TPase activity of 
PBP1 in the presence or absence of PG. *, P<0.05; **, P<0.01 
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5.9 PBP2B interacts with YrrL  
To test if YrrL interacts with the class B PBP2B, pull-down assays and SPR were performed 
using purified YrrL and PBP2B. First, in vitro pull-down assays were used with Ni-NTA to test 
if His-YrrL retains PBP2B. Formaldehyde (0.2%) was used to stabilise possible weak 
interactions. For controls, beads were incubated with His-YrrL or PBP2B alone. SDS-PAGE 
analysis shows that His-YrrL bound to Ni-NTA and PBP2B was not pulled down by the beads 
in the absence of His-YrrL (Figure 3.54 A). PBP2B in the presence of His-YrrL appeared in 
both the applied and bound fractions suggesting that His-YrrL pulled down PBP2B. These 
results indicate that PBP2B interacts with YrrL.   
SPR was used as a second method to study the interaction between YrrL and PBP2B and 
determine the interaction KD. Ampicillin was immobilized to the sensor chip, followed by the 
covalent binding of PBP2B. The remaining free ampicillin was digested with β-lactamase, 
followed by a 1 M NaCl buffer wash of the chip surface. As a control, a surface without PBP2B 
was prepared in the same way. YrrL was injected at concentration 500, 250, 125, 62.5 and 31.2 
nM and the responses were recorded. An increase in the signal was observed upon the injection 
of YrrL over both surfaces during association (Figure 3.54 B). However, at equilibrium, the 
signal for the PBP2B surface was significantly higher than the control surface followed by a 
decrease in both signals during dissociation. The signal for the PBP2B-surface minus the 
control did not show saturation of binding at the injected PBP2B concentrations (Figure 3.54 
C). Although higher concentrations of injected YrrL are required to reach saturation, the SPR 
and the binding curves suggests that YrrL interacts with PBP2B.  
The KD of the interaction was calculated using SigmaPlot software based on the assumption of 
one interaction site with YrrL. The response values (RU) at equilibrium during the association 
phase were plotted against analyte concentrations (nM) to generate the binding curve (Figure 
3.54 D). The KD of the interaction of PBP2B with PBP3 was 101.6 ± 11.6 nM calculated from 
three independent experiments.  
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Figure 3.54 Interaction of PBP2B with YrrL by SPR and in vitro crosslink/pull-down  
(A) Pull down experiment performed to test if PBP2B and His-YrrL interact. Coomassie stained SDS-
PAGE analysis for the His-YrrL and PBP2B sample shows both proteins in the applied and bound 
fractions suggesting that His-YrrL retained PBP2B. His-YrrL efficiently bound to the bead and PBP2B 
was not pulled down in the absence of His-YrrL. A, Applied; B, bound fractions.  
(B) SPR sensorgrams showing the response for YrrL when injected over a surface with immobilized 
PBP2B or a control surface at concentrations 25, 50, 100, 300 and 500 nM. The PBP2B-surface 
exhibited a higher signal than the control surface during association suggesting an interaction between 
PBP2B and YrrL.  
(C) SPR sensorgram showing the response for the PBP2B-surface minus control. The saturation of 
binding was not achieved at the injected YrrL concentrations.  
The response values during equilibrium were plotted against the injected YrrL concentrations. 
The KD of the PBP2B-YrrL interaction was determined by non-linear regression using Sigma Plot 
software. The value is the average KD ± standard deviation of three independent experiments. 
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5.10 Conclusions and discussion 
MltG from E. coli (EcMltG) was proposed to be have an endolytic transglycosylase activity 
based on its ability to hydrolyse bonds at internal positions within the glycan polymer (Yunck 
et al., 2016). YrrL is the B. subtilis homologue of the lytic transglycosylase (LT) EcMltG, 
however, YrrL showed no activity against PG from wild-type cells or the ΔdacA mutant 
irrespective of the presence or absence of cell division PBPs. Therefore, it remains a conundrum 
what the activity of YrrL is and/or what activates it in the cell. The comparison of the amino 
acid sequence of YrrL and Lmo1499, a membrane bound lytic transglycosylase from Listeria 
monocytogenes (LmMltG), showed 67% similarity and 50% identity between the two proteins 
(Figure 3.55). EcMltG was also described to have high similarity with LmMltG, and both 
proteins featured a LysM domain, which is known to be involved in PG binding, and a catalytic 
domain close to the C-terminus of the protein (Figure 3.56) (Buist et al., 2008). Moreover, the 
LysM domain of YrrL had 49% sequence identity to the LysM domain of LmMltG. This 
sequence homology appears at the N-termini of both LTs close to the transmembrane domain 
region of the protein (Figure 3.55 and 3.56). These results suggest that the LysM domain of 
YrrL perhaps binds to the newly synthesised glycan strand in close proximity to the cytoplasmic 
membrane.  
Pulse chase studies indicated that the formation of the anhydroMurNAc sugar by LT enzymes 
occurs shortly after lipid II polymerization (Burmant and Park, 1983; Glauner and Höltje, 
1990). This result suggests that LT enzymes exist in close proximity to PG synthases or as part 
of the PG synthesis machinery. Moreover, EcMltG interacts with PBP1B by bacterial two-
hybrid (Yunck et al., 2016). Consistent with these results, YrrL interacts with two cell division 
synthases PBP1 and PBP2B. Moreover, the interaction between YrrL and PBP1 had no effect 
on the GTase activity of the synthase, however, YrrL significantly reduced the TPase activity 
of PBP1. These results suggest that lytic transglycosylases like YrrL and MltG might modulate 
PG synthesis not only through their catalytic activities but also by regulating the activities of 
PG synthases.  
The absence of MltG from S. pneumoniae cells caused a round cell morphology, suggesting a 
role in cell elongation (Tsui et al., 2016). Conversely, the interaction of EcMltG with the cell 
division synthase EcPBP1B suggests that MltG is part of the cell division machinery. In B. 
subtilis, YrrL interacted with the cell division synthase BsPBP2B, however, the absence of both 
YrrL and YocA resulted in occasionally bloated cells and bulges at the lateral cell wall. 
Therefore, based on the existing results it is not clear what role YrrL plays in B. subtilis.  
150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.55 Amino acid sequence alignment for L. monocytogenes MltG and YrrL     
The amino acid sequence analysis for LmMltG and YrrL showed 67% similarity and 50% 
identity between the two proteins. The amino acid sequence analysis of the LysM domain 
(Black Square) of YrrL and LmMltG identified 41% identity and 63% similarity. *, highly 
conserved residues within the LysM domain. †, MltG active site 
Figure 3.56 The crystal structure of MltG from L. monocytogenes 
Cartoon representation of the structure of LmMltG (Lmo1499) from the PDB data base (PDB 
ID: 4IIW) (http://www.rcsb.org/pdb/home/home.do). 180˚ rotation of LmMltG structure along 
the Y axis. The active site is in red and the LysM domain is in green. Blue arrows indicate the 
N- or C-terminus of the protein.  
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 Association between PG synthases and lytic transglycosylases 
Koch and Doyle proposed the inside-to-outside model for PG growth in Gram-positive cells 
(Koch and Doyle, 1985). In their model, the synthesis of new PG material occurs at the 
innermost layer of the sacculus close to the cytoplasmic membrane whereas the hydrolysis of 
the PG happens at the outermost layer. The PG protects the cell from rupture and maintains cell 
shape hence, its enlargement must occur by a safe mechanism to avoid defects that could lead 
to lysis. Despite progress made in the understanding of PG growth, the molecular mechanisms 
of cell wall growth are largely unknown particularly in Gram-positive bacteria. B. subtilis has 
at least five hypothetical lytic transglycosylases (YomI, SleB, CwlQ, YuiC and SleC) only 
known to play roles in the lysis of the spore cortex for germination (Kumazawa et al., 2007; 
Quay et al., 2015; Smith et al., 2000; Sudiarta et al., 2010). Recently, Bernhardt and colleagues 
identified a potential membrane bound LT with endo-lytic activity in E. coli named MltG that 
interacts with the PG synthase EcPBP1B (Yunck et al., 2016). The absence of MltG resulted in 
increased average length of the glycan strand suggesting a role in chain length determination. 
Moreover, EcPBP1B interacts with the lytic transglycosylase MltA via the scaffold protein 
MipA (Vollmer et al., 1999). Slt, another LT from E. coli, selectively interacted with PBP3 and 
PBP7/8 supporting a multi-protein model that includes both synthases and hydrolases (Romeis 
and Höltje, 1994). As shown in this work, the lytic transglycosylase homologue from B. subtilis 
YrrL interacted with the class A and B PG synthases PBP1 and PBP2B. Moreover, YrrL 
modulated the TPase activity of the synthase PBP1 in the presence or absence of PG. The lack 
of enzymatic activity and the limited knowledge about YrrL made it challenging to understand 
the role of such a protein in PG synthesis. However, based on our current knowledge, we 
propose that hypothetical LT enzymes in B. subtilis may not only be associated with lysis of 
the spore cortex but also with PG synthesis complexes. However, more experimental evidences 
are required to characterize the function of YrrL in the cell.  
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Table S1  List of primers used in this study 
Name 
Restriction 
site 
5’-3’ sequence Reference/comment 
AG124 - CCATCATCTGGTGCGAAAGG ponA seq F 
AG125 - CCGCAAAGCCGATTAATTGG ponA seq R 
JS01 - AAGCACACGCAGGTCATTTG 
Check for integration into 
aprE 
JS02 - CCATCCGTCGATCATGGAAC 
Check for integration into 
aprE 
JS05 SalI 
CGGTCGACGCTTGTTGTTGAT
TACATTGAGGTG 
5’ ugtP (construction of 
pJS01) 
JS06 SphI 
CTGCATGCCGTATGCTCTCAA
GTACGCC 
3’ ugtP (construction of 
pJS01) 
JS07 BamHI 
GTGGATCCGTGACAGAGGCA
CCCGCTTC 
5’ pgcA (construction of 
pJS02) 
JS8 SacI 
GCGAGCTCAGCCGGATCATTT
ACAATGAC 
3’ pgcA (construction of 
pJS02) 
JS09 SalI 
GAGTCGACCGATCATAAGGA
AGGTGC 
5’ gtaB (construction of 
pJS03) 
JS10 EcoRI 
GTGAATTCGCCGTTGATCAGG
TCTTCGCAG 
3’ gtaB (construction of 
pJS03) 
JS17 - 
GTGGCGACAGATTACGTGAA
GG 
5’ ugtP for sequencing 
JS18 - 
TTGCTTGGATGAGTGCCGATC
TCCAG 
3’ ugtP for sequencing 
JS19 - 
CTCCACTGTTACATCGCCGAA
CC 
5’ pgcA for sequencing 
JS20 - 
TCGCGTTTACCTGCTCAATGA
C 
3’ pgcA for sequencing 
JS35 - 
TCCGTTTCCCGCATCTCAGCC
TC 
5’ ponA upstream 
(construction of JS06) 
JS36 - 
CCGTTCCCAAGACTGTTAAAC
C 
3’ ponA downstream 
(construction of JS06) 
JS43  
GAAAGCGCCCTTTCCGATATT
AC 
5’ gtaB upstream 
(construction of JS07) 
JS46  
CCTCTTCCAAAGTAATATCGA
CACATGC 
3’ gtaB downstream 
(construction of JS07) 
JS49 - ACCACCAGTGATTATGCC 
Check for integration in 
amyE (5’) 
JS50 - 
CCGCTCGCCATGACTTCACTA
AC 
Check for integration in 
amyE (3’) 
180 
JS51 XbaI 
TCTAGAACGCTAGCACCCATT
AGTTCAACAAACG 
Amplification of Cm cassette 
from PCotC-cotC-gfp (5’) 
JS53 BsgI 
CGTGCAGAATTCGTACAGTCG
GCATTATCTC 
Amplification of Cm cassette 
from PCotC-cotC-gfp (3’) 
JS56 - 
GCTCTAGATTTCGGTAATCAG
CTCATCAAG 
5’ ponA downstream 
(construction of JS06) 
JS57 XbaI 
GCTCTAGATCACGGCTGTTAA
ATTGATCTG 
3’ ponA upstream 
(construction of JS06) 
JS59 NdeI 
GCGCCATATGTTAAAAAAGTG
TATTCTACTAGTATTTCTATGC
GTCGGATTG 
5’ pbpC (construction of 
pJS05) 
JS60 BamHI 
GCGGATCCTAGTTCATTCGGC
CTCAGATCCC 
3’ pbpC (construction of 
pJS05) 
JS63 NdeI 
CGCATATGTGGGATCGCATGG
AAGCATTCGTGAAAC 
5’ pbpC (construction of 
pJS06) 
JS67 XbaI 
CGCTCTAGAAAGACGGTTCGT
GTTCGTGCTGAC 
Amplification of erm cassette 
from pMUTIN4 (5’) 
JS68 EcoRI 
CGCGAATTCAGCTCCTTGGAA
GCTGTCAGTAG 
Amplification of erm cassette 
from pMUTIN4 (3’) 
JS69 XbaI 
CGCTCTAGAAGCCTGCTGCTG
GAATTATGGCTTTACG 
3’ gtaB upstream 
(construction of JS07) 
JS70 EcoRI 
CAGGAATTCGCTCTTCATTAT
CAACTGCGAAGAC 
5’ gtaB downstream 
(construction of JS07) 
JS79 - CAAGCAGCTGGCTGACGAC pbpC internal for sequencing  
JS80 - AGGACGGCGAGGATCTTCAC pbpC internal for sequencing 
JS81 - CCCGATCCAGAAATCGTC pbpC internal for sequencing 
JS82 - 
CCCTACAGTGTTATGGCTTGA
ACAATC 
5’ Phy-spank for pDR111 
JS83 - 
CCCTACAGTGTTATGGCTTGA
ACAATC 
3’ amyE for pDR111 
JS84 NheI 
GCGCTAGCCGCATGATTCAAA
TGCCAAAAAAG 
5’ pbpB (construction of 
pJS07) 
JS85 BamHI 
GGATCCGCGGTAGAACGATG
CTCCTCTGAAG 
3’ pbpB (construction of 
pJS07) 
JS88 - GTCTGTGCTTGAGGATAAGG lytE upstream  
JS89 - GATCCGTTTGCGTGTTTC lytE downstream  
JS90 - 
CCCGCTCCCGACATTCCAGTT
ATAATGAC 
cwlO upstream 
181 
JS91 - 
GTTAATGGCTTCCCATGGCCT
TTACC 
cwlO downstream 
JS93  GGTGATTGTAATGAAGCTCAG 3’ ugtP  downstream 
JS94 NheI 
CGGCTAGCTGTATTCAAATAA
CCGGAAAAGCGAACGGCGAA
G 
5’ pbpB (construction of 
pJS08) 
JS95 - 
AAGCGACAAATCCGGCTGGG
AG 
pbpB internal for sequencing 
JS98 - GTGGCAGCAGCCAACTCAG 5’ PT7-promotor for pET-28a(+)  
JS99 - GCCACGATGCGTCCGGCGTAG 3’ PT7-terminator for pET-28a(+) 
JS100 EagI 
GAACGGCCGAGCTCCTTGGA
AGCTGTCAGTAG 
Amplification of erm cassette 
from pMUTIN4 (3’) 
JS101 - CTGCGAGAGAACACCTTGAC 
5’ S827 upstream 
(construction of JS32) 
JS102 XbaI 
CGTCTAGAACGCCATTACGAT
AGCAC 
3’ S827 upstream 
(construction of JS32) 
JS103 EagI 
CACGGCCGATATTCAGCCATC
AATAAAAGCGGTTAC 
5’ S827downstream 
(construction of JS32) 
JS104 SphI 
GAGCATGCCCGTCAAGTTGCG
AAACGGCTTAT 
3’ ugtP (construction of 
pJS04) 
JS128 - 
ATGGCTAGCATGACTGGTGGA
C 
5’ to amplify pET-28a(+) for 
ligase free cloning 
JS129 - 
ATGGCTGCCGCGCGGCACCA
G 
3’ to amplify pET-28a(+) for 
ligase free cloning 
JS130 - 
CTGGTGCCGCGCGGCAGCCAT
ATGCCAAAAAAGAATAAATT
TATGAATAGAG 
5’ pbpB* (construction of 
pJS09) 
JS131 - 
TGTCCACCAGTCATGCTAGCC
ATGCCTGCATAACGACGGCTT
TC 
3’ pbpB* (construction of 
pJS09) 
JS132 - 
CTGGTGCCGCGCGGCAGCCAT
ATGTTAAAAAAGTGTATTCTA
CTA 
5’ pbpC* (construction of 
pJS10) 
JS133 - 
TGTCCACCAGTCATGCTAGCC
ATGTTCATTCGGCCTCAGATC
CC 
3’ pbpC* (construction of 
pJS10) 
JS134 - 
CTGGTGCCGCGCGGCAGCCAT
ATGTATATCAATCAGCAAAAA
AAATCG 
5’ yrrL (construction of 
pJS11) 
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JS135 - 
TGTCCACCAGTCATGCTAGCC
ATGCGGAAAGCGAACAAAAG
GAGAG 
3’ yrrL (construction of 
pJS11) 
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Figure S1 HPLC chromatograms corresponding to Figure 3.39 and 3.40 
HPLC analysis of new peptidoglycan synthesised by PBP1 alone, PBP1 with PBP3, PBP1 with PBP3* 
or PBP3 alone. Muropeptide peaks are annotated as in Figure 2.5. 
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Figure S2 HPLC chromatograms corresponding to Figure 3.39 and 3.40 
HPLC analysis of new peptidoglycan synthesised by PBP1 alone, PBP1 with PBP3 or PBP1 with 
PBP3*, in the presence of PG from 168CA cells or ΔdacA mutant. Muropeptide peaks are annotated as 
in Figure 2.5. 
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Figure S3 HPLC chromatograms corresponding to Figure 3.44 (A) and (B) 
HPLC analysis of new peptidoglycan synthesised by PBP1 alone, PBP1 with PBP2B, PBP1 with 
PBP2B* or PBP2B alone. Muropeptide peaks are annotated as in Figure 2.5. 
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Figure S4 HPLC chromatograms corresponding to Figure 3.44 (A) and (B) 
HPLC analysis of new peptidoglycan synthesised by PBP1 alone, PBP1 with PBP2B or PBP1 with 
PBP2B*, in the presence of PG from 168CA cells or ΔdacA mutant. Muropeptide peaks are annotated 
as in Figure 2.5. 
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Figure S5 HPLC chromatograms corresponding to Figure 3.53 
HPLC analysis of lipid II or of new peptidoglycan synthesised by PBP1 alone, PBP1 with YrrL or YrrL 
alone. Muropeptide peaks are annotated as in Figure 2.5. The muropeptide of Peak number 7 is 
unknown. 
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Figure S6 HPLC chromatograms corresponding to Figure 3.53 
HPLC analysis of new peptidoglycan synthesised by PBP1 alone or PBP1 with YrrL, in the presence 
of PG from 168CA cells or ΔdacA mutant. Muropeptide peaks 1-6 are annotated as in Figure 2.5. The 
muropeptide of Peak number 7 is unknown. 
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